Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
52 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ÃËFò£ò⹠2 MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠Ãó£ÅâC, «ê£î¬ù, èŸHËîâ¢, à ŸðËF (MôÆ° èO¡ ðò¡ð£´) ÃAòõŸP⢠ÃÅõè MôÆ°èO¡ º¬ø ò£ù ðó£ñKŠ¹, ðò¡ð£ì£ù¶ MôÆ°èO¡ «î¬õèÅ, ÃõŸP¡ ðò¡ð£´, «ï£âè⹠ÃAòõŸP¡ îŠð¬ìJ⢠ÃPMòâ¢, ªî£Nâ¢ÂºÂ¬Ã¸Ë bËÃ±Â£Ã¹Ë Â«Ã®Â¬ÃµÃ¨Â¬Ã·â ê£Ëâ°Ã® î£Aø¶. MôÆ°, è£â¢Ã¯Â¬Ã¬Å ðó£ñKŠ¹, ªè£Å¬èèÅ, ï¬ì º¬øèÅ, ðEò£÷ËèÅ, Fâ ì «ñô£â¡Â¬Ã± à ÅOâ ì MôÆ°èO¡ ïâ¢ÃµÂ£âºMâ¢ Â«Ã¯Ã³Â®Ë Ã®Â£âèË” ãŸð´Ë¶⹠å¼ GÃõùËî£⢠ïìËîŠð´â¹, «ñŸªè£Å÷Šð´â¹, Fâ ì «ñŸð£Ë¬õ, ªî£Nâ¢ÃªÂ£Ë ²è£î£óâ¹, ð£¶è£Š¹, GÃõù MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ´â °¿M¡ (äãC»C) ªêòâ¢Ã°Â£Â´Ã¨Å, MôÆ° õêFâè£ù õ®õ¬ñŠ¹, «ñô£â¡Â¬Ã± à ÅOâ ì ìù˶ ïìõ®â¬èè¬÷»⹠å¼ MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠(ÃQ«ñ⢠Fâ ì⹠âù °PÅ HìŠð´Aø¶) î¡ÃŠªè£â¡Â´Å֦. Ãâ°Ã® ÃËFò£ò⹠åâ ´ªñ£ËÃ®Ë Fâ ìâ¹, ºâAò «ñŸð£Ë¬õŠªð£ÃŠ¹è¬÷ õ¬óòÃâAø¶. ðòÃÅ÷ Fâ ìË” à ¼õ£âè à î¾õîŸè£ù õNè£â ´îâ¢Ã¨Â¬Ã·Â»â¹ õöÆ°Aø¶. 3, 4, 5 ÃËFò£òÆèŠFâ ìâ ÃÃèO¡ MõóÆè¬÷ à Å֓âAò¶: ìõ º¬ø«ò, ²ŸÃâà öâ¢, õ£Nì õêF, «ñô£â¡Â¬Ã±, è£â¢Ã¯Â¬Ã¬Å ðó£ñKŠ¹, ªð÷bè ÞõêF ÃAò¬õò£°â¹. 嚪õ£¼ GÃõùº⹠õNè£â ®â° ãŸð GËõAâèŠð´⹠å¼ Fâ ìËFŸ°Š«ð£¶ñ£ù Ãî£óÆè¬÷ GÃM õöÆ°õ«î£´, ªð£¼â°Ã®âîò MFº¬øèÅ, ªè£Å¬èèÅ, õNè£â ´î⢠èÃâ° ÃÃÆè «õâ¡Â´â¹.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠53 Fâ ìâ¹: MôÆ°, è£â¢Ã¯Â¬Ã¬Å ðó£ñKŠ¹, ªè£Å èÅ, ï¬ìº¬øèÅ, ðEò£÷ËèÅ, Fâ ì «ñô£â¡Â¬Ã± à ÅOâ ì MôÆ°èO¡ ïâ¢ÃµÂ£âºMâ¢ Â«Ã¯Ã³Â®Ë Ã®Â£âèË” ãŸð´Ë¶⹠å¼ GÃõùËî£⢠ïìËîŠð´â¹, «ñŸªè£Å÷Šð´⹠Fâ ì «ñŸð£Ë¬õ, ªî£Nâ¢ÃªÂ£Ë ²è£î£óâ¹, ð£¶è£Š¹, GÃõù MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ´â °¿M¡ (äãC»C) ªêòâ¢Ã°Â£Â´Ã¨Å, MôÆ° õêFâè£ù õ®õ¬ñŠ¹, «ñô£â¡Â¬Ã± à ÅOâ ì ìù˶ ïìõ®â¬èè¬÷»⹠å¼ MôÆ°Šðó£ñKŠ¹ ñŸÃ⹠ðò¡ð£â Â´Ë Fâ ì⹠ªè£â¡Â´Å֦. å¿Æ°º¬øèÅ, ªè£Å¬èèÅ, «è£â ð£´èŠÃÅõè MôÆ°èO¡ ðò¡ð£´ å¡Ãâªè£¡à ªî£ì˹¬ìò, ªêòô£âè⹠ªè£â¡Ã¬ å¿Æ°º¬øèÅ, ªè£Å¬èèÅ, õNè£â ´îâ¢Ã¨Å, ï¬ìº¬øè÷£⢠GËõAâèŠð´Aø¶. MôÆ° ïô MFº¬øèŠ(USDA 1985; US Code, 42 USC 289d) ÃÅõè MôÆ°èO¡ ñQî£Hñ£ù ðó£ñKŠ¹, ðò¡ð£´ °PËî ªð£¶ ²è£î£ó ǐ›â ªè£Å (PHS 2002) à ÅOâ ì ðô êñKâè îŠð¬ìJ ô£ù ïìõ®â¬èèÃâÂ°Ë ÂªÃ®Â£Ã¬Ë¹¬ìò å¿ÆÂ°ÂºÂ¬Ã¸Ë Â«Ã®Â¬ÃµÃ¨Â¬Ã· ÚõNè£â ® èõùËF⢠ªè£ÅAø¶. êñKâè£M⢠Ãâ¢Ã´Â£Ã® GÃõùÆèO⢠ÚõNè£â ®J¡ ðò¡ð£´, ñQî£Hñ£ù ðó£ñKŠ¹ ñŸÃ⹠Êð°FèO⢠ªð£¼â°Ã®âîò ÃÅõè MôÆ°èO¡ ðò¡ð£´ ÂªÃ®Â£Ã¬Ë Ã°Â£Ã¹ ìù˶ MFº¬øè¬÷»⹠H¡ðŸÃõî£èâ 輶Aø¶. «ê£î¬ù, Ãó£ÅâC, ðJŸCJ⢠ðò¡ð´ËîŠð´⹠º¶ªè½â¹Â¹ MôÆ°èO¡ ðò¡ð£´, ðó£ñKŠ¹â è£ù êñKâè ÃóC¡ «è£â ð£´è¬÷»⹠ÚõNè£â ® èÃâA⢠â´Ë¶âªè£ÅAø¶ (äÃËãC- IRAC 1985; H¡ ìʹ à ¬õŠð£Ëâè¾â¹) ñŸÃâ¹ H¡õ¼⹠ªè£Å¬èèÃâ° 効î⢠ÃOâAø¶: MôÆ°èO¡ ðò¡ð£â “â °¬øâè Ãâ¢Ã´Â¶ ñ£Ÿl®Ÿè£ù ñ£Ÿà õNè¬÷â è¼ËF⢠ªè£Åõ¶ (¸â¡ÂµJË Ã¬ñŠ¹èÅ, èEQ à ¼õèŠð´Ë¶îâ¢Ã¨Å Ãâ¢Ã´Â¶ èEî ñ£FKèÅ) · ñQîËèÅ, MôÆ°èO¡ ëó£âAòâ¹, ÃPõ£ËËî «ñâ¹Ã°Â£Â´, êÃèËF¡ ñ ÃAòõŸP¡ îŠð¬ìJâ¢
54 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ï¬ìº¬øèO¡ õ®õ¬ñŠ¹ ñŸÃ⹠ªêòâ¢Fø¡ · ªð£¼Ëîñ£ù ÃùÆèÅ, îóâ¹, MôÆ°èO¡ ââ¡E⏠· êê÷èKòâ¹, ¶¡ðâ¹, õLÂ¬Ã²Ë Ã®MËŠð¶ Ãâ¢Ã´Â¶ °¬øŠð¶ · ªð£¼Ëîñ£ù õL îEŠ¹, õL Gõ£óE, ñòâè ñ¼â°Â¶Å ðò¡ð£´ · ñQî£Hñ£ùI° ÃÃFâ èâ ìË” Gþî⢠· «ð£¶ñ£ù è£â¢Ã¯Â¬Ã¬Å ðó£ñKŠ¹ õöÆ°î⢠· î°Fò£ù ïðËè÷£⢠ÃòâèŠð´â¹, GèâºËîŠð´⹠ªð£¼Ëîñ£ù MôÆ°Š«ð£â°õó˶, õ÷ËŠ¬ð õöÆ°î⢠· î°Fõ£Åâ°Ã®, ÃÃðõ⹠õ£Åâ°Ã® ðEò£÷ËèO¡ ªï¼âèñ£ù «ñŸð£Ë¬õJ¡ W⺠à J¼Å÷ MôÆ°èŠe¶ ðK«ê£î¬ù ïì˶îâ¢. Ãâ «è£â ð£´èÅ, õNè£â ® ðŸPò M÷âèËFŸ°⹠ï¬ìº¬øŠð´Ë¶õâ¹, ÃP¾, G¹Ã˶õâ¹, ÃÃðõâ¹, ªî£Nâ¢ÂºÂ¬Ã¸ ê£Ëâ°Ã® bËñ£ùËFø¡ ÃAò¬õ ǔ›. õNè£â ®, ªî£ì˹¬ìò MFº¬øèÅ, ªè£Å 芫è£â ð£´èÃâ° ãŸð Fâ ìGóâ¢Ã¨Å ªêòâ¢Ã°Â´ËîŠðì «õâ¡Â´â¹. «ñ½â¹, õNè£â Â®Ë Ã®Ã³ÆèO¡ G¬ôò£ù ðò¡ð£â “ à ÃFªêÅõîŸè£è â¿îŠðâ ì ï¬ìº¬ø è¬÷ GÃõ¾â¹, ÚõŠ«ð£¶ ñFŠð£Å¾ ªêÅò¾⹠GÃõùÆèŠáâ°MâèŠð´A¡øù. MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ®¡ ðâ¢Â«ÃµÃ Ãâ¹ÃªÆ芰PËî ôî⢠îèõ⢠èŠÃÅõè MôÆ° Ãó£ÅâC GÃõù⹠(ILAR) ñŸÃâ¹ Hø ìñŠ¹è÷£⢠îò£KâèŠðâ ì Hø ªõOf´èO⢠A“âA¡øù (H¡ ìʹ-Ã). õNè£â ®J⢠à Å÷ Mâ¦Ã«Â£Ã¹â °PŠ¹èŠõNè£â ®J⢠ªè£´âèŠðâ ì ÃPâ¬èè¬÷ ÃîKâ°⹠ôî⢠îèõâ¢Ã¨Â¬Ã· õ£êè¼â° õöÆ°Aø¶. ªõOJìŠðâ ì Mâ¦Ã«Â£Ã¹Å Hó²ó⹠Ãâ¢Ã´Â£Ã® G¬ôJâ¢, õNè£â ®J⢠Cô îèõâ¢Ã¨Å ÃÅõè MôÆ° ÃPMòL⢠𣶠ãŸÃâªè£Å÷Šðâ ì ï¬ì ÂºÂ¬Ã¸Ë Ã®Ã³Â¾Ã¨OL¼â°Â¶ ªðøŠð´A¡øù (ÃËFò£ò⹠- 1 äŠð£Ëâè¾â¹).
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠55 MôÆ° Mâ¦Ã«Â£Ã¹â¹, MôÆ°èO¡ ðò¡ð£´ ÂªÃ®Â£Ã¬Ë Ã°Â£Ã¹ Hó²óÆ芪î£ìËâ°Â¶ à ¼õ£A õ¼õî£⢠ÚõŠ«ð£¬îò îèõâ¢Ã¨Å, ð£¬îò Cøâ°Ã® ï¬ìº¬øèÃì¡ Fâ ìÆèŠÃ–â°F¼âè «õâ¡Â´â¹. Fâ ì «ñô£â¡Â¬Ã± å¼ ðòÃÅ÷ Fâ ìõ¬óM¡ ªð£ÃŠ¹èÅ, ðE芪îOõ£è õ¬óòÃâèŠðì, ìõ å¿Æ°º¬ø, «ñô£ ⡠¬ñ ÃFè £óË¶ì ¡ Ã¥ ¼ Æ A ¬ Ãâ èŠð ì «õâ¡Â´â¹. êñKâè Ãâ ì£â C êâ ìñ£ù¶ GÃõù ÃFè£K (äå), èõQ˶âªè£ÅÃ⹠è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË (ãM), GÃõù MôÆ°Šðó£ñKŠ¹ ðò¡ð£â ´â °¿ (äãC»C) ÃAòõŸPŸ° å¼ êâ ìgFò£ù îŠð¬ì¬ò à ¼õ£â°Aø¶. ÚõNè£â ® «ñŸ ªê£¡ù è¼Ë¶è¬÷ ìù˶ êñKâè£ ñŸÃ⹠êñKâè£ Ãâ¢Ã´Â£Ã® MôÆ°Šðó£ñKŠ¹, Ã°Ã²Ã¹Â£Ã·Ë Fâ ìÆèÃâè£ù ºâAòñ£ù Ãòâèâ ªè£Å¬èè¬÷ ÃÆWèKâAø¶. M ôÆ° Šðòù£÷Ëè ¬÷ «ñ Ÿð£Ë¬ õ J ´ õ¶ ñâ ´ñâ¢Ã´Â£Ã±â¢ ÃõËè¬÷ ÃîKâè¾⹠Ãâ¹Ã¡à ÃÃèÃâA“J⢠Fø¬ñò£ù î¬ô¬ñ˶õº⹠å˶¬öŠ¹⹠ÃõCò⹠(Lowman 2008; Van Sluyters 2008). ôîô£è å¿Æ°º¬ø, GF ºèõË, GÃõù ÃÆWè£ó ìñŠ¹èÃìù£ù ªî£ì˹èŠÃËFâ ìËF¡ Ã¥Â¼Æ A¬Ãâ°Ã® ð°Fò£°â¹. ÃÆ«è ²¼âèñ£è, ÚõNè£â ® º¿õ¶⹠Mõ£FâèŠðâ ìð®, Fâ ìõ¬óM¡ ºî¡¬ñ «ñŸð£Ë¬õŠªð£ÃŠ¹èŠäå, ãM, äãC»C¾ì¡ à Å÷ù. Ã²Â£Ë Ã²Â£Kì⹠ÃPâJ´õ¶ â¡ð¬î à ø¾èÅ, ÃFè£óÆèŠñŸÃ⹠嚪õ£¡P¡ ªð£ÃŠ¹èŠªîOõ£è¾⹠ªõOŠð¬ìò£è¾⹠õ¬ó òÃâèŠðâ ì GÃõùâ èâ ì¬ñŠH⢠ÃõËèO¡ ðE芪ð£¼â°Ã® «õâ¡Â´â¹. ìõ å¡P¬Ãâ°Â¶, ªè£Å¬èèÅ, ï¬ìº¬øè¬÷ GÃM, å¿Æ°º¬ø ÃÃâèË” à ÃFªêÅA¡øù, õ¬óM¡ ªêòâ¢Fø¬ùâ èâ¡Ã¨Â£EâA¡øù, «ñ½⹠à òËîó ÃPMòâ¢, ñQî£H ñ£ù MôÆ°Šðò¡ð£â “ ÃîKâA¡øù. Ãâ°Ã®â
56 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ÃÃè¬÷ à Å֓âAò, ÃõŸP⢠å¼ êñ¡ð£â “ ãŸð´Ë¶⹠Fâ ìñ£ù¶, MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¾, Mâ¦Ã«Â£Ã¹Ë îóËF¡ Iè à òËâ°Ã® îóG¬ôè¬÷ ìì»⹠«ð£¶, õ÷ÆÃ¨Â¬Ã·Ë Føâ¹Ã°Ã¬Å ðò¡ð´Ëî Cøâ°Ã® õ£ÅŠ¬ðâ ªè£â¡Â´Å֦ (Bayne and Garnett 2008; Van Sluyters 2008). Gó⢠«ñô£â¡Â¬Ã±Å ªð£ÃŠ¹ GÃõù ÃFè£K GÃõù ÃFè£K (äå) Fâ ì Gó½âè£ù ÃÃFŠªð£ÃŠ¬ðâ ªè£â¡Â´Å÷£Ë. üŠHÃ⹠åâ ´ªñ£Ëî Fâ ìËF¡ GóL¡ ªêòâ¢Â«Ã¯Â£â° äå, ãM ñŸÃ⹠äãC»C ñËFJ⢠ðAóŠðâ ì ªð£ÃŠð£è üâè «õâ¡Â´â¹. Fâ ìËF¡ å⠴ªñ£Ëîâ ªêòâ¢Fø¬ù à ÃFŠð´Ëî «î¬õò£ù Ãî£óÆè¬÷ å¶âè äå-â° ÃFè£ó⹠à Å֦. Gó⢠«î¬õè¬÷ ã.M., äãC»C, Fâ ìË¶ì¡ ªî£ì˹¬ìò ñŸøõËèŠ(â´Ë¶âè£â ´, ÃìÆèO¡ «ñô£â¡Â¬Ã± áNòËèÅ, ªî£Nâ¢ÃªÂ£Ë ²è£î£ó, 𣶠裊¹ŠðEò£÷ËèÅ, Mâ¦Ã«Â£QèÅ) äå-âÂ°Ë ÂªÃ®Oõ£è ¾⹠ªî£ìËâCò£è¾⹠ªîKMâè «õâ¡Â´â¹. GËõ£èËF¡ ÃËî HóFGFò£è, õ÷ÆÃ¨Â¬Ã·Ë Fâ ìI´õ¶â¹, îóI° MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ®¡ Fâ ì Ãôâ°è¬÷ GÃõùËF¡ «ï£âèÆèÃì¡ Ã¬ÃŠð¬î à ÃFªêÅõ¶ äå-M¡ ªð£ÃŠð£°â¹. GÃõù ÃFè£K: Ã Ã²Ë GËõ£èËF¡ HóFGFò£è, Fâ ìËF¡ ÃÃFŠªð£ÃŠ¬ð õAâAø£Ë. ÃµÃ·Ë Fâ ìIì⢠ñŸÃâ¹ GÃõùËF¡ °Pâ«è£Ãì¡ Fâ ì Ãôâ°è¬÷ å¼ÆA¬ÃŠð¬î à ÃFªêÅõîŸè£ù ªð£ÃŠ¬ðâ ªè£â¡Ã¬ÃµË. èõQ˶âªè£ÅÃ⹠è£â¢Ã¯Â¬Ã¬Ã±Â¼ËÂ¶ÃµË (ãM) ÃÃµË GÃõùËF⢠ðò¡ð´ËîŠð´⹠ìù˶ ÃÅõè MôÆ°èO¡ ëó£âAòËFŸ°â¹, ïâ¢ÃµÂ£âºMŸ°⹠ªð£ÃŠð£ùõË. GÃõùñ£ù¶, ìù˶ MôÆ°èÃâ° ñ£ù «ðµî⢠è£â¢Ã¯Â¬Ã¬Å ðó£ñKŠ¹ Fâ ìË” GËõAŠðîŸè£ù õ÷ÆèŠà â ð슫ð£¶ñ£ù
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠57 ÃFè£óË” ã.M.â° õöÆè «õâ¡Â´â¹. ÚõNè£â ® »ì¡ Fâ ìGó⢠ÃÃÆ°Aøî£ â¡ð¬î à ÃFŠð´Ëî, ã.M. MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ®¡ Hø Ãâ¹ÃªÆè¬÷ «ñŸð£Ë¬õJì «õâ¡Â´â¹ (â´Ë¶âè£â ´: õ÷ËŠ¹, õ£Nì õêF). GÃõù «ï£âèâ¹, Fâ ìËF¡ °Pâ«è£ÅèÅ, GÃÃµÃ¹Ë F⢠MôÆ°Šðò¡ð£â ®¡ ñ, Fâ ì Ã÷¾, º¿«ïó ð°F«ïó ëô£ê¬ù è£â¢Ã¯Â¬Ã¬â «ê¬õ芫î¬õò£ â¡ð¬î bËñ£Qâ°â¹. å¼ º¿«ïó è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË Ã®Ã·ËF⢠A“âèMâ¢Â¬Ã´ â¡ø£â¢, Fâ Ã¬Ë Â«Ã®Â¬ÃµÃ¨Ãâ° ãŸøõ£à ÚõŠ«ð£î£ù ììªõOJ⢠å¼ Ã«ô£ê¬ù Ãâ¢Ã´Â¶ ð°F«ïóâ è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õK¡ ǐ› A“âè «õâ¡Â´â¹. Êð®ò£ù êñòÆèOâ¢, FùêK MôÆ°Šðó£ñKŠ¹, ðò¡ð£´ «ñô£â¡Â¬Ã±â° å¼ Ã¯Ã°Ë ÂªÃ°Â£ÃŠ«ðŸè «õâ¡Â´â¹. ªð¼MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ìÆè¬÷â ªè£â¡Ã¬ GÃõùÆèŠðô è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õËè¬÷Šðò¡ð´Ëî ô£⹠â¡ø£½â¹, è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õâ¹, MôÆ°Šðó£ñKŠ¹, õêF ïìõ®â¬èè¬÷ å¼ GËõ£è Ãô° GËõAŠð¶ ªð¼â¹Ã°Â£Â½â¹ Fâ ìËF¡ ìù˶ Ãâ¹ÃªÆ è¬÷»⹠GËõAŠðîŸè£ù å¼ Fø¬ñò£ù õNº¬ø ò£°â¹. ÃÅ¡ õNè£â ®, êñKâè¡ 裫ôx Ã犫ôð«óâ ìK ÃQñ⢠ªñ®C¡, ACLAM-¾¬ìò â«ð£¶ ñ£ù è£â¢Ã¯Â¬Ã¬ ðó£ñKŠ¹âè£ù õNè£â ´îâ¢Ã¨Ãâ°â (ICLAM 1996) 効î⢠ÃOâAø¶. Ãâ°Ã® õNè£â ´îâ¢Ã¨O⢠ìù˶ MôÆ°èÃâ°⹠è£â¢Ã¯Â¬Ã¬ èõQŠ¬ð õöÆ°îâ¢, ÃõŸP¡ ñ¼Ë¶õŠðF¾èÅ, MôÆ°èŠÃ¼â°⹠õêFèÃâ° õöâèñ£ù è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õK¡ «ê¬õèÅ, ªð£¼Ëîñ£ù Fø¬ñò£ù ñ¼Ë¶õâ¹, «ï£ÅË Ã®Â´Å Â¹, Ãõêóè£ô è£â¢Ã¯Â¬Ã¬Å ðó£ñKŠ¹âè£ù ãŸð£´ èÅ, êâ ìŠð®ò£ù MôÆ°â ªè£Åºî⢠ªêÅõîŸè£ù ìñŠ¹, «ð£â°õó˶ âù ãM-J¡ Hø ªð£ÃŠ¹èŠW«ö à Å÷ Gó⢠«ñŸð£Ë¬õŠHKM½â¹, H¡ÃÅ÷ ÃËFò£òÆèO½⹠«è£®â ´â è£â ìŠðâ ´Å÷ù. å¼ Fâ ì⹠Føâ¹Ã°Ã¬â ªêòâ¢Ã°Ã¬, ã.M, äãC»C Óǘ ªîOõ£ù ªî£ìËâCò£ù ªî£ì˹ üâè «õâ¡Â´â¹.
58 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® GÃõù MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ´â °¿ GÃõùËF¡ Fâ ìâ ÃÃèÅ, õêFèO¡ ñFÅ d´, «ñŸð£Ë¬õâ° äãC»C (Ãâ¢Ã´Â¶ Ãâ êññ£ù) ªð£ÃŠð£°â¹. Ãâ°Ã®Å ªð£ÃŠ¬ð G¬ø«õŸø, ÃŠ«ð£¶ñ£ù ÃFè£óâ¹, õ÷ÆèŠÃ¼âè «õâ¡Â´â¹ (â´Ë¶âè£â ´: áNòËèÅ, ðJŸC, èEQèÅ, ÂªÃ®Â£Ã¬Ë Â¹Â¬Ã¬Ã² à ðèóÃÆèÅ). äãC»C-á ðÆ°, ªêòâ¢Ã°Â£Â´ °PËî MKõ£ù îèõâ¢Ã¨Å Ãâ°Ã® ÃËFò£òËF⢠HŸð°FJ⢠õöÆèŠðâ ´Å÷ù. Ãâ ´ŠðEèŠGÃõùÆèÃâA¬ì«òò£ù Ãâ ´ŠðEèŠMôÆ°Šðó£ñKŠ¹, ðò¡ð£â ®Ÿè£ù ªð£ÃŠ¹ °PËî ªîOõŸø ñè¬÷ à ¼õ£â°⹠Ãòâ¢Â¬Ã°â ªè£⡠´Å֦. MôÆ°Šðò¡ð£´ (MôÆ°Š«ð£â°õóËFŸ° Êð£Ÿðâ ì) êâ¹Ã°â°Ã®Å ðâ ì ÃËî¬èò Ãâ ´ŠðEèO⢠ðƫ蟰⹠GÃõùÆèÃâ° º¬øò£ù, â¿Ë¶ŠÃËõ ¹Kî⢠(â´Ë¶âè£â ´: åŠðâ°Ã®â¹, ¹Kâ°Â¶Ã˾ åŠðâ°Ã®â¹ Ãâ¢Ã´Â¶ å˶¬öŠ¹), ÞâÃìËFŸ° ªõOJ ô£ù MôÆ°Šðó£ñKŠ¹, ðò¡ð£´, MôÆ° à K–, äãC»C ñFŠð£Å¾, «ñŸð£Ë¬õ (AAALAC 2003) ÃAò õŸ¬ø à Å֓âA üâè «õâ¡Â´â¹. ôîô£èŠðƫ蟰⹠GÃõùÆèO¡ äãC»C-CâèŠïìËîŠð´⹠ðEèÃâè£ù ªïPº¬øè¬÷ ñÃÞ, «î˾ ªêÅòô£â¹. ðEÃ²Â£Ã·Ë Â«Ã±Ã´Â£â¡Â¬Ã± ðJŸC»⹠èâ¢M»⹠MôÆ°èO¡ ðó£ñKŠ¹, ðò¡ð£â ´ì¡ ÂªÃ®Â£Ã¬Ë Â¹Â¬Ã¬Ã² ìù˶ŠðEò£÷ËèÃ⹠à òËîó ÃPMò L½⹠MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¬Ãµ à ÃFŠð´Ëî à î¾⹠õ¬èJ⢠ÃÅõè MôÆ° ÃPMòL¡ îŠð¬ìâ ªè£Å¬èèO½⹠«ð£¶ñ£ù Ã÷¾ èâ¢M, ðJŸC, î°F ªðŸP¼âè «õâ¡Â´â¹. å¼ Fâ ìË” ïì˶õ⹠«ñ⹠ð´Ë¶õ⹠«î¬õò£ù ðEò£÷ËèO¡ ââ¡Eâ, î°FèÅ, GÃõùËF¡ õ¬è, îóâ¹, «ð£¶ñ£ù MôÆ°Šðó£ñKŠ¬ð õöÆ°õîŸè£ù GËõ£è ìñŠ¹, ÃìËF¡
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠59 ªð÷bèŠðâ¡Â¹Ã¨Å, ðó£ñKâèŠð´⹠MôÆ°èŠââ¡Eâ, Ãó£ÅâC, «ê£î¬ù, èŸHËîâ¢, à ŸðËF ïìõ®â¬èèO¡ ñ à ÅOâ ì ðô è£óEè¬÷â ê£Ëâ°Â¶Å֦. ðEò£÷ËèŠðJŸCâ° (Anderson 2007) ÃîóõOâ芪ð£¼Ëîñ£ù õêFè¬÷ õöÆ°õ¶ GÃõùÆèO¡ ªð£ÃŠð£°â¹, «ñ½⹠«ñŸð£Ë¬õ õöÆ°õ¶⹠ðJŸCË Fâ ìËF¡ ªêòâ¢Fø¬ù ñFÅ H´ õ¶⹠äãC»C-¡ ªð£ÃŠð£°⹠(Foshay and Tinkey 2007). ìùËÂ¶Ë Fâ ìŠðEò£÷ËèŠðJŸC»⹠ÃõÊð´ËîŠðì «õâ¡Â´â¹. è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õË, Hø ªî£Nâ¢ÂºÂ¬Ã¸Å ðEò£÷ËèŠñ¼Ë¶õ⹠ð£ËŠð¶, Fâ ìGó¬ô «ñŸð£Ë¬õ J´õ¶ âùŠðEò£ŸÃâ¹ Ãîó¬õ è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË Ã¨Å, GÃõùËF¡ MôÆ°Šðò¡ð£â ´â à öL⢠à ð«ò£èŠð´ËîŠð´⹠à JKùÆèO¡ ëó£âA òˬî»⹠ïâ¢ÃµÂ£âºÂ¬ÃµÂ»â¹ êKò£ù º¬øJ⢠ñFÅ d´ ªêÅÃ²Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ ÃÃðõâ¹, ðJŸC, G¹Ã˶õ⹠ÃAòõŸ¬øâ ªè£â¡Â®Â¼âè «õâ¡Â´â¹. ðóâ°Ã® Fâ ìõ¬ó¾ º¬øŠð® è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õËèŠÃÅõè MôÆ° õêF GËõ£è⹠ñŸÃâ¹ Ãâ°GËõ£èËF⢠ªð£¼Ëîñ£ù ÃÃðõ«ñ£ Ãâ¢Ã´Â¶ ðJŸC«ò£ ªðŸP¼âè «õâ¡Â´â¹. Fâ ìËF¡ «ï£âèˬð£Ã˶, Hø °PÅ Hâ ì ¶¬øèO⢠G¹Ã˶õ⹠õ£Åâ°Ã® õâ¢Â½Ã¯Ë芫î¬õŠðìô£â¹. â´Ë¶âè£â ì£è, õêF õ®õ¬ñŠ¹, ¹¶ŠHËîâ¢, ñQîõ÷ «ñô£â¡Â¬Ã±, ÃÅõè MôÆ°èO¡ «ï£Jòâ¢, åŠdâ ´ ñóðµMòâ¢, à ðèóÃÆèÅ, ðó£ñKŠ¹, «ï£òP ÃÅõèâ ªêòâ¢Ã°Â£Â´Ã¨Å, ïìË” «ñô£â¡Â¬Ã± ÃAò¬õ. ÃÅõè MôÆ° ÃPMòâ¢, ñ¼Ë¶õ⹠ÃAòù M¬óõ£è ñ£Põ¼A¡øù. ìõ õ÷Ëâ°Â¶ õ¼⹠¶¬øèÃâ¹Ãì. ªî£Nâ¢ÂºÂ¬Ã¸ áNòËèŠêeðËFò ï¬ìº¬øèÅ, ªêòâ¢ÂºÂ¬Ã¸Ã¨Â¬Ã·Å ðŸP ÃPâ°F¼âAø£ËèŠâ¡ð¬î»â¹, ÃÅõè MôÆ°èŠà òËîóŠðó£ñKŠ¬ðŠªðÃA¡øù â¡ð¬î»⹠à ÃFŠð´Ëî õöâèñ£ù ªî£Nâ¢ÂºÂ¬Ã¸ «ñâ¹Ã°Â£Â´, ªî£ìËâCò£ù èâ¢Mâè£ù õ£ÅŠ¹è¬÷»⹠Ãîó¬õ»⹠Ãâ°Ã® GÃõù⹠õöÆè «õâ¡Â´â¹ (Colby et.al 2007).
60 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® MôÆ°Šðó£ñKŠ¹ŠðEò£÷ËèŠMôÆ°è¬÷â èõQ˶⠪è£ÅðõËèÃâ°â êKò£ù º¬øJ⢠ðJŸC ÃOâèŠðì «õâ¡Â´â¹ (H¡ ìʹ à ð£Ëâè¾â¹), «ñ½⹠Ãâ°Ã®Ë Fâ ìËÂ¬Ã®Ë Føâ¹Ã°Ã¬â ªêòâ¢Ã°Â´Ë¶õ⹠MôÆ°èO¡ ñQî£H ñ£ù⹠ê£Ëâ°Ã® ðó£ñKŠ¹, ðò¡ð£â “ âOî£â°õ⹠GÃõù⹠º¬øò£ù èâ¢M, «õ¬ô ê£Ëâ°Ã® ðJŸC ÃOâè «õâ¡Â´â¹. áNòËèÃ⹠ðJŸCªðø «õâ¡Â´â¹. ÃõËèŠîóŠðâ ì ðEè¬÷Šªð£ÃŠð£è º®âè ÃÃðõ⹠ªðŸP¼âè «õâ¡Â´â¹. Fâ ìGó⢠«ï£âèËF¡ð®, ðâ¢Â«ÃµÃ HK¾èO⢠(â´Ë¶âè£â ´, è£â¢Ã¯Â¬Ã¬ õ÷ËŠ¹, GËõ£èâ¹, è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË ÂªÃ®Â£Nâ¢Â¸â ðâ¹) G¹Ã˶õ⹠ªðŸø ðEò£÷Ë芫î¬õŠðìô£â¹. MôÆ°Šðó£ñKŠ¹ŠðEò£÷ËèÅ, ªî£Nâ¢Â¸â ð õâ¢Â½Ã¯ËèÃâ°ŠðJŸC ÃOâè ðô õNèŠà Å÷ù (Pritt and Duffee 2007) . ðô èâ¢ÃKèŠè£â¢Ã¯Â¬Ã¬Ë ªî£N⢠¸â ðËF⢠(AVMA 2010) ÃÆWè£ó⹠ªðŸÃÅ÷ù. ªð¼⹠ð£ô£ù¬õ ëê£C«òâ ÃçŠêJ¡v ðâ ìÆè¬÷ õöÆ°⹠2 Ãâ¡Â´ Ã°Â£Ã¬Ë Fâ ìÆèÅ, Cô 4 Ãâ¡Â´ Ã°Â£Ã¬Ë Fâ ìÆ芪è£â¡Ã¬ Ã÷Æè¬ô ÃPMò⢠ðâ ìÆè¬÷ õöÆ°A¡øù. ÃÅõè MôÆÂ°Ë ÂªÃ®Â£Nâ¢Â¸â ð õâ¢Â½Ã¯Ë èÅ, ªî£Nâ¢Â¸â ðMòô£÷ËèÃâè£ù ꣡Pî⺠Fâ Ã¬Æ Ã¨Å Ãô⹠ðâ ì⹠Ãâ¢Ã´Â£Ã® ðJŸC, êñKâè¡ Ã«ê£C«òû¡ Ã§Ã°Â£Ë Â«Ã´Ã°Â«Ã³â ìK ÃQñ⢠êJ¡v (AALAS)-ÃL¼â°Â¶ A“âAø¶, «ñ½⹠²ò õNè£â ´ î½ì¡ ð®â芪ð£¼Ëîñ£ù õEègFò£è A“âèâ îò ðâ¢Â«ÃµÃ ðJŸC Ãî£óÆèŠà Å÷ù (H¡ ìʹ Ã). ÃÅõè MôÆ°è¬÷Šðó£ñKâ°⹠ðEò£÷Ë芪î£ìËâ°Ã® èâ¢M ïìõ®â¬èèO⢠ôðì «õâ¡Â´â¹. «ñ½⹠à ÅÃK½⹠«îCò ÃÅõè MôÆ° ÃPMò⢠Ãâ ìÆèO½⹠Hø ªî£ì˹¬ìò ªî£Nâ¢ÂºÂ¬Ã¸ ìñŠ¹èO½⹠ðÆǏُ áâ°MâèŠðì «õâ¡Â´â¹. èôⰠ¶¬óò£ìâ¢, ðJŸCË Fâ ìÆèÅ, ðEèÅ, ðó£ñKÅ H⢠à Å÷ à JKùÆèÃâ°Šªð£¼â°Ã®âîò °PŠ¹ Ãî£óÆèÅ, ôîô£è «õ¬ô ê£Ëâ°Ã® ðJŸC ÃAòù MôÆ°Šðó£ñKŠ¹â°Šªð£ÃŠð£ù 嚪õ£¼
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠61 ðEò£÷¼â°⹠GÃõùËî£⢠õöÆèŠðì «õâ¡Â´â¹ (Kreger 1995). GÃõùŠðJŸCË Fâ ìÆèO¡ å¼ÆA¬ÃÅ Ã°Â£Ã·Ë Ã¨Å MôÆ° Ã¯Ã´Ë Ã®Ã¨Ãµâ¢ Â¬Ã±Ã²â¹ (AWIC), ÃÅõè MôÆ° ïô¡, ðJŸC ðKõËËî¬ù (LAWTE), AALAS ILAR (NRC 1991) ÃAòõŸP¡ à îM¬òŠªðøô£â¹. MôÆ°Šðó£ñKŠ¹â è£ù è«ù®ò 辡CL¡ (CCAC 1993) ðK«ê£î¬ù MôÆ°èO¡ ðó£ñKŠ¹, ðò¡ð£â ®Ÿè£ù õNè£â ®, Hø èO¡ õNè£â ´îâ¢Ã¨Å ÃÅõè MôÆ° Mâ¦Ã«Â£Q èO¡ ÃôèÆèO⢠ñFŠ¹Iâè ôî⢠õ÷Æè÷£°⹠(H¡ ìʹ Ã). Ãó£ÅâCâ °¿ ºî¡¬ñ ÃÅõ£÷ËèÅ, Þ Ãòâ°ïËèÅ, Ãó£ÅâCË ÂªÃ®Â£Nâ¢Â¸â ð õâ¢Â½Ã¯ËèÅ, ÂºÂ¬Ã¹ÃµË Ã°â Ã¬Ë FŸ° «ñŸðâ ì ÃÅõ£÷ËèÅ, ñ£ÃõËèÅ, CøŠ¹ õ¼¬è î¼⹠Mâ¦Ã«Â£QèŠà ÅOâ ì Ãó£ÅâCâ °¿âèO¡ à ÃÅ HùËèÃâ°Š«ð£¶ñ£ù ªîO¾ «õâ¡Â´â¹. º¡ªñ£NòŠðâ ì °PÅ Hâ ì ï¬ìº¬øèÅ, ðò¡ ð´ËîŠð´⹠ÃùÆèŠêâ¹Ã°â°Ã®Å ðâ ì «î¬õò£ù ÃP¾⹠G¹Ã˶õº⹠ÃõËèÃⰠüŠð¬î à ÃFªêÅÃ²Ë Ã®Â°â°Ã® èâ¢M¬ò»⹠ðJŸC¬ò»⹠õöÆè «õâ¡Â´â¹. (Conarello and Shepard 2007). Ãó£ÅâCâ °¿âèO¡ °PÅ Hâ ì «î¬õèÃâ° ãŸðŠðJŸC ÃOâèŠðì «õâ¡Â´â¹. âšõ£ø£JÃâ¹, ìù˶ Ãó£ÅâCâ °¿âèÃâ¹ MôÆ° ðó£ñKŠ¹, ðò¡ð£â ´â êâ ìâ¹, äãC»C ªêòâ¢Ã°Â£Â´, MôÆ°Šðò¡ð£â ®¡ ªïPº¬øèÅ, áà ÃË (3R) ê£Ëâ°Ã® è¼Ë¶âèÅ, MôÆ°èO¡ ðò¡ð£´, ªî£Nâ¢ÃªÂ£Ë ²è£î£óâ¹, MôÆ°Šðò¡ð£´ ªî£ìËð£ù ð£¶è£Š¹ HóâC¬ùèÅ, MôÆ°è¬÷â ¬èò£Ãî⢠ªî£ìËð£ù Câèâ¢Ã¨Â¬Ã·Å ¹è£óOâ°⹠º¬øèŠÃAòõŸP⢠ðJŸC ªðø «õâ¡Â´â¹. ªî£ŸøŸø Ãìõ CA␠¸â ðâ¹, ñòâè ñ¼â°Â¶, õL ðŸPò Gõ£óE, 輬Ãâªè£¬ô ðŸPò Hø ð£ìÆèŠêâ ìŠð® ǔ›. ðJŸC¬ò õ½Šð´Ëî ¾â¹, ªî£Nâ¢Â¸â ðâ¹, êâ ìâ¹, Hø ªî£ì˹¬ìò ð°F èO⢠ãŸð´⹠ñ£ŸøÆè¬÷ŠHóFðLâ°â¹Ã°Â®Ã²Â£Ã¹ ¹¶ŠHËîâ¢Ã¨Â¬Ã· õöÆè¾⹠ªî£ìËâCò£ù èâ¢MË Fâ ìÆèŠõöÆèŠðì «õâ¡Â´â¹. ðJŸC õ£ÅŠ¹èO¡
62 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® Ãâ ìõ¬Ãò£ù¶ ìù˶ MôÆ°Šðòù£OèÃâ°⹠MôÆ°Šðó£ñKÅ Â¬Ã°Ë ÂªÃ®Â£Ã¬Æ°õ º¡ «ð£¶ñ£ù ðJŸC üŠð¬î à ÃFªêÅò «õâ¡Â´â¹. äãC»C äãC»C à ÃÅ HùËèÃâ° ÃõËèO¡ ðE, ðÆA¬ùŠ¹Kâ°Â¶ÂªÃ¨Â£ÅõîŸè£ù ðJŸC õ£ÅŠ¹èŠõöÆèŠð´õ¬î à ÃFªêÅõ¶ GÃõùËF¡ ªð£ÃŠð£°â¹. ÃËî¬èò ðJŸCò£ù¶ GÃõùËF¡ Fâ ìGóL⢠¹Fò à ÃÅ HùËè¬÷ ÃPºèŠð´Ë¶⹠«ð£¶, ÂªÃ®Â£Ã¬Ë Â¹Â¬Ã¬Ã² êâ ìâ¹, å¿Æ°º¬øèÅ, õNè£â ´îâ¢Ã¨Å, ªè£Å¬èèÅ, MôÆ° õêFèÅ, MôÆ°èO¡ ðò¡ð£´ Gè¿⹠ÃÅõèÆèÅ, MôÆ° ªïPº¬ø, Fâ ìGó⢠ñFŠð£ÅM¡ ªêòâ¢ÂºÂ¬Ã¸Ã¨Å ÃAòõŸPŸè£ù º¬øò£ù ð£ìËFâ ì⹠üâè «õâ¡Â´â¹ (Greene et al.2007). ÃPMòL⢠MôÆ°èO¡ ðó£ñKŠ¹, ðò¡ð£´ ðŸPò ÃõËèO¡ ¹Kî¬ô «ñâ¹Ã°Â´Ë¶õîŸè£ù ÂªÃ®Â£Ã¬Ë ÃµÂ£ÅŠ¹ èÃ⹠õöÆèŠðì «õâ¡Â´â¹. â´Ë¶âè£â ì£è, äãC»C à ÃÅ HùËèÅ, MôÆ°Šðó£ñKŠ¹ ðEò£÷ËèÅ, Ãó£ÅâCâ °¿âè¬÷â êâ°Fâèô£â¹; ªî£ì˹¬ìò ðËFKâ¬èè¬÷ õ£CËîâ¢, ìÃò îŠð¬ìJô£ù ðJŸCâè£ù ê£ËFòË” õöÆè «õâ¡Â´â¹; Ãâ ìÆèŠÃâ¢Ã´Â¶ ðâ ì¬øèO⢠èôâ°Â¶ÂªÃ¨Â£Å÷¾⹠õ£ÅŠ¹èŠõöÆèŠðì «õâ¡Â´â¹. ªî£Nâ¢ÃªÂ£Ë ²è£î£óâ¹, ðEò£÷ËèO¡ ð£¶è£Š¹ 嚪õ£¼ GÃõùº⹠MôÆ°Šðó£ñKŠ¹ ñŸÃ⹠ðò¡ð£â ®¡ å⠴ªñ£ËÃ®Ë Fâ ìËF¡ (CFR1984a, b, c; DHHS 2009; PHS 2002) å¼ ºâAòŠð°Fò£è, å¼ ªî£Nâ¢ ÃªÂ£Ë Â²Ã¨Â£Ã®Â£Ã³ Ã°Â£Â¶Ã¨Â£Å Â¹Ë Fâ ìË” ( OHSP) GÃMŠðó£ñKâè «õâ¡Â´â¹. æâââvH-Ãù¶ ñËFò, ñ£Gô à ÅÃË MFº¬øèÃì¡ Ã¥ËF¼âè «õâ¡Â´â¹. 𣶠裊ð£ù, ëó£âAòñ£ù ðEJìˬîŠðó£ñKŠðF⢠èõù⹠ªê½Ëî «õâ¡Â´â¹ (Gonder 2002; Newcomer 2002; OSHA 1998a). æâââvH-á ðEò£ù¶, ÃÅõè õêF, Ãó£ÅâC ïìõ®â¬èèÅ, Ãð˶èÅ, MôÆ° ÃùÆèŠÃAò õŸ¬øŠªð£ÃËî¶. «îCò Ãó£ÅâC 辡CL¡ ªõO fì£ù, Ãó£ÅâC MôÆ°èO¡ ðó£ñKŠ¹ ñŸÃâ¹
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠63 ðò¡ð£â ®⢠ªî£Nâ¢ÃªÂ£Ë ²è£î£óâ¹, ð£¶è£Š¹ (NRC 1997) â¡ø Ãâ¢, å¼ ðòÃÅ÷, MKõ£ù æâââvH-ä Gþõ⹠ðó£ñKŠð «õâ¡Â®Ã² õNè£â ´îâ¢Ã¨Å, °PŠ¹è¬÷â ªè£â¡Â´Å֦ (H¡ ìʹ Ã) å¼ ðòÃÅ÷ æâââvH-â°, Ãó£ÅâCË Fâ ì⹠(ÃÅõ£÷ ó£⢠°PÅ HìŠð´õ¶), MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠(ãM, äå, äãC»C-Ã⢠°PÅ HìŠð´õ¶), ²ŸÃâà ö⢠²è£î£óâ¹, Ã°Â£Â¶Ã¨Â£Å Â¹Ë Fâ ìâ¹, ªî£Nâ¢ÃªÂ£Ë ²è£î£óâ «ê¬õèÅ, GËõ£è⹠(â´Ë¶âè£â ´: ñQî õ÷ÆèÅ, GF, õêF, ðó£ñKŠ¹ŠðEò£÷ËèÅ) ÃA«ò£ K¡ å¼ÆA¬ÃŠ¹ «î¬õŠð´Aø¶. å¼ ð£¶è£Š¹â °¿¬õ Gþõ¶ îèõ⢠ªî£ì˹ⰠõNõ°â°â¹. «ñ½⹠ö ðEJìËF⢠²è£î£óâ¹, ð£¶è£Š¹ °PËî ñFÅ dâ “ áâ°Mâ°â¹. Cô êâ°Ã®ËŠðÆèO⢠ÃËî¬èò °¿¾â° å¼ å¿ÆÂ°ÂºÂ¬Ã¸Ë Â«Ã®Â¬ÃµÂ»â¹ Ã Å֦. ðEJìŠð£¶è£Š¹ â¡ð¶ ÞâÃìË” Ãâ¢Ã´Â¶ õêF¬ò Ãòâèâîò, Ãî¡ Ã¡ø£ìâ ªêòâ¢Ã°Â£Â´Ã¨O⢠ªð£ÃŠ«ðŸèâîò «ñŸð£Ë¬õò£÷Ëè¬÷»⹠(â´Ë¶âè£â ´: ºî¡¬ñ ÃÅõ£÷Ë, õêF Ãòâ°ïË, å¼ è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õŠðEò£÷Ë) ìù˶ áNòËèO¡ ð£¶è£Šð£ù ðE ï¬ìº¬øè¬÷»⹠ê£Ëâ°Â¶Å֦. èâ ´Šð£´ ñŸÃ⹠î´Š¹ à ËFèŠå¼ MKõ£ù æâââvH Ãù¶ èâ ´Šð£´èÅ, î´Š¹ à ËFèO¡ ÃFè£óŠð®G¬ôâ° à â ðâ ®¼âè «õâ¡Â´â¹, ö Ãð˶âè¬÷ ììò£÷⹠è£â¡Ã°Â¶, Ãâ°Ã® Ãð˶èÃì¡ ªî£ì˹¬ìò Ãð£òË” ñFÅ d´ ªêÅõFL¼â°Â¶ Ãóâ¹HâAø¶. ÃðË” GËõAŠð¶ H¡õ¼⹠G¬ôè¬÷ à Å֓âAò¶: ºîô£õî£è, à ðèóÃÆèO¡ ªð£¼Ëîñ£ù õ®õ¬ñŠ¹, ªêòâ¢Ã°Â£Â´, ªð£¼Ëîñ£ù ð£¶è£Š¹, à ðèóÃÆèO¡ ðò¡ð£´ (ªð£PJò⢠èâ ´Šð£´èÅ). Ãóâ¡Ã¬Â£ÃµÃ®Â£Ã¨, ªêòâ¢ÂºÂ¬Ã¸ èÅ, º¬øò£ù Ãòâè ï¬ìº¬øèO¡ à ¼õ£âè⹠(âvæHèÅ- SOP ; GËõ£èâ èâ ´Šð£´èÅ) ê£Ëâ°Ã®Â¶. ÃÃFò£è, áNòËèÃâ° ªð£¼Ëîñ£ù îQŠðâ ì ð£¶è£Š¹ à ðèóÃÆè¬÷ (HHà -PPE) õöÆ°îâ¢. ªð£¼Ëîñ£ù «ñô£â¡Â¬Ã±, ð£¶è£Š¹ ï¬ìº¬øèÃì¡ CøŠ¹Šð£¶è£Š¹ à ðèóÃÆèŠðò¡ð´ËîŠðì
64 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® «õâ¡Â´â¹ (NIH 2002; OHSA 1998a, b). Ãâ°Ã® à ËFè¬÷Šðò¡ ð´ËF ÃðË” îMËâè ðEò£÷ËèÃâ°ŠðJŸC òOâèŠðì «õâ¡Â´â¹, ïâ¢Ã´ îQŠðâ ì ²è£î£óˬðà «õâ¡Â´â¹, ÃõËèO¡ ðEâà öL⢠ãŸð´⹠Ãð˶è¬÷ŠðŸP ÃPâ°F¼âè «õâ¡Â´â¹, ê£îùÆèO¡ êKò£ù «î˾, ðò¡ð£â ¬ìŠ¹Kâ°Â¶ÂªÃ¨Â£Å÷ «õâ¡Â´â¹, GÃõŠðâ ì ï¬ìº¬øè¬÷ŠH¡ðŸø¾â¹, õöÆèŠðâ ì HHÃ-äŠðò¡ð´Ëî¾⹠«õâ¡Â´â¹. ÃðË” ììò£÷⹠è£Ãâ¢, Ãð£ò ñFÅ d´ GÃõù æâââvH-Ãù¶ ðEâà öL⢠ãŸðìâ îò Ãð˶è¬÷ ììò£÷⹠èâ¡Â´ ÃîÃì¡ ÂªÃ®Â£Ã¬Ë Â¹Â¬Ã¬Ã² Ãð£òÆ芰P˶ å¼ ºâAòñ£ù ñFÅ dâ “ ïìËî «õâ¡Â´â¹. MôÆ°â «ê£î¬ù, ðò¡ð£â ´ì¡ ªî£ì˹¬ìò Ãð£òÆèŠÃ¬ìò£÷⹠è£ÃŠðâ ´, °¬øâ°Ã®Ã°â êñ£è ãŸÃâªè£Å÷Ëîâè Ã÷MŸ°â °¬øâèŠð´õ¬î å¼ ðòÃÅ÷ æâââvH à ÃFªêŠAø¶. ÃðË” ììò£÷⹠è£Ãâ¢, Ãð£ò ñFÅ d´ â¡ð¶ ªî£ìËâCò£ù ªêòâ¢ÂºÂ¬Ã¸Ã¨Ã·Â£Â°â¹. ìõ Fâ ìË¶ì¡ ªî£ì˹¬ìò Ãð˶è¬÷ ñFÅ H´ õâ¹, ð£¶è£Š¹ º¬øè¬÷â ªêòâ¢Ã°Â´Ë¶õ⹠î°Fò£ù ïðËè¬÷ à Å֓âAò¶. êâ¹Ã°â°Ã®Å ðâ ì ¶¬ø èO⢠ë£ùºÅ÷ ²è£î£ó, ð£¶è£Š¹ õâ¢Â½Ã¯ËèŠÃð£ò ñFÅ d´ ªêŶ ÃõŸ¬ø GËõAŠðîŸè£ù ï¬ìº¬ø è¬÷ «ñâ¹Ã°Â´Ë¶õF⢠ôðì «õâ¡Â´â¹. ê£ËFòñ£ù Ãð˶èO⢠à JËõNŠªð£¼â èŠ(â´Ë¶âè£â ´: ªî£ŸÃâ A¼IèÅ, ïâ²èÅ), Ãóê£òùŠªð£¼â èŠ(â´Ë¶âè£â ´: ¹ŸÃ«ï£ÅèÅ, ñóðµŠHøâºÂ¾Ã¨Å), èFËiâ² (â´Ë¶âè£â ´: «ó®«ò£GÃâ¬ô´ èŠâÃ⹠èFËiⲊªð£¼â èÅ, ââv-èFËèÅ, Ã¥Oâ èFËèÅ) ªð÷bè Ãð˶èŠ(â´Ë¶âè£â ´: áCèÅ, ñ¼â°Ãâ ´â °ö£ÅèÅ) îMËâèŠðì «õâ¡Â´â¹. Cô è÷ ÞèÅ, õùMôÆ° Ãó£ÅâC «ð£¡ø Ãê£î£óà «ê£î¬ù G¬ô¬ñèÃì¡ ªî£ì˹¬ìò Ãð£òÆèÃâ¹ bËâèŠðì«õâ¡Â´â¹. MôÆ°â è®, åšõ£¬ñ, ÃÃ³ÃªÂ£Ã²Ã¹Ë Â¶Å Â¹Ã³Â¾Å ÂªÃ°Â£Â¼â èÅ, Ãóñ£ù î¬óèÅ, Ãâ¡Â´ ¶¬õŠH èÅ, Hø à ðèóÃÆèÅ, Ãâ°îâ¢, ãEŠðò¡ð£´, MôÆAù£⢠ðó¾⹠«ï£Å芫ð£¡ø Hø ê£ËFòñ£ù
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠65 Ãð˶èŠÃ¬ìò£÷⹠è£ÃŠðâ ´ ñFÅ d´ ªêÅòŠðì «õâ¡Â´â¹. ê£ËFòñ£ù Ãð£òÆèŠÃ¬ìò£÷⹠è£ÃŠðâ ì¾ì¡, ÃõŸ¬øâ °¬øâè, êñ£Oâè, ªð£¼Ëîñ£ù à ËFÃ¨Â¬Ã·Ë bËñ£Qâè, ªî£ì˹¬ìò Ãð£òÆ芰PËî ºâAòñ£ù ñFÅ d´ ïìËîŠðì «õâ¡Â´â¹. æâââvH-Ã⢠ðEò£÷Ëèììò ðÆèOÅ H¡ Ã÷¾, ð®G¬ôò£ù¶ MôÆ°èÅ, ðò¡ð´ËîŠð´⹠ªð£¼â è÷£⢠ãŸð´⹠Ãð˶èO¡ îŠð¬ìJ⢠ìñò «õâ¡Â´â¹. ð£FÅ H¡ bMóâ¹, ðEò£÷ËèŠð£FŠ¹â° Ã÷£èâîò G¬ô (â´Ë¶âè£â ´: «ï£ªòFËŠ¹ G¬ô); °PÅ Hâ ì ðEJìËF⢠ªî£N⢠ê£Ëâ°Ã® «ï£Š(Newcomer 2002; NRC 1997) ÃAò¬õ èõQâèŠðì «õâ¡Â´â¹. ÃðËÂ¶Ã¨Â¬Ã·Ë ÂªÃ®Â£Ã¬Ëâ°Â¶ ììò£÷⹠è£â¡Ã°Â¶â¹ ñFÅ d´ ªêÅõ¶⹠ÚõŠ«ð£¶ ê£ËFòñ£ù Ãð£òèóñ£ù G¬ô¬ñèŠÃâ¢Ã´Â¶ âAâ ìËîâ ì Gèâºâ°F¼âèâîò (Near miss)â êâ¹Ã°ÃµÆè¬÷ ÚõŠ«ð£¶ Þ ªêÅõ¶⹠ÃP⏠îò£KŠð¶⹠ÃõCòñ£ù¬õ. õêFèÅ, à ðèóÃÆèÅ, èâ¡Ã¨Â£EŠ¹ æâââvH-ä ÃîKâÃ¨Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ ÃÃèŠFâ ì GóL¡ «ï£âèâ¹, ªêòâ¢Ã°Â£Â´Ã¨Â¬Ã·Å ªð£Ã˶ ñ£Ãð´â¹. ÃõŸP¡ õ®õ¬ñŠ¹ âFËð£ËËî Ãð˶èO¡ ð£FŠ¬ðâ °¬øâè ªð£PJò⢠èâ ´Šð£´èÅ, à ðèóÃÆ Ã¨Â¬Ã· ñò£èŠðò¡ð´Ëî «õâ¡Â´â¹ (ÃËFò£ò⹠5- ä»⹠ð£Ëâè¾â¹). îQÃ¯Ã°Ë ÃÅ–J¡ à òËîóñ£ù¶ ÃõCò⹠â¡ðî£â¢, Fâ ìËFŸ°Šªð£¼Ëîñ£ù ãŸð£´ èÅ, 迾îâ¢, °Oò⢠õêF芫î¬õ. Hø ÃËFò£õCòŠªð£¼â èÃâ¹ A“âè «õâ¡Â´â¹. à JËõNŠªð£¼ÅèŠðò¡ð´ËîŠð´A¡ø ÃìÆèOâ¢, ¸â¡ÂµJKòâ¢, à JKò⢠ñ¼Ë¶õ ÃÅÃµÃ¨Æ Ã¨O⢠à JË Ã°Â£Â¶Ã¨Â£Å Â¹ (BMBL; DHHS 2009), ȉv®â-USDA îó G¬ôèŠ(USDA 2002) êâ¹Ã°ËîŠðâ ì «ï£Åâ èâ ´Šð£´ î´Š¹ ¬ñòÆèŠ(CDC), «îCò ²è£î£ó GÃõùÆèO¡ (NIH) ëô£ê¬ùè¬÷, ªð£¼Ëîñ£ù õêF õ®õ¬ñŠ¹, ð£¶è£Š¹ ï¬ìº¬øèÃâªèù ãŸè «õâ¡Â´â¹. Ãâ°Ã® õ®õ¬ñŠ¹, ð£¶è£Š¹ Ãâ¹ÃªÆèŠðò¡ð´ËîŠð´⹠ªð£¼â è÷£⢠ãŸð´⹠ÃðËF¡ Ã÷¬õ îŠð¬ì
66 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ò£èâ ªè£â¡Ã¬Â¬Ãµ. MôÆ°ŠðK«ê£î¬ù Þ áNÃ²Ë Ã¨Å ÃµÂ£NìËF¡ Hø °®J¼Šð£÷ËèÅ, ªð£¶ñâèŠÃAÂ«Ã²Â£Ë MôÆ°ŠðK«ê£î¬ùJ⢠ðò¡ð´ËîŠð´⹠Ãð£òèóñ£ù à JKòâ¢, «õFJò⢠ªð÷b芪ð£¼â èO¡ ð£FÅ HL¼â°Â¶ ð£¶è£âèŠðì «õâ¡Â´â¹. Ã CøŠ¹ õêFèÅ, ð£¶è£Š¹ à ðèóÃÆ芫î¬õŠðìô£⹠(DHHS 2009; Frasier and Talka 2005; NIH 2002). «î¬õŠð´⹠«ð£¶, ÃÅ¡ õêFèŠHø MôÆ° õ£NìŠð°FèÅ, Ãó£ÅâC ñ¼Ë¶õ ÃÅõèÆèÅ, «ï£Šªè£â¡Ã¬ MôÆA¡ ðó£ñKŠ¹Šð°FJL¼â°Â¶ HKâèŠðì «õâ¡Â´â¹. ìõ êKò£ù º¬øJ⢠ììò£÷⹠è£ÃŠðì «õâ¡Â´â¹. ÃÆWèKâèŠðâ ì ïðËèŠñâ ´«ñ ÃÆ«è ¸¬öò «õâ¡Â´â¹. ðEò£÷ËèÃâ° à ì⢠è£òâ¹, ð£FŠ¹ ãŸð´õîŸ è£ù õ£ÅŠ¬ðâ °¬øâè, õêFèÅ, à ðèóÃÆèÅ, ï¬ìº¬øèŠõ®õ¬ñâèŠðâ ´, «îËâ°ÂªÃ®Â´âèŠðâ ´, ªêòâ¢Ã°Ã¬Â¾â¹ «õâ¡Â´â¹ (NIOSH 1997a, b). ðEâ à öL⢠èùóè à ðèóÃÆèÅ, MôÆÂ°Ã¨Â¬Ã·Ë Ãâ°õ¶ «ð£¡ø ªêòâ¢Ã¨O¡ «ð£¶ è£ò⹠ãŸð´⹠Ãð£òË” GõËËF ªêÅ»⹠ªð£PJò⢠èâ ´Šð£´èÅ, à ðèóÃÆè¬÷â è¼ËF⢠ªè£Å÷ «õâ¡Â´â¹ (â.M.ââ¹.ã- AVMA 2008) MôÆ° åšõ£¬ñâ° Ã÷£èâîòõËèO¡ ð£FŠ¬ðâ èâ ´Šð´Ëî¾⹠î´âè¾⹠«õâ¡Â´â¹. (Harrison 2001; Huerkamp et al. 2009) MôÆ°Šðó£ñKÅ H⢠õêFèO⢠(â´Ë¶âè£â ´: ªðKò Ã÷Mô£ù ªè£P˶â¡Eè¬÷Šðó£ñKËîâ¢, Hø õ÷ËŠ¹ ïìõ®â¬èèÅ) îâè® ãŸð´⹠è£òÆèÃâ è£ù ê£ËFòâÃÃè¬÷»⹠ñFÅ d´ ªêÅò «õâ¡Â´â¹. ªð£¼Ëîñ£ù MôÆ° õ£Nì ÃÂ¬Ã±Å Â¹Ã¨Â¬Ã·Ë Â«Ã®Ëâ°ÂªÃ®Â´Å Ã°Ã®Å¸Â°Ë ÂªÃ®Â£Nâ¢ÂºÂ¬Ã¸ ÃP¾⹠bËÃ±Â£Ã¹Ë FøÃ⹠«î¬õŠð´Aø¶. «èÅMâ°Kò Ãð˶èO¡ ñ, ðò¡ð´ËîŠð´⹠MôÆ°èO¡ õ¬èèÅ, õêF èO¡ õóâ¹Â¹Ã¨Å, Fø¡èÅ, ðK«ê£î¬ùèO¡ õ®õ¬ñŠ¹ ÃAòõŸ¬øŠªð£ÃËî¶. ñ£²ð´ËîŠðâ ì à þ, ð´â, ñôâ¹, CÃcË ÃAòõŸ¬øâ èâ ´Šð£ì£ù º¬ø J⢠¬èò£÷âîò õ¬èJ⢠ðK«ê£î¬ù MôÆ°è¬÷ ¬õâè «õâ¡Â´â¹. ªð£¼Ëîñ£ù õêFèÅ, à ðèóÃÆèÅ, ð´â¬èè¬÷ ÃèŸÃõîŸè£ù ï¬ìº¬øèŠH¡ðŸøÅ
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠67 ðì «õâ¡Â´â¹. ð£¶è£Š¹ à ðèóÃÆ芺¬øò£èŠðó£ñKâèŠðì «õâ¡Â´â¹. ÃõŸP¡ ªêòâ¢Ã°Â£Â´ ÚõŠ«ð£¶ êKð£ËâèŠðì «õâ¡Â´â¹. «î¬õŠð´⹠ÃìÆèO⢠(â´Ë¶âè£â ´: ÃòQò£âè⹠ªêÅ»⹠èFËiâ²) ÃÃñFâèŠðâ ì ð£FŠ¹ õóâ¹Â¹Ã¨Â¬Ã· eÃõîŸè£ù ê£ËFòâÃÃèŠÃ¼â°⹠ÃìËF⢠(CFR 1984b) Ãð£ò èóñ£ù à JKòâ¢, «õFJòâ¢, ªð÷b芪ð£¼â èO¡ ð£îèË” ñFÅ H´õ⹠èâ¡Ã¨Â£EŠð⹠ªð£¼Ëî ñ£ù õNº¬øèŠH¡ðŸøŠðì «õâ¡Â´â¹. ðEÃ²Â£Ã·Ë Ã°JŸC å¼ ªð£¶õ£ù MFò£è, ð£¶è£Š¹ â¡ð¶ ð£¶è£Šð£ù ï¬ìº¬øè¬÷â è´¬ñò£èŠH¡ðŸÃ⹠ðJŸC ªðŸø ðEò£÷Ëè¬÷Šªð£ÃËî¶. Ãð˶ŠðEJ⢠üâ°⹠ðEò£÷ËèÃâÂ°Ë ÂªÃ®Oõ£è õ¬ó òÃâèŠðâ ì ï¬ìº¬øèŠõöÆèŠðì «õâ¡Â´â¹, °PÅ Hâ ì à âºG¬ôèOâ¢, îÆèŠèì¬ñè¬÷Šð£¶è£Šð£è G¬ø«õŸÃõâ¹, êâ¹Ã°â°Ã®Å ðâ ì Ãð˶è¬÷Š¹Kâ°Â¶ÂªÃ¨Â£Åõâ¹, «î¬õò£ù ð£¶è£Š¹è¬÷â ªêò⢠ð´Ë¶õF⢠Fø¬ñò£ùõËè÷£è üŠðâ¹, îQÃ¯Ã°Ë Ã°Â£Â¶Ã¨Â£Å Â¹ à ðèóÃÆèŠõöÆèŠðì «õâ¡Â´â¹. MôÆ° õN «ï£Å, «õFJòâ¢, à JKòâ¢, ªð÷bè Ãð˶èŠ(â´Ë¶âè£â ´: èFËiâ², åšõ£¬ñ), Ãê£î£óà G¬ô¬ñèŠÃâ¢Ã´Â¶ ðK«ê£î¬ù ªïPº¬øèO¡ å¼ ð°Fò£è üâ°⹠ð£îèÆèŠ(â´Ë¶âè£â ´: «ï£ªòFËŠ¹â °¬øð£´Å÷ MôÆ°èO⢠ñQÃ®Ë F²âèO¡ ðò¡ð£´), èN¾Šªð£¼â è¬÷â ¬èò£Ãî⢠ÃAòõŸ¬øâ °P˶ ÃõËèÃâ°ŠðJŸC ÃOâèŠðì «õâ¡Â´â¹. îQÃ¯Ã°Ë Â²Ã¨Â£Ã®Â£Ã³â¹, HHÃ-á ªð£¼Ëîñ£ù ðò¡ð£´, Hø è¼Ëî£Å¾èŠ(â´Ë¶âè£â ´: èËŠðâ¹, «ï£ŠÃâ¢Ã´Â¶ «ï£ªòFËŠ¹ êâFJ¡ «ð£¶ â´âèŠðì «õâ¡Â®Ã² º¡ ââêKâ¬èèÅ) ÃõËèO¡ ðEJìËF⢠èõùËF⢠ªè£Å÷ «õâ¡Â´â¹. îQÃ¯Ã°Ë Â²Ã¨Â£Ã®Â£Ã³â¹ Cøâ°Ã® îQÃ¯Ã°Ë Â²Ã¨Â£Ã®Â£Ã³â¹ Â«Ã°ÂµÃµÂ¶ ªð¼â¹Ã°Â£Â½â¹ ªî£N⢠º¬øJâ¢ Ã£Å¸Ã°Â´â¹ Ã¨Â£Ã²Ë ÂªÃ®Â£Å¸Ãâè£ù õ£ÅŠ¬ðâ °¬øâ°â¹. ÃŠªð£¼Ëîñ£ù ªè£Å
68 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® èŠGÃõŠðâ ´ ï¬ìº¬øŠð´ËîŠðì «õâ¡Â´â¹. «ñ½⹠GÃõù⹠Môư芬õâèŠðâ ´Å÷ ÃÅÃµÃ¨Æ Ã¨O⢠ðò¡ð´Ëð£¼Ëîñ£ù à ¬ìèÅ, HHà âÃâ¹ (â´Ë¶âè£â ´: ¬è»¬øèÅ, ºèîèÅ, ºèâ èõêÆèÅ, î¬ô à ¬ø, ÃÆAèÅ, º¿ à ¬ì à ¬øèÅ, è£ôEèÅ, è£ôE à ¬øâ 裊¹èÅ) õöÆè «õâ¡Â´â¹. ÿâè¬ìâ°Ã® à ¬ì¬ò à Kò º¬øJ⢠ʹøŠð´Ëî «õâ¡Â´â¹. ÃõŸ¬øâ êô¬õ ªêÅò «õâ¡Â´â¹ Ãâ¢Ã´Â¶ ÃŬñò£âè «õâ¡Â´â¹, «ñ½⹠ìõ ªõOŠ¹ø ºèõËè÷£⢠ðò¡ ð´ËîŠðâ ì£⢠CøŠ¹ MF芪êòâ¢Ã°Â´ËîŠðì «õâ¡Â´â¹. ðEò£÷ËèŠîÆ芬èè¬÷â è¿õ «õâ¡Â´â¹; A¼I câè⹠ªêÅò «õâ¡Â´â¹; îQ Ã¯Ã°Ë Â²Ã¨Â£Ã®Â£Ã³Ë¬îŠðó£ñKâè îâè® Ã¬ìè¬÷ ñ£Ÿø «õâ¡Â´â¹. MôÆ° ìøèO⢠ÃE»⹠ªõOŠ¹ø Ó èŠð£FŠ¹Ÿø£⢠ªõO«ò ÃõŸ¬ø ÃEòâÃ죶 ( NRC1997) . MôÆ°èŠîÆè¬õâèŠðâ ì Ãâ¢Ã´Â¶ ðò¡ð´ËîŠðâ ì ìøèO½⹠ÃÅõèÆèO½⹠꣊Hì, °®âè, ¹¬èJ¬ô ªð£¼â è¬÷Šðò¡ð´Ëî, Ãö° ê£îùŠªð£¼Åè¬÷Šðò¡ð´Ëî, è⡠¸â¡Ã£® è¬÷â ¬èò£÷ Ãâ¢Ã´Â¶ ÃEò ðEò£÷Ëè¬÷ ÃÃñFâèâ Ã죶 (DHHS 2009; NRC 1997; OSHA 1998a). Ãð£òÆè¬÷ à Å֓âAò MôÆ°ŠðK«ê£î¬ù Ãð£òèóñ£ù ªð£¼â è¬÷â ªè£â¡Â´ MôÆ°ŠðK«ê£î¬ù¬òâ ªêÅò °PÅ Hâ ì ð£¶è£Š¹ õNº¬ø Ã¨Â¬Ã·Ë Â«Ã®Ëâ°ÂªÃ®Â´â°⹠«ð£¶, MôÆ°èO¡ ðó£ñKŠ¹, õ£Nì õêF, Ãð£òŠªð£¼â èO¡ «êIŠ¹, ÞŠªð£¼÷÷¾ îò£KËîâ¢, à ì⢠Fóõâ¹, F²âè¬÷â ¬èò£Ãîâ¢, èN¾èÅ, êìô⹠ÃèŸøâ¢, î÷ËFL¼â°Â¶ îŸè£Lèñ£èŠðò¡ð´ËîŠðâ ´ ÃèŸøŠðìâîò ªð£¼â èŠ(â´Ë¶âè£â ´: â¿îŠðâ ì ðF¾èÅ, ðK«ê£î¬ù ê£îùÆèÅ, ñ£FKâ °ŠHèÅ) îQŠðâ ì ð£¶è£Š¹ ÃAòõŸP⢠ÃFè èõù⹠â´Ë¶âªè£Å÷ «õâ¡Â´â¹. GÃõùÆèŠÃð£òèóñ£ù à JKòâ¢, «õFJòâ¢, ªð÷b芪ð£¼â èO¡ ðK«ê£î¬ù¬ò GËõAâ°⹠â¿Ë¶ŠÃËõ ªè£Å¬èè¬÷»⹠ï¬ìº¬øè¬÷»⹠ªè£â¡Â®Â¼âè «õâ¡Â´â¹. Ãð£òèóñ£ù ªð£¼â èÅ
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠69 Ãâ¢Ã´Â¶ ï¬ìº¬øèO¡ ñFÅ d´, ð£¶è£Šð£ù ðò¡ð£â ®⢠FøÃÅ÷ ïðËè¬÷ ôð´Ë¶⹠õ¬èJ⢠å¼ «ñŸð£Ë¬õâ ªêòâ¢ÂºÂ¬Ã¸ (ð£¶è£Š¹â °¿ «ð£¡ø¬õ) à ¼õ£âèŠðì «õâ¡Â´â¹, «ñ½⹠°PÅ Hâ ì ð£¶è£Š¹ Ãâè¬øèÃâ°Šðò¡ð´Ëî «õâ¡Â®Ã² ï¬ìº¬øèÅ, õêFè¬÷ ñFŠð£Å¾ ªêÅò «õâ¡Â´â¹. Ãð˶âè¬÷ ñFÅ H´õâ¹, ÃõŸP¡ èâ ´Šð£â ´âÂ°Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ Ã°Â£Â¶Ã¨Â£Å Â¹Ã¨Â¬Ã·Ë bËñ£QŠðâ¹, áNòËèÃâÂ°Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ ðJŸC, Fø¡èŠÃ¼Šð¬î »â¹, Ãó£ÅâCJ¡ ð£¶è£Šð£ù ïì˔ⰠõêF芫ð£¶ñ£ù¬õ â¡ð¬î»⹠à ÃFŠð´Ëî, º¬øò£ù Ã°Â£Â¶Ã¨Â£Å Â¹Ë Fâ ìÆèŠGÃõŠðì «õâ¡Â´â¹. GÃõùŠð£¶è£Š¹â ªè£Å¬èè¬÷â èâ¡Ã¨Â£Eâè¾â¹, à ÃFŠð´Ëî¾⹠ªî£N⢠¸â ð Ãîó¾ õöÆèŠðì «õâ¡Â´â¹. ÃÅõ£÷Ë, Ãó£ÅâCâ °¿, è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õË, MôÆ°Šðó£ñKÅ Â¹Ë ÂªÃ®Â£Nâ¢Â¸â ð õâ¢Â½Ã¯Ë, ªî£Nâ¢ÃªÂ£Ë ²è£î£óŠð£¶è£Š¹ õâ¢Â½Ã¯ËèŠÃA«ò£¬ó à Å֓âAò å¼ °¿M¡ Ãâ ´ õ°º¬ø Þ «ï£âèË” «ñâ¹Ã°Â´Ëîâôâ¹. BMBL (DHHS 2009) ñŸÃâ¹ NRC (1997) ÃAò¬õ Ãð£òèóñ£ù à JKò⢠ê£Ëâ°Ã® î÷ÆèO⢠ðEò£Ÿà õîŸè£ù ï¬ìº¬øèÅ, ªêź¬øèÅ, ð£¶è£Š¹ à ðèóÃÆèÅ, õêFèÅ, «î¬õè¬÷ŠðKâ°Â¶Â¬Ã³âA¡øù. ÃPòŠðì£î Ãð˶ ªè£â¡Ã¬ ªð£¼â è¬÷â ¬èò£Ã⹠õêFèÅ, Ãð˶â èâ ´Šð£´, ñ¼Ë¶õâ èâ¡Ã¨Â£EŠ¹ °P˶ ªð£¼Ëîñ£ù C®C (CDC) ðEò£÷ËèÃì¡ èôâ°Ã®Â£Â«Ã´Â£Câè «õâ¡Â´â¹. Ãó£ÅâCJâ¢, ªè£®ò «ï£Åâ A¼Iè÷£ù â«îËâ°ÂªÃ®Â´âèŠðâ ì ªð£¼â èŠñŸÃ⹠ïâ²èÅâ ÃAòõŸ¬øŠðò¡ð´Ë¶⹠GÃõùÆèÅ, ÃõŸP¡ ªè£Åºîâ¢, ðó£ñKËîâ¢, ʹøŠð´Ë¶ õîŸè£ù å¼ Fâ ìˬî»⹠ï¬ìº¬øè¬÷»⹠à ¼õ£âè «õâ¡Â´â¹ (CFR1998, 2002) Richmond et al. 2003) . ñ Q î «ï£ÅâA¼Iè÷£⢠âOF⢠ð£FâèŠðìâîò, Ãâ¢Ã´Â¶ ÃÃµÅ¸Â¬Ã¸Ë Ã®Â¼Mâèâîò, «ï£ªòFËŠ¹â °¬øð£´Å÷ Ãâ¢Ã´Â¶ ñóðµ Ãô⹠ñ£ŸøŠðâ ì MôÆ°èO¡ (Tââ¹Ã£-GMAs-Genetically Modified Animals) ðò¡ð£´; ñQÃ®Ë F²âèÅ, à Jóµ õK¬êèO¡ ðò¡ð£´; ââ°Ã®ÂªÃµÂ£Â¼ ªî£Ÿà «ï£ÅŠðâ ì MôÆ° ñ£FK»⹠ÃÆ° «õ¬ô
70 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ªêÅ»⹠ðEò£÷ËèO¡ à ìâ¢Ã¯Ã´â¹, ð£¶è£ŠHŸ° ÃFè ÃðË” ãŸð´Ë¶⹠(Lassniget al.2005; NIH 2002). Ãð£òèóñ£ù ªð£¼â èŠÃžâ à öL«ô«ò õ¬óòÃ˶ ¬õâèŠðì «õâ¡Â´â¹. â´Ë¶âè£â ì£è, Ãð£òèóñ£ù ªð£¼â è¬÷â ¬èò£Ãîâ¢, GËõAËî⢠ÃAòõŸP¡ «ð£¶ 裟«ø£â ìâ èâ ´Šð£â ¬ìŠðò¡ð´Ë¶îâ¢, òËîñ£ù MôÆ°èO¡ à ìŸÃà Þ ( CDC ñŸÃâ¹ NIH 2000 ) Ãóê£òù Ãð£òÆèÃì¡ ðE¹Kî⢠(Thomann 2003) ÃAò¬õ. à ö⢠ñ£ê¬ìõ¬îâ èâ ´Šð´Ëî ñòâè õ£»âèO¡ èN¾èŠÃNâèŠðì «õâ¡Â´â¹. îQ Ã¯Ã°Ë Ã°Â£Â¶Ã¨Â£Å Â¹ ªð£PJòâ¢, GËõ£èâ èâ ´Šð£´èŠðEÃ²Â£Ã·Ë Ã¨O¡ ð£¶è£ŠHŸè£ù ºî⢠«î¬õò£°â¹. ðEâà ö ½â°Šªð£¼Ëîñ£ù HHà (PPE), GÃõù⹠õöÆ°⹠ÃŬñò£ù ð£¶è£Š¹ à ¬ìèŠà â ðì ìù˶⹠«î¬õò£ù «ð£ªîâ¢Ã´Â£â¹ õöÆèŠðì «õâ¡Â´â¹. Ãð£òèóñ£ù ªð£¼â 芪è£â¡Ã¬ «õ¬ôŠð°Fâ° ªõO«ò Ãâ¢Ã´Â¶ MôÆ° õ£Nì ââ¢Â¬Ã´â° Êð£⢠ð£¶è£Š¹ à ¬ìèÅ, à ðèóÃÆèŠÃEòâÃ죶 (DHHS 2009). «î¬õŠðâ ì£⢠MôÆ°èO¡ ðó£ñKŠ¹â ªêò⢠èÃâ°ŠH¡ ÞŠªð£¼Šîò£Kâ°⹠ð°Fè¬÷ Mâ ´ ªõO«òÃ⹠«ð£¶ °O˶Mâ ´â ªêâ¢ÃµÂ¶ ïâ¢Ã´Â¶. Ãð£òèóñ£ù ªð£¼Š°PÅ Hâ ì Ãùõ¬è, Ãð£ò⹠ªõOŠð´⹠ê£ËFò⹠ªè£â¡Ã¬ à öL⢠ðEò£÷ËèÃâ° à âºG¬ô ê£Ëâ°Ã® ð£¶è£Š¹ ÃEè¬÷ õöÆè «õâ¡Â´â¹ (CFR 1984C). â´Ë¶âè£â ì£è, ñQîâ°óÆAùÆè¬÷â ¬èò£ÅÂ«ÃµÂ£Ë Â¬Ã¨Â»Â¬Ã¸Ã¨Å, º¿â¬èŠð£¶è£Š¹¬øèÅ, ªð£¼Ëîñ£ù ºèîèÅ, ºèâèõêÆèÅ, èâ¡Ã£®èŠÃAò HHÃ-âè¬÷ ªè£â¡Â®Â¼âè «õâ¡Â´â¹ (NRC 2003a). ÃFè êËî⹠à Å÷ ð°FèO⢠ªêMŠð£¶è£Š¹ üâè «õâ¡Â´â¹ (OSHA 1998c). òËîñ£ù 裟à õN˶èÅèŠÃâ¢Ã´Â¶ có£MèÃâ° à Å÷£èâîò ð°FèO⢠ðE¹K»⹠ðEò£÷Ë芪ð£¼Ëîñ£ù ²õ£êŠð£¶è£Š¬ðâ ªè£â¡Â®Â¼âè «õâ¡Â´â¹ (Fechter 1995; McCullough 2000; OSHA 1998d, OSHA 1998Aa). ²õ£êâ è¼M «ê£î¬ù, ²õ£êâ è¼MJ¡ êKò£ù ðò¡ð£´, ðó£ñKÅ
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠71 H⢠ðJŸC üâè «õâ¡Â´â¹ (DHHS 2009; NRC 1997; OSHA 1998a). ðEò£÷ËèÃâè£ù ñ¼Ë¶õ ñFÅ d´, î´Š¹ ñ¼Ë¶õ⹠ñ¼Ë¶õ ñFÅ d´, î´Š¹ ñ¼â°F¡ å¼ Fâ ì «ñâ¹Ã°Â£Â´, Ãî¡ ªêòô£âè⹠ÃAò¬õ ðJŸC ªðŸø ²è£î£ó G¹ÃËè÷£ù ðEâà ö⢠ê£Ëâ°Ã® ²è£î£ó ñ¼Ë¶õËèÅ, ªêMLòËèOìI¼â°Â¶ ªðøŠðâ ì îèõâ¢Ã¨Â¬Ã· à Å֓âAòî£è üâè «õâ¡Â´â¹. ñ¼Ë¶õ, êâ ìgFò£ù è£óEèÅ, Ãó² MFº¬øèO¡ H¡ùE J⢠ªð£¼Ëîñ£ù MîËF⢠è¼îŠðì «õâ¡Â´â¹ (â´Ë¶â è£â ´: PL 104-191). îQŠðâ ì ðEò£÷ËèÃâ° ãŸðìâîò Ãð£òÆè¬÷ ñFÅ H´õ ÃÃµË Ã°EJ⢠«êËõ ºâ°Â¬Ã®Ã² ²è£î£ó ÃP⏘ ñFÅ d´ ªêÅõ¶ ïâ¢Ã´Â¶. °PÅ Hâ ì Ãð£ò õ¬èèO⢠à Å÷ ðEò£÷ËèÃⰠÚõŠ«ð£¶ ñ¼Ë¶õ ñFÅ d´èŠÃP¾ÃËîŠð´A¡øù. â´Ë¶âè£â ì£è, ²õ£êŠð£¶è£Š¹ «î¬õŠð´⹠ðEò£÷ËèÃâ°, ÃõËèŠà ì⢠gFò£è¾⹠à ÷Mò⢠gFò£è¾⹠²õ£êâ è¼M¬òâ êKò£èŠðò¡ ð´Ëî º®»⹠â¡ð¬î à ÃFŠð´Ëî ñ¼Ë¶õ ñFÅ d´ «î¬õŠðìô£⹠(Sargent and Gallo 2003). ªð£¼Ëîñ£ù «ï£ÅË Ã®Â´Å Â¹ Ãâ ìõ¬à H¡ðŸøŠðì «õâ¡Â´â¹. ªìâ ìùú§â° (NRC 1997) âFó£è MôÆ°Šðó£ñKŠ¹ŠðEò£÷ËèÃâ° «ï£ÅËî´Š¹ áC «ð£´õ¶ ºâAòâ¹. «ñ½⹠«ï£Å˪à Ãð£òËF⢠à Å÷õËèÃâ°⹠Ãâ¢Ã´Â¶ «óHv ¬õóv «ð£¡ø °PÅ Hâ ì «ï£Åâ A¼IJ¡ î£âèËFŸ° âFó£è¾⹠(â´Ë¶âè£â ´: ªî£ŸÃ«ï£Åâè£ù ÃðËF⢠à Å÷ à JKùÆèÃì¡ ðE¹Kâ°Ã®Â£â¢) º¡ªùâêK⏠«ï£ÅË Ã®Â´Å Â¹ ñ¼â°Â¶ è¬÷ õöÆè «õâ¡Â´â¹. ªýð¬ì®v H ¬õóv (â´Ë¶â è£â ´: ñQî ÃóËîâ¹, ñQÃ®Ë F²âèÅ, ªêâ¢ÃµKèŠÃâ¢Ã´Â¶ Ã˪FèÃì¡ ðE¹Kâ°Ã®Â£â¢). ªî£ŸÃ«ï£Šî´ŠÃC芰P˶ Ãó£ÅâC ïìËîŠðì «õâ¡Â´â¹. Ãâ°Â«Ã¯Â£Åâ° âFó£ù î´ŠÃC ðKâ°Â¶Â¬Ã³âèŠð´Aø¶. «ñ½⹠°PÅ Hâ ì ðKâ°Â¶Â¬Ã³Ã¨Å BMBL (DHHS 2003a2009) Ã⢠A“âA¡øù. å¼ ðEê£Ëâ°Ã® ²è£î£ó, ð£¶è£Š¹
72 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® G¹Ãó£⢠(NRC 1997) GËÃJâèŠðâ ì °PÅ Hâ ì à âºG¬ôèO⢠ñâ ´«ñ º¡ «õ¬ôõ£ÅŠ¹ Ãâ¢Ã´Â¶ º¡ - ªõOŠð£´ ÃóËî «êèKŠ¹ ÃP¾ÃËîŠð´Aø¶. ö «ð£¡ø êâ°Ã®ËŠðÆèOâ¢, â´âèŠðâ ì ÃóËî ñ£FKèO¡ ììò£÷â¹, îìñPîâ¢, «êI˶ ¬õËîâ¢, «êIŠðè G¬ô¬ñèŠÃAòõŸ¬øâ è¼ËF⢠ªè£Å÷ «õâ¡Â´â¹. «ñ½⹠ÃóËî ñ£FKèŠðò¡ð´ËîŠð´⹠«ï£âèñ£ù¶ ªð£¼â°Ã®âîò Ãó² êâ ìÆèÃì¡ Ã¥Ë¶Š«ð£è «õâ¡Â´â¹. ÃÅõè MÃ´Æ Â°Ã¨ Ãì ¡ ª î £ì˹ ªè£â¡Ã¬ ïðËèÃâ° ÃÅõè MôÆ° åšõ£¬ñ å¼ °PÅ HìËîâè HóâC¬ùò£è ñ£P»Å֦ (Bush and Stave 2003; Gordon 2001;Wolfle and Bush 2001; Wood 2001). ñ¼Ë¶õâ èâ¡Ã¨Â£EÅ Â¹Ë Fâ ìñ£ù¶ åšõ£¬ñè¬÷ Ãóâ¹Ã°ËF«ô«ò èâ¡Ã¬Pò áâ°Mâè «õâ¡Â´â¹ (Bush 2001; Bush and Stave 2003; Seward 2001). 㟪èù«õ è£ÃŠð´⹠å¼ ïðK¡ åšõ£¬ñ¬ò ÃPò Ãõó¶ ñ¼Ë¶õ õóô£Ÿ¬ø ñFÅ d´ ªêÅò «õâ¡Â´â¹. ðEÃ²Â£Ã·Ë Ã°JŸCJâ¢, ÃÅõè MôÆ° åšõ£¬ñ, ÃÂ¬Ã®Ë Ã®Â´Å Ã°Ã®Å¸Ã¨Â£Ã¹ èâ ´Šð£â ´ ïìõ®â¬èèÅ, åšõ£¬ñ ÃP°Pè¬÷ º¡Ãâ ®«ò ììò£÷⹠è£Ãâ¢, ÃPâJìâ¢, MôÆ°èÃì¡ ðEò£ŸÃõîŸè£ù êKò£ù ¸â ðÆèŠðŸPò îèõâ¢Ã¨Å üâè «õâ¡Â´â¹. îMó ÃõŸ¬ø ñ£Ÿlì£èâ ªè£Å÷â Ã죶 (Gordon et al. 1997; Schweitzer et al 2003; Thulin et al 2002). ªð£PJò⢠Ãâ¢Ã´Â¶ ªêòâ¢ÂºÂ¬Ã¸ èâ ´Šð£´èÃâ° à èâ°Ã® (Harrison 2001; Reeb-Whitaker et al. 1999). ²õ£êŠð£¶è£Š¹â° HHà ÃõCò⹠â¡ø£â¢, «î¬õŠð´⹠ªð£¼Ëîñ£ù «ê£î¬ùèÅ, ðJŸCèŠõöÆèŠðì «õâ¡Â´â¹. MôÆè£⢠ðó¾⹠«ï£ÅèO¡ (Zoonosis) î´Š¹ æâââvH-á å¼ ð°Fò£è üâè «õâ¡Â´â¹ (DHHS 2009; NRC 1997). ê£ËFòñ£ù Ãâ¢Ã´Â¶ ÃPòŠðâ ì ð£îèÆèÅ, êâ°Â«Ã®AâèŠð´⹠²è£î£ó Ãð£òÆèÅ, «ï£Å芰P˶ îñ¶ «ñŸð£Ë¬õò£÷ËèÃâÂ°Ë ÂªÃ®KMâè ðEò£÷ËèŠÃP¾ÃËîŠðì «õâ¡Â´â¹. ñQîËèÃâ°Šðó¾⹠ñQîâ°óÆ°èO¡ «ï£ÅèŠè´¬ñò£ù Ãð˶è÷£è üâèô£⹠(NRC 2003a). MôÆÂ°Ë ÂªÃ®Â£Nâ¢Â¸â ð õâ¢Â½Ã¯Ë èÅ, è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õËèÅ, ÃÅõ£÷ËèÅ, ñ£ÃõËèÅ,
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠73 Ãó£ÅâC ªî£Nâ¢Â¸â ð õâ¢Â½Ã¯ËèÅ, ðó£ñKÅ Â¹Ë ÂªÃ®Â£Nô£÷ËèÅ, ñQîâ°óÆ°èO⢠ÃÃðõ⹠ªè£â¡Ã¬ õËèÅ, ÃõŸP¡ F²âèÅ, à ì⢠FóõÆèÅ, ñQîâ °óÆ°èO¡ õ£NìŠð°FŠðó£ñKÅ H⢠à Å÷õËèÃâ° è£ê«ï£ŠðK«ê£î¬ù¬ò õöâèñ£è ïìËî «õâ¡Â´â¹. ñâè£C¡ªý˪ðv ¬õóv 1 (Macacine herpesvirus 1) , (ÂºÂ¡Ã¹Ë ÂªÃªË«è£HbC¡ªý˪ðv ¬õóv 1, Cercopithecine herpesvirus 1 Ãâ¢Ã´Â¶ ªý˪ðvH ¬õóv, Herpes B virus) âÃ⹠¬õóú§â° ªõOŠð´õîŸè£ù ê£ËFòâ ÃÃèŠÃ¼Šðî£â¢, Ãâ°óÆ°èO¼â°Â¶ à JKò⢠ñ£FKèO⢠(ÃóËîâ¹, F²âèÅ) ðE¹K»⹠Ãâ¢Ã´Â¶ ¬èò£Ã⹠ïðËèÃâ° MôÆ°âè®, Có£ÅŠ¹ ãŸðâ ì£⢠Ãõêó CA␠G¬ôòÆè¬÷Šðò¡ð´Ëî ÃÃñF»⹠ÃP¾ÃË Ã®Â½â¹ Ã¼âè «õâ¡Â´â¹. (Cohen et al. 2002). Ãâ°óÆ°èÅ, ÃõŸP¡ F²âèÅ, à ì⢠FóõÆèÅ, MôÆ°èÃâ° Â«Ã¯Ã³Â®Ë ÂªÃ®Â£Ã¬Ë¹ ªè£â¡Ã¬ Ãâ¡Â´, à ðèóÃÆ芪î£ì˹¬ìò ð£FÅ HŸ°ŠHøè£ù èõùñ£ù CAâ; Ãî¡ H¡ù£¬÷ò M¬÷¬õ ÃPî⢠ÃAò¬õ ªêò⢠ð´ËîŠðì «õâ¡Â´â¹ (ibid; NRC 2003a). ìù˶ Mð˶âèÅ, è®èÅ, Có£ÅŠ¹èÅ, åšõ£¬ñ âFËM¬ùèŠ(NRC 1997) ÃAòõŸ¬ø ÃP⏠ªêÅõîŸè£ù ªîOõ£ù ï¬ìº¬øèŠGÃõŠðì «õâ¡Â´â¹, «ñ½⹠ö «ð£¡ø êâ¹Ã°ÃµÆèÃâè£ù ñ¼Ë¶õŠðó£ñKŠ¹ à ìù®ò£èâ A“âè «õâ¡Â´â¹ (Cohen et al. 2002; DHHS 2009). ðEÃ²Â£Ã·Ë Ã°Â£Â¶Ã¨Â£Å Â¹ êòô£ù Ãêâ¹Ã°Â£MîÆÃ¨Â¬Ã·Ë Ã®Â´â°⹠Fâ Ã¬Æ Ã¨Å ÂªÃ°Â£Â¶ÃµÂ£Ã¨ ÃòŸ¬èŠ«ðóN¾èÃâÂ°Ë b˾ 裵⹠Ã«î «õ¬÷Jâ¢, å¼ GÃõùËF¡ ðEò£÷ËÃ¨Â¬Ã·Ë Â¶Â¡Â¹ÃËîâ¢, î£â°îâ¢, ÞâÃìËF⢠Ã˶eøâ¢, bJìâ¢, è£âºÅ ¹ÃËâCò£⢠ÃNËî⢠«ð£¡ø °ŸøMò⢠ïìõ®â¬èèŠe¶ MNŠ¹Ã˾ ǔ›. ÃÅõè MôÆ°èÅ, Ãó£ÅâCŠðEò£÷ËèÅ, à ðèóÃÆèÅ, õêFèÅ, à JKò⢠ñ¼Ë¶õ Ãó£ÅâC «ð£¡øõŸP⢠à â¡Ã¬Â£Â°â¹ Ãâ²ÃËîâ¢Ã¨Â¬Ã·Â»â¹ èÃâA⢠â´Ë¶â ªè£Å÷ «õâ¡Â´â¹. «õ¬ôõ£ÅŠ¹â° ºâ°Â¬Ã®Ã² ðK«ê£î¬ù, ªð÷bè ñŸÃ⹠îèõ⢠ªî£Nâ¢Â¸â ðÅ
74 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ð£¶è£Š¹ à ÅOâ ì î´Š¹ ïìõ®â¬èèŠðKYLâèŠðì «õâ¡Â´â¹ (Miller 2007). MôÆ° ïô⹠ê£Ëâ°Ã® Ãâè¬øè¬÷ Mê£ó¬à ªêÅîâ¢, ÃP⏠ÃOËî⢠MôÆ° ïô¬ùŠð£¶è£Šð¶ â¡ð¶ Fâ ìË¶ì¡ ªî£ì˹¬ìò 嚪õ£¼ ïðK¡ ªð£ÃŠð£°â¹. MôÆ° ïô Ãâè¬øè¬÷ŠðŸP ÃPâ¬èòOŠð⹠Mê£KŠð⹠õNº¬øè¬÷ GÃõù⹠à ¼õ£âè «õâ¡Â´â¹, «ñ½⹠MôÆ°èO¡ ïô¡è¬÷ŠðŸPò ÃP⏠ÃOŠðîŸè£ù ºâAò˶õâ¹, õNº¬ø芰P˶ áNòËèŠÃPâ°F¼âè «õâ¡Â´â¹. êñKâè£Mâ¢, Ãâ°Ã® Ãâè¬øè¬÷ ñà Þ ªêÅõ⹠Mê£KŠð⹠ªð£ÃÅ H½Å÷ äæ (IO), äãC»C-(IACUC)-â° ÃFè£ó⹠à Å֦. ÃËî¬èò ÃPâ¬èèÃâè£ù ðFLâ¢, êâ¹Ã°â°Ã®Å ðâ ì ðEò£÷ËèÃâ°Šð£¶è£Š¹ ðŸPò Ãâè¬øèŠÃPMâèŠðì «õâ¡Â´â¹. Mê£ó¬ÃJ¡ èâ¡Â´H®Š¹ èÃ⹠«î¬õªòQâ¢, F¼Ëî ïìõ®â¬èèÃ⹠ðAóŠðì «õâ¡Â´â¹. HóâC¬ù, èâ¡Â´H®Š¹èÅ, â´âèŠðâ ì ïìõ®â¬èèŠðŸP äæ-¾â° å¼ ÃP⏠êñËÅ HâèŠðì «õâ¡Â´â¹. ¹è£óOâèŠðâ ì H¡ â´âèŠðâ ì ââ°Ã® êKò£ù ïìõ®â¬èèÃâ¹ ÃõÊð´ËîŠðì «õâ¡Â´â¹. ð£¶è£Š¹ Ãâè¬øè¬÷ ÃP⏠ÃOŠðîŸè£ù õNº¬øèŠà Å÷ù. ºâAò ÃìÆèOâ¢, GÃõù ÃµÂ¬Ã´Ë Ã®Ã·ÆèOâ¢, îÆè÷¶ Ãâè¬ø¬ò âšõ£à ÃOŠð¶, ò£¼â° ÃOŠð¶ â¡ðîŸè£ù õNº¬øèÃì¡ Ã¶ ªõOJìŠðì «õâ¡Â´â¹. ÃËî GËõ£èâ¹, äæ, äãC»C î¬ôõË, ã.M à â ðì ðô ªî£ì˹ º¬ùèŠðKⰠ¶¬óâèŠð´A¡øù. Ãâ°Ã®â ªêòâ¢Ã°Â£â ®⢠ììò£÷⹠è£â Ã¬Â£Ã±â¢ Â¹Ã¨Â£Ë ÃOâè M¼â¹Â¹Â«ÃµÂ£Â¼â° êâ¹Ã°â°Ã®Å ðâ ì / ÃPâ¬èòOâ°⹠îóŠHù¼â° âFó£ù °Ÿøâê£â ´, ðNõ£Æèâ¢Ã¨OL¼â°Â¶ ð£¶è£Š¹⹠üâè «õâ¡Â´â¹. GÃõùËF¡ MôÆ°Šðò¡ð£â ´ ïìõ®â¬è芰P˶ áNòËèÃâè£ù ðJŸC, õöâèñ£ù îèõ⢠ªî£ì˹ (ªð£ÃŠð£÷Ë, ðó£ñKŠð£÷Ë, GËõ£è áNòË芫ð£¡øõËèŠMôÆ°Šðò¡ð£â ®Ÿ° Êð£⢠à Å÷õËèÅ), CóñÆè¬÷â °¬øâèâôâ¹.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠75 Fâ ìõ¬ó¾ «ñŸð£Ë¬õ äãC»C-á ðÆ° äãC»C ìñŠ¹⹠ªêòâ¢Ã°Â£Â´â¹ äãC»C-J¡ ªð£ÃŠ¹ â¡ð¶ Fâ ìGó¬ô «ñŸð£Ë¬õJ´õ¶⹠õöâèñ£ù º¬øJ⢠ñFÅ d´ ªêÅõ¶⹠ðâ¹. ªð£¼Ëîñ£ù H¡ùE Ãî£óŠªð£¼â èÅ, ªð£¼Ëîñ£ù Ãî£óÆèÃâè£ù ÃÃñF, «î¬õŠðâ ì£⢠äãC»C à ÃÅ HùËèÃâ° ÃõËèO¡ ðEèÅ, ªð£ÃŠ¹è¬÷Š¹Kâ°Â¶ÂªÃ¨Â£Åõâ¹, °¿M¡ º¡ ªè£â¡Â´ÃµÃ³Å ðâ ì Câèâ¢Ã¨Â¬Ã· ñFÅ d´ ªêÅõîŸ °⹠à î¾õîŸè£ù °PÅ Hâ ì ðJŸC ÃOŠð¶ GÃÃµÃ¹Ë F¡ ªð£ÃŠð£°â¹. °¿ à ÃÅ HÃ¹Ë H¡õ¼⹠î°F à ÅÃ·ÃµË Â· è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË ÃªÂ£Â¡PÃ®âº ÂªÃ°Å¸Ã¸ÃµË (â´Ë¶âè£â ´: ACLAM, ECLAM, JCLAM, KCLAM) Ãâ¢Ã´Â¶ ÃÅõè MôÆ° ÃPMò⢠ñŸÃ⹠ñ¼Ë¶õËF⢠ðJŸC, ÃÃðõâ¹; GÃõùËF⢠à JKùÆèO¡ ðò¡ð£â ®⢠ÃÃðõâ¹. · °¬øâ°Ã®Ã°â ê⹠MôÆ°è¬÷ à Å֓âAò Ãó£ÅâC J⢠ÃÃðõ⹠õ£Åâ°Ã® Mâ¦Ã«Â£Qò£èŠðE¹K»⹠å¼õË. · °¬øâ°Ã®Ã°â ê⹠Mâ¦Ã«Â£Ã¹â¹ ê£ó£î H¡ùEJ⢠üâ°Â¶ å¼ à ÃÅ HùË, GÃõùËF¡ à Å«÷ Ãâ¢Ã´Â¶ ªõO«ò üŠðõË. · MôÆ°èO¡ êKò£ù ðó£ñKŠ¹, ðò¡ð£â ®⢠ªð£¶ êÃè ïô¡è¬÷ŠHóFGF˶õŠð´Ëî °¬øâ°Ã® ðâ ê⹠å¼ ªð£¶ à ÃÅ HÃ¹Ë Â«Ã®Â¬Ãµ. ªð£¶ à ÃÅ HÃ¹Ë ÃÅõè MôÆÂ°Å Ã°Ã²Ã¹Â£Ã·Ë Ã¨Ã·Â£Ã¨Â«ÃµÂ£, GÃõùË¶ì¡ ââ°Ã® õ¬èJ½⹠ªî£ì˹¬ì òõËè÷£è«õ£ Ãâ¢Ã´Â¶ GÃõùË¶ì¡ Ã¬Ãâ°Ã® å¼ ïðK¡ à ìù® °´â¹Ã° à ÃÅ Hùó£è«õ£ üâèâÃ죶. ªð£¶ à ÃÅ HùË, ðƫ蟹, ¶¬Ãâ ªêôMùÆèÃâè£ù ªî£¬è¬òŠªðøô£⹠(â´Ë¶âè£â ´: à þ, õ£èù õêF, ðòÃâ¹), Ãù£⢠Ãâ°Ã® áFò⹠«ð£¶ñ£ù õ¼ñ£ù Ãî£óñ£è üâè º®ò£¶ â¡ð«î£´, êÃèâ¹,
76 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ªð£¶ñâèÃì¡ à ÃÅ HùK¡ ªî£ìˬð ªð¼ñ÷M⢠êñóê⹠ªêÅ»⹠Ãð£ò˔⠪è£â¡Ã¬Ã°Â® ªð¼â°ÂªÃ®Â£Â¬Ã¨ ò£è üâèâ Ã죶. ðô GËõ£è Ãô°èŠÃâ¢Ã´Â¶ ¶¬øè¬÷â ªè£â¡Ã¬ ªðKò GÃõùÆèÃâ°, å¼ GËõ£è Ãô°ì¡ áà GËõ£AèÃâ° «ñ⢠ªî£ì˹ð´Ëîâ Ã죶 (USDA 1985). GÃõùËF¡ Ã÷¾, Fâ ìËF¡ ñ ñŸÃâ¹ Ã÷¾ ÃAò¬õ °¿M¡ à ÃÅ HùËèO¡ ââ¡Eâ¬è¬ò»⹠ÃõËèO¡ Gòñù MFº¬øè¬÷»⹠bËñ£Qâ°â¹. ðóâ°Ã® Ãó£ÅâCË Fâ ìÆè¬÷â ªè£â¡Ã¬ GÃõùÆèÅ, MôÆ°Šðò¡ð£â ´ ªïPº¬øè¬÷â êKò£è ñFÅ H´ õŠðô ¶¬øèŠê£Ëâ°Ã® ÃÃðõê£LèOL¼â°Â¶â¹ Mâ¦Ã«Â£QÃ¨Â¬Ã·Ë Â«Ã®Ë¾ ªêÅò «õâ¡Â®J¼âèô£â¹. õNè£â ®J¡ Hø HK¾èO⢠MõKâèŠðâ ´Å÷ ð® ÂºÂ¿Ë Fâ ìˬî»⹠Ãî¡ ÃÃè¬÷»⹠«ñŸð£Ë¬õâ ªêÅõâ¹, ñFÅ d´ ªêÅõ⹠Ãâ°Ã®â °¿ ªð£ÃŠð£°â¹. Ãî¡ «ñŸð£Ë¬õâ ªêòâ¢Ã°Â£Â´Ã¨Oâ¢, º¡ªñ£NòŠðâ ì MôÆ°Šðò¡ð£â ®¡ ñÃÞ, 効îâ¢, (ªïPº¬ø ñÃÞ) MôÆ°Šðò¡ð£â ®⢠º¡ªñ£NòŠðâ ì °PÅ HìËîâè ñ£ŸøÆèŠÃAò¬õ ÃìÆ°â¹. ÃÅõè õêFèÅ, MôÆ°Šðò¡ð£â ´Šð°F Ã¨Â¬Ã·Ë ÂªÃ®Â£Ã¬Ëâ°Â¶ Þ ªêÅîâ¢; Fâ ìËF¡ õöâèñ£ù Þ; MôÆ°Šðó£ñKŠ¹, ðò¡ð£´ ðŸPò ð£¬îò ñFÅ d´; GÃõùËF⢠MôÆ°èO¡ ðó£ñKŠ¹, ðò¡ð£´ êâ¹Ã°â°Ã®Å ðâ ì Ãâè¬øè¬÷ŠªðÃõ⹠ñFŠð£Å¾ ªêÅõ⹠å¼ õNº¬ø¬ò Gþî⢠ÃAò¬õ ÃìÆ°â¹. °¿ îù¶ ªð£ÃŠ¹è¬÷ G¬ø«õŸø «î¬õŠðâ ì£⢠îâè® êâ°Fâè «õâ¡Â´â¹. «ñ½⹠°¿â Ãâ ìÆèO¡ ðF¾èÅ, èôâ°Â¶Â¬Ã³Ã²Â£Ã¬â¢Ã¨O¡ º®¾èŠðó£ñKâèŠðì «õâ¡Â´â¹. Fâ ìõ¬ó¾ ñÃÞ, è÷ õêFèO¡ Þ芰¬øâ°Ã®Â¶ Ãâ¡Â´Â«Ã®Â£Ãâ¹ Ãâ¢Ã´Â¶ ǔ›â«èŸð îâè® Gèö «õâ¡Â´â¹ (â´Ë¶âè£â ´: MôÆ° ïôâ êâ ì⹠ñŸÃâ¹ Hø ªè£Å¬èŠð®). ñFŠð£Å¾ ñŸÃ⹠ÞⰊHø°, Fâ ìËF¡ G¬ô °P˶ äæ-¾â° â¿îŠðâ ì ÃP⏠(ã«îÃâ¹ CPò è¼Ë¶èŠà â ðì) êñËÅ HâèŠðì «õâ¡Â´â¹.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠77 ªïPº¬ø ñFŠð£Å¾ MôÆ°Šðò¡ð£â ´ ªïPº¬ø â¡ð¶ ÃÅõè MôÆ°èO¡ º¡ªñ£NòŠðâ ì ðò¡ð£â ®¡ MKõ£ù M÷âèñ£°â¹. ÃÅõ£÷ó£⢠ªïPº¬ø îò£KŠðF½â¹, äãC»C-J¡ ñFŠð£ÅM½⹠H¡õ¼⹠î¬ôŠ¹èŠè¼îŠðì «õâ¡Â´â¹: · MôÆ°èO¡ º¡ªñ£NòŠðâ ì ðò¡ð£â ®¡ îŠð¬ì Gò£òº⹠«ï£âèºâ¹. · °¿M¡ ìù˶ à ÃÅ HùËèÃ⹠âOF⢠¹Kâ°Â¶ ªè£Å÷âîò MôÆ°èO¡ ðò¡ð£â “ à Å֓âAò ï¬ìº¬øèŠðŸPò ªîOõ£ù, ²¼âèñ£ù ÂªÃ®Â£Ã¬Ë MõKŠ¹. · °¬øõ£ù à Å«÷Ã⹠ï¬ìº¬øèÅ, Hø ÃùÆèÅ, îQ¬ñŠð´ËîŠðâ ì à ʹ îò£KŠ¹, ªê⢠Ãâ¢Ã´Â¶ F² õ÷ËŠ¹, èEQ à ¼õèŠð´Ë¶î⢠ÃAò õŸP¡ º¬øò£ù ðò¡ð£´, ðò¡ð£â ®¡ ñ (H¡ ìʹ Ã, ñ£ŸÃè¬÷Šð£Ëâè¾â¹). · ÃùÆèŠñŸÃ⹠º¡ªñ£NòŠðâ ì MôÆ°èO¡ ââ¡E⏘ Gò£òŠð´Ë¶îâ¢; ê£ËFòŠð´⹠êñòÆèO⢠MôÆ°èO¡ ââ¡Eâ, «ê£î¬ùâ °¿ Ã÷¾èŠÃAòù ¹ÅOMõó gFò£è Gò£òŠð´ËîŠðì «õâ¡Â´â¹. (â´Ë¶âè£â ´: ââ¡E⏠ðŸPò ßø⢠ð°Šð£Å¬õ õöÆ°îâ¢; H¡ ìʹ Ã, ðK«ê£î¬ù õ®õ¬ñŠ¹ ñŸÃ⹠¹ÅOMõóÆè¬÷Šð£Ëâè¾â¹). · «ê£î¬ùèO⢠«î¬õòŸø ñëê£FŠ¹. · îóñŸø õ£Nì õêF ñŸÃ⹠õ÷ËÅ Â¹Ë Â«Ã®Â¬ÃµÃ¨Å. · MôÆ°èO¡ ïâ¢ÃµÂ£âºM⢠º¡ªñ£NòŠðâ ì ï¬ìº¬øèO¡ î£âèâ¹. · ªð£¼Ëîñ£ù õLË Ã®EŠ¹, õL Gõ£óE, ñòâè ñ¼â°Â¶ (õL Ãâ¢Ã´Â¶ à Å«÷Ã⹠º¬øJ¡ °Pf´èÅ, ªïPÂºÂ¬Ã¸Ã¨Â¬Ã·Ë Ã®Ã²Â£KŠð⹠ñFŠð£Å¾ ªêÅõ⹠à îõâôâ¹. H¡ ìʹ à - ñòâè ñ¼â°Â¶, õL ñŸÃâ¹ Ãìõ CAâ¬ê¬òŠð£Ëâè¾â¹). · ðô îóŠðâ ì ªêòâ¢ÂºÂ¬Ã¸Ã¨Å ªè£â¡Ã¬ Ãìõ CA␠º¬øè¬÷ GèâºË¶îâ¢.
78 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® · Hâ°Â¬Ã®Ã² ï¬ìº¬øŠðó£ñKŠ¹, Ãõî£QŠ¹ (â´Ë¶âè£â ´: CAââ°ŠHâ°Â¬Ã®Ã² ðó£ñKŠ¹, Ãìõ CAââ°ŠH¡ù£ù MôÆ° ñFÅ dâ ´Šð®õÆè¬÷ ìÃËîâ¢). · âFËð£ËâèŠðâ ì Ãâ¢Ã´Â¶ «îËâ°ÂªÃ®Â´âèŠðâ ì ÃÃF º®¾âè£ù M÷âèâ¹, Gò£òâ¹; êKò£ù «ïóËF⢠î¬ôJ´õîŸè£ù Ã÷¾«è£â¢Ã¨Å ñŸÃ⹠ªêòâ¢ÂºÂ¬Ã¸. · å¼ ÃÅML¼â°Â¶ MôÆ°è¬÷ câ°îâ¢, õL Ãâ¢Ã´Â¶ ñù ÿËî M¬÷¾èŠâFËð£ËâèŠðâ ì£⢠輬Ã⠪裬ôJ¡ ǔ›. · Þ º®â°Ã®H¡ câ¡Ã¬Ã¨Â£Ã´Ã±Â£Ã¨ õ£¿⹠à JKÃ¹Æ Ã¨Â¬Ã·â èõQ˶⠪è£ÅõîŸè£ù Fâ ìIì⢠à â ðì, 輬Ãâªè£¬ô Ãâ¢Ã´Â¶ MôÆ°è¬÷ ÃèŸÃ⹠º¬ø. · ðò¡ð´ËîŠðâ ì ï¬ìº¬øèO⢠ðEÃ²Â£Ã·Ë Ã¨O¡ ðJŸC, ÃÃðõËF¡ «ð£¶ñ£ù Ã÷¾, êâ¹Ã°â°Ã®Å ðâ ì ðEò£÷ËèO¡ ðEèÅ, ªð£ÃŠ¹èÅ. · Ãð£òèóñ£ù ªð£¼â èO¡ ðò¡ð£â ®¡«ð£¶ ð£¶è£Šð£ù ðEâà ö¬ô õöÆ°îâ¢. Mâ¦Ã«Â£Ã¹Ë î°F, ñÃÞâè£ù ªð£ÃŠ¹ ªð£¶õ£è äãC»C-ⰠÊð£Ÿðâ ´ à Å֦ â¡ø£½â¹, °¿ à ÃÅ HùËèŠMôÆ°èO¡ ïô¡, ðò¡ð£´ ÂªÃ®Â£Ã¬Ë Ã°Â£Ã¹ ªïPº¬øJ¡ ÃPMò⢠ÃÃè¬÷ ñFÅ d´ ªêÅò «õâ¡Â´â¹. â´Ë¶âè£â ì£è, ¹Fò è¼Ë” «ê£FŠð¶, ñ£FK Ã÷¾, °¿M¡ ââ¡Eâ, èâ ´Šð£´èO¡ «ð£¶ñ£ù ñ ÃAò¬õ «î¬õòŸø MôÆ°èO¡ ðò¡ð£â Â¬Ã¬Ë Ã®Â´Å Ã°Â¶ Ãâ¢Ã´Â¶ 塬ø ñëê£î¬ù ªêÅÃµÂ¬Ã®Ë Ã®Â´Ëî⢠ÃAòõŸ¬ø Â«Ã¯Ã³Â®Ã²Â£Ã¨Ë ÂªÃ®Â£Ã¬Ë¹ ð´Ëîô£â¹. Cô äãC»C «èÅMèÃâ°, ªõOG¹ÃËèOì I¼â°Â¶ ªðÃ⹠îèõ⢠ÃP¾ÃËîô£è«õ£ Ãâ¢Ã´Â¶ ÃõCòñ£è«õ£ üâèô£â¹. º¬øò£ù Mâ¦Ã«Â£Ã¹Ë î°F ñFŠð£Å¾âè£ù ꣡ÃèŠÃâ¢Ã´Â£Ã® G¬ôJâ¢, ÃËî¬èò ñFŠð£Å¬õ ïì˶õ¶ Ãâ¢Ã´Â¶ «è£¼õ¬î äãC»C ðKYLâèô£⹠(Mann and Prentice 2004). ªïPº¬øèO⢠ªðò KìŠðâ ì äãC»C-à ÃÅ HùËèÅ, Hø è¼Ë¶ ºóâ¡Ã°Â£Â´ à Å÷õËèŠÃâ°Ã® ªïPº¬ø芪î£ìËð£ù º®¾èO L¼â°Â¶ îÆÃ¨Â¬Ã·Ë Ã®Â£Æè«÷ MôâAâªè£Å÷«õâ¡Â´â¹.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠79 Cô «ïóÆèOâ¢, ªïPº¬øèOâ¢ ÂºÂ¡Ã¹Ë Ãªâ°Fâè£î, ïâ¹Ã°Ëî°â°Ã® º¬øJ⢠èEâè«õ£ èâ ´Šð´Ëî«õ£ º®ò£î õL Ãâ¢Ã´Â¶ ñùà ¬÷âê¬ô ãŸð´Ë¶⹠ê£ËFòâÃÃèŠÃ¼âèâôâ¹. ï¬ìº¬øèÅ, ÃÅM¡ «ï£âè⹠ðŸPò ªð£¼Ëîñ£ù ¹øGÂ¬Ã´Ë Ã®Ã¨Ãµâ¢Ã¨Â¬Ã· M â¦Ã«Â£ ù Å Hó² Ã³Æ Ã¨ Å, è £â¢Ã¯Â¬Ã¬ ñ ¼ ˶õËèÅ, ÃÅõ£÷ËèÅ, MôÆ°èOìI¼â°Â¶ ãŸð´⹠ð£FŠ¹èŠ°P˶ ÃPâ°Â¶ ñŸøõËèOìI¼â°Â¶ ªðø «õâ¡Â´â¹. å¼ °PÅ Hâ ì ªêòâ¢ÂºÂ¬Ã¸Â¬Ã²Å ðŸP ÃFè⹠ÃPòŠðì£ Mâ ì£â¢, MôÆ°èO¡ eî£ù ªêòâ¢ÂºÂ¬Ã¸J¡ M¬÷¾ èÅ, Ãó£ÅâCâ °¿M¡ Fø¡èŠÃóâ¡Â¬Ã¬Â»â¹ ñFÅ H´ õîŸè£è Ã衫ø õ®õ¬ñâèŠðâ ì, õ¬óòÃâèŠðâ ì º¡ ÞèÅ, äãC»C «ñŸð£Ë¬õJ¡ W⺠ïìËîŠð´õ¶ ªð£¼Ëîñ£ù¶. Ãâ°Ã®â à âºG¬ôèO⢠CôõŸPŸè£ù ªïPº¬ø Ãâ¢Ã´Â¶ õNº¬ø ñFÅ dâ ®Ÿ è£ù ªð£¶õ£ù õNè£â ´îâ¢Ã¨Å W«ö ªè£´âèŠðâ ´Å÷ù. Ãù£⢠ìõ ââ¢Ã´Â£ GèâºÂ¾Ã¨O½⹠ªð£¼â°Ã®Â£Â¶. äãC»C-J¡ ñFŠð£Å¾âè£ù CøŠ¹â è£óEèŠCô MôÆ°Šðò¡ð£â ´ ªïPº¬øèOâ¢, äãC»C- J¡ ñÃÃÅM¡ «ð£¶ GõËËFâèŠðì£î õL, ñù à ¬÷âêâ¢, Hø MôÆ° ïô¡èÃâè£ù Ãâè¬øèŠè£óÃñ£è CøŠ¹â èõù⹠«î¬õŠð´⹠ï¬ìº¬øèŠÃâ¢Ã´Â¶ õ°º¬øèŠÃ¼âèâôâ¹. W«ö»Å÷ î¬ôŠ¹èŠäãC»C CøŠð£èâ è¼ËF⢠ªè£Å÷ «õâ¡Â®Ã² ªð£¶õ£ù Ãâ¹ÃªÆèÅ. ö«ð£¡ø ð°FèOâ¢, MôÆ°èO¡ ïô¡èÃâ° âFó£ù ÃÅM¡ «ï£âèÆè¬÷ â¬ì«ð£ì äãC»C èì¬ñŠðâ ´Å֦. ðK«ê£î¬ù õNº¬øèO¡ ²ËFèKŠ¹âè£ù õ£ÅŠ¹èÅ, ªð£¼Ëî ñ£ù MôÆ° Ãâ¢Ã´Â£Ã® ñ£Ÿà õNè¬÷Šðò¡ð´Ë¶îâ¢, °¬øõ£ù MôÆ°èO¡ ðò¡ð£´ ÃAòõŸ¬øâ è¼ËF⢠ªè£Åõî¡Ãôâ¹, GÃõùº⹠ºî¡¬ñ ÃÅÃµÂ£Ã·Ë (Hä) ñQî£Hñ£ù MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ®Ÿè£ù îÆè÷¶ ªð£ÃŠ¹è¬÷ G¬ø«õŸø Ãóâ¹Hâèô£â¹. ðK«ê£î¬ù ñŸÃ⹠ñQî£Hñ£ù ÃÃF º®¾èŠMâ¦Ã«Â£Ã¹ «ï£âèÆèÅ, °Pâ«è£Åè¬÷ ìì»⹠«ð£¶ å¼ ÃžŠðK«ê£î¬ù º®¾â° õ¼Aø¶.
80 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® MôÆ°èO¡ ñQî£Hñ£ù ÃÃF º®¾èŠâ¡ð¶ å¼ «ê£î¬ù MôÆA¡ õL, ñù à ¬÷âê⢠î´âèŠð´õ¶, GÃËîŠð´õ¶ Ãâ¢Ã´Â¶ Gõ£óÃ⹠ªðÃõ¶ ðâ¹. ñQî£Hñ£ù ÃÃF º®¾èO¡ ðò¡ð£´, ðK«ê£î¬ùâ °Kò MôÆ°èO¡ ÃÃF º®¾èÃâ° å¼ ñ£Ÿlâ “ õöÆ°õî¡ Ãô⹠«ê£î¬ùº¬øâ ²ËFèKŠ¹â°ŠðÆèOâAø¶. Ãî¡ M¬÷õ£è ñóÃâ¹ Ã â ðì GõËËFâèŠðì£î Ãâ¢Ã´Â¶ è´¬ñò£ù MôÆ° õL ñŸÃ⹠¶¡ð⹠ãŸð´õ¶ î´âèŠð´Aø¶. ñQî£Hñ£ù ÃÃF º®¾ ªð£¼Ëîñ£ùî£è¾⹠ïâ¹Ã°Ã¨Ã±Â£Ã¹Ã®Â£Ã¨Â¾â¹ üâè «õâ¡Â´â¹ (Hendriksen and Steen 2000; Olfert and Godson 2000; Sass 2000; Stokes 2002) à Å«÷Ã⹠«ê£î¬ùèOâ¢, ðK«ê£î¬ùèŠñQî£Hñ£ù ÃÃF º®¾èŠªï¼âè ñ£è ìÃâèŠðâ ´Å÷ù (Wallace 2000) . äãC»C ªïPº¬ø ñFŠð£ÅM¡ «ð£¶ ö èõùñ£èâ è¼îŠðì «õâ¡Â´â¹. ìù˶ ÞèÃ⹠ñQî£Hñ£ùºÅ÷ ÃÃF º®¾è¬÷Šðò¡ð´Ëî «õâ¡Â´â¹ â¡ø£½â¹, ªð£¶õ£è ÞèÅ, èâ ®ñ£FKèÅ, ªî£ŸÃ«ï£ÅèÅ, î´ŠÃC êõ£â¢Ã¨Å, õL ñ£FKèÅ, ÃFËâC, «ñ£«ù£â «÷£ù⢠á®ð£®èO¡ à ŸðËF, ïâCò⢠M¬÷¾è¬÷ ñFÅ d´ ªêÅîâ¢, à ðèóÃÆèÅ, èEQJ¡ ÃòÆ° Fø¡, üîò ÃóËîâ°ö£Š(è£Ë®«ò£ õ£v°ôË) ÃFËâCJ¡ ñ£FKèŠÃAòõŸP⢠CøŠ¹â èõù⹠«î¬õŠð´â¹. ÃÅM¡ «ï£âèÆèÅ, º¡ªñ£NòŠðâ ì ñ£FK ÃAò Ãóâ¡Â¬Ã¬Â»â¹ ðŸPò ¶â¢Lòñ£ù ÃP¬õâ ªè£â¡Ã¬ Hä-PI, MôÆ°Šðò¡ð£â ®¡ ñQî£Hñ£ù ñŸÃâ¹ Mâ¦Ã«Â£Ã¹ gFò£ù ªïPº¬øJ⢠å¼ ÃÅM¡ ÃÃF º®¬õ ììò£÷⹠è£Ã¾â¹, M÷âè¾â¹, «êËâè ¾⹠«õâ¡Â´â¹. üŠHÃâ¹, ñQî£Hñ£ù ÃÃF º®¾ è¬÷ ììò£÷⹠è£â¡Ã°Â¶ ªð¼â¹Ã°Â£Â½â¹ êõ£ô£ù¶. ãªù¡ø£⢠ñ£FK, ÃùÆèŠ(ñŸÃâ¹ Cô «ïóÆèO⢠Ãùõ¬è Ãâ¢Ã´Â¶ Ãù˪Š¹), MôÆ°èO¡ ²è£î£ó G¬ô, Þ «ï£âèÆèÅ, GÃõùâ ªè£Å, å¿Æ° ÂºÂ¬Ã¸Ë Â«Ã®Â¬ÃµÃ¨Å, ÚõŠ«ð£¶ ºóâ¡Ã°Â´â¹ ÃPMò⢠Hó²óÆèŠà â ðìŠðô è£óEè¬÷ â¬ì«ð£ì «õâ¡Â´â¹. ñQî£Hñ£ù ÃÃF ÂºÂ®Â¾Ã¨Â¬Ã·Ë bËñ£QŠð¶, Hä, è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË Ã±Å¸Ã⹠äãC»C ÃAòõŸ¬ø à Å֓âAòî£è üâè «õâ¡Â´â¹. «ñ½⹠ÃŬõË
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠81 ªî£ìÆ°õ ÂºÂ¡Ã¹Ë ÂºÂ®â°Ã®ÃµÂ¬Ã³ ö õ¬óòÃâèŠðì «õâ¡Â´â¹ (Olfert and Godson 2000; Stokes 2000). å¼ ªïPº¬øJ⢠ªð£¼Ëîñ£ù ÃÃF º®¾ ê£Ëâ°Ã® è¼Ë” äãC»C ñFÅ d´ ªêÅõ ºâAòñ£ù îèõâ¢, ñQî£Hñ£ù ÃÃF º®¾èO¡ ¶â¢Lòñ£ù õ¬óò¬ø (ñFÅ dâ ´ Ã÷¾«è£â¢Ã¨Å à â ðì), MôÆ° è¬÷â èâ¡Ã¨Â£EŠðî¡ GèâºÂªÃµâ¡, ñFÅ dâ ®Ÿ°Šªð£ÃŠð£ù ðEò£÷ËèÃâ° ñQî£Hñ£ù ÃÃF º®¾è¬÷ŠðŸP»⹠ñQî£Hñ£ù ÃÃFº®¬õ Óâ°Ã®Â¾Ã¬Â¡ «î¬õŠð´⹠ªêòâ¢ÂºÂ¬Ã¸Ã¨Å ðŸP»⹠ðJŸC, ÃÆWè£ó⹠ÃAò¬õ ÃìÆ°â¹. º¡Ãâ ®«ò 輬Ãâªè£¬ô (Toth 2000) ðŸPò ¹Kîâ¢, «ï£»Ÿø Gô¬ñ J⢠MôÆA¡ ïìË” Ãâ¢Ã´Â¶ à ìLò⢠õ¬óò¬øèŠ(ibid), °PÅ Hâ ì ÃÅM⢠MôÆ° ñFÅ dâ ´ŠðF¾èO¡ ðò¡ð£´ Morton 2000; Paster et al. 2009) Hä, äãC»C-â° º¡ªñ£NòŠðâ ì ÃÃF º®¾è¬÷ ñFÅ Hì¾⹠à ¼õ£âè¾⹠à î¾â¹. ¹¶¬ñò£ù Þ芺¡ªñ£NòŠð´⹠«ð£¶ Ãâ¢Ã´Â¶ ñ£Ÿà ÃÃF º®¾âè£ù îèõâ¢Ã¨Å Ãâ¢Ã´Â£Ã®Â«Ã°Â£Â¶, ªõÅ«÷£â ì ÞèO¡ ðò¡ð£´ ñQî£Hñ£ù ÃÃF º®¾è¬÷ ììò£÷⹠èâ¡Â´ õ¬óòÊð⹠Hä, äãC»C, è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË Ã¨O“ǘ å¼IËî è¼Ë” ììõ⹠å¼ Cøâ°Ã® º¬øò£°â¹. äãC»C-»ì¡ îèõ⢠ªî£ì˹âè£ù å¼ Fâ ì õ®õ⹠ÃËî¬èò ÞèO¡ «ð£¶⹠ÃŠH¡ù¼⹠üâè «õâ¡Â´â¹. ðô ªõOf´èŠñQî£H ñ£ù ÃÃF º®¾èO¡ ðò¡ð£´, ÃîŸè£ù °PÅ Hâ ì Fâ ìÆè¬÷ŠðŸP °PÅ H´A¡øù (â´Ë¶âè£â ´: CC.VC-CC.AC 1998 äââ¢Ã£ÃË- ILAR 2000: æÃC®-OECD 1999; Toth 1997; »«èCCÃË- UKCCCR 1997). âFËð£ó£î º®¾èŠMâ¦Ã«Â£Ã¹â¹ ê£Ëâ°Ã® «îìL¡ îŠð¬ì â¡ð¶ ¹¶¬ñò£ù ðK«ê£î¬ù ñ£PèŠðŸPò Mê£ó¬à ò£°â¹. Iè¾⹠¹¶¬ñò£ù ñ£PèŠÃPºèŠð´ËîŠð´⹠«ð£¶ MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¬Ãµ ð£Fâèâîò âFË Ã°Â£Ã³Â£Ã® M¬÷¾èÃâè£ù ê£ËFòâÃÃèŠÃ¼Šðî£â¢, MôÆ°è¬÷ îâè® èâ¡Ã¨Â£EŠð¶ «î¬õŠðìô£â¹. âFËð£ó£î à ¼õ õ¬èè¬÷ à ¼õ£â°⹠à Å÷£Ëâ°Ã®
82 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ßø⢠ªè£â¡Â®Â¼Å ðî£â¢, âFËð£ó£î M¬÷¾è¬÷â èâ¡Ã¨Â£Eâè «õâ¡Â®Ã²Ã®Å¸Â° Tââ¹Ã£-âèŠå¼ â´Ë¶â è£â ´ ð⹠(Dennis 1999). Tââ¹Ã£âèÅ- GMAs, °PŠð£è âLèÅ, e¡èO⢠ºâAòñ£ù MôÆ° ñ£FKè÷£°â¹. «ñ½⹠ÃõŸP¡ Ãô⹠ñóðµ ¬èò£Ãî½âè£ù ¹Fò º¬øèÅ, «êËâ¬è芪î£ìËâ°Â¶ à ¼õ£âèŠð´A¡øù (Gondo 2008). ñóðµ¬õâ ¬èò£Ãî⢠å¼ °PÅ Hâ ì ÃôâA¬ùâ ªè£â¡Â´Å÷î£ Ãâ¢Â¬Ã´Ã²Â£ â¡ð¬îŠªð£¼â ð´Ëî£ñâ¢, Ãóâ¹Ã°ËF⢠M¬÷Mâ°⹠à ¼õ õ¬è芪ð¼â¹Ã°Â£Â½â¹ èEâè º®ò£î¬õò£°â¹. «ñ½⹠ö MôÆ° ûO¡ ââ°Ã®â èâ ìËF½⹠ÃõŸP¡ à JË ÃµÂ£âºÂ¬Ãµ ð£Fâ°â¹. âFËð£ËËî Ãâ¢Ã´Â¶ âFËð£ó£î M¬÷¾èÃâ° õN õ°â°â¹. â´Ë¶âè£â ì£è, Cô GèâºÂ¾Ã¨O⢠ñóðµ ñ£Ÿøñ£ù¶ âFËð£ó£î «ï£ªòFËŠ¹â °¬øð£â ®Ÿ° õNõ°Ëî¶. Ãîù£ô£ù Tââ¹Ã£ êâ°Ã®F¬ò CøŠ¹ à JË Môâ° G¬ô¬ñèO¡ W⺠¬õâèŠðì «õâ¡Â®J¼â°Ã®Â¶ (Mumphrey et al. 2007). °PÅ Hâ ì F²âèO⢠ñ£Ÿl´ ñóðµ âÃ⹠®ó£¡vp¡è¬÷ (Transgenes) «ïó®ò£è ªõOŠð´ËîŠðò¡ð´⹠áâ°MŠ¹ ñóðµ êóõK¬êèŠñ£à ðâ ì Ã÷Mô£ù °PÅ Hâ ì ñ¬òâ ªè£â¡Â®Â¼â°Ã®Ã¹ (èC¾Ëñ). ö âFËð£ó£î à ¼õ õ¬èâ° õNõ°â°⹠(Moore-head et al 2003). Ãâ°Ã® â´Ë¶âè£â ´èŠâFËð£ó£î M¬÷¾èO¡ ð¡ºèËñ¬ò M÷â° A¡øù; MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¬Ãµ à ÃFŠð´Ëî M죺òŸC»ì¡ èâ¡Ã¨Â£Eâè¾⹠ñŸÃ⹠ªî£Nâ¢ÂºÂ¬Ã¸ bËÅ H¡ ÃõCòˬî»⹠õL»Ã˶A¡øù (Dennis 2000). ¹Fî£è à ¼õ£âèŠðâ ì Tââ¹Ã£ õKJ¡ ºî⢠êâ°Ã®F «ï£Å, õL Ãâ¢Ã´Â¶ ¶òóËF¡ ÃP°PèÃâè£è HøŠH L¼â°Â¶ ºFË ÃµÃ²Â¶ÃµÂ¬Ã³ èõùñ£è èõQâèŠðì «õâ¡Â´â¹. ʹFò à ¼õ õ¬è °PÅ Hâ ì ñóðµ õ¬èèŠÃùŠªð¼âè⹠ªêÅÃµÂ¬Ã®Ë Ã®Â´âAøî£ â¡ð¬î »⹠è£à «õâ¡Â´â¹. ãªùQ⢠ö ðò¡ð´ËîŠðâ ì MôÆ°èO¡ ââ¡EâJ⢠ÃFèKŠ¹, MôÆ°Šðò¡ð£â ´ ªïPº¬øJ¡ F¼ËîËFŸ° õNõ°â°⹠à âºG¬ôèŠâ¡ð¬î ÃÅõ£÷ËèŠèâ¡Â´ÂªÃ¨Â£Å÷ô£â¹. Tââ¹Ã£-á Ãóâ¹Ã° °Ã£â¹Ãªâ¹ MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¬Ãµ âFËñ¬øò£èŠð£Fâ°⹠å¼ G¬ô¬ò ªõOŠð´Ë¶â¹
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠83 «ð£¶, ö äãC»C-â° ªîKMâèŠðì «õâ¡Â´â¹. «ñ½⹠¹Fò à ¼õ õ¬è¬òâ CøŠð£è õ¬óòÃâè áÃâ¹ MKõ£ù ð°Šð£Å¾ «î¬õŠðìô£⹠(Brown et al. 2000; Crawley 1999; Dennis 2000). ÃËî¬èò èâ¡Ã¨Â£EŠ¹⹠ÃP⏠Jì½â¹, ö «ð£¡ø ªêòâ¢Fø¡ Iâè ïìõ®â¬èèŠMôÆ°èO¡ ïâ¢ÃµÂ£âºM⢠ñóðµ ñ£ŸøËF¡ î£âèËÂ¬Ã®Ë Ã®MËâè º®»ñ£ Ãâ¢Ã´Â¶ °¬øâè º®»ñ£ Ã¢Â¡Ã°Â¬Ã®Ë bËñ£Qâè à î¾A¡øù. Tââ¹Ã£-õKâ° °PÅ Hâ ì ñQî£Hñ£ù ÃÃF º®¾è¬÷»⹠GþA¡øù. ªð÷bèâ èâ ´Šð£´ ªð÷bèâ èâ ´Šð£´ â¡ð¶ å¼ MôÆA¡ Ãòâ¢Ã°Â£Ã¹ ÃòâèË” ðK«ê£î¬ù, ñ£FK芫êèKŠ¹, ñ¼â°Â¶ GËõ£èâ¹, CA␠Ãâ¢Ã´Â¶ ðK«ê£î¬ù ê£Ëâ°Ã® ¬èò£Ãî⢠ÃAòõŸPŸè£è ¬èò£⢠Ãâ¢Ã´Â¶ è¼MèO¡ Ãô⹠H®Ë¶¬õâ°⹠õNº¬øè¬÷Šðò¡ð´Ë¶õ â¹. ðô Ãó£ÅâC, ðò¡ð£´èO⢠Môư芰ÃAò è£ôÆèÃâ°, ªð£¶õ£è Cô GIìÆèÃâ°ŠH®Ë¶ ¬õâèŠð´A¡øù. H®Ë¶ ¬õâ°⹠ê£îùÆèO¡ Ã÷¾, õ®õ¬ñŠ¹, ªêòâ¢Ã°Â£Ã¬Â£Ã¹Â¶ êê÷èKòâ¹, õL, ¶¡ð⹠ñŸÃâ¹ MôÆ° Ãó£ÅâC áNòËèÃâ° è£ò⹠ãŸð´õîŸè£ù ê£ËFòÆè¬÷â °¬øâè ªð£¼Ëîñ£ùî£è üâè «õâ¡Â´â¹. «ïËñ¬øò£ù õ½Ãâ ì⢠¸â ðÆè¬÷Šðò¡ð´Ë¶õî¡ Ãôâ¹, Ãó£ÅâC ï¬ìº¬øèÃì¡ Ã¥Ë¶¬öâè Ãâ¢Ã´Â¶ °ÃAò è£ôËFŸ° ìêò£ñ⢠üâè ï£ÅèÅ, ñQîâ°óÆAùÆèŠñŸÃâ¹ Hø MôÆ° èÃâ°ŠðJŸC ÃOâè º®»⹠(Boissy et al. 2007; Laule et al. 2003; Meunier 2006; Prescott and Buchanan-Smith 2003; Reinhardt 1991, 1995; Sauceda and Schmidt 2000;Yeates and Main 2009). Ãó£ÅâC «ï£âèÆè¬÷ ììõ áPò¬ñ ò£îî£è üËî⢠ñŸÃ⹠°PŠð£è äãC»C-(NRC-2003b) Ã⢠ÃÆWèKâèŠðâ ®¼â°Ã®Â£â¢ Ã¥Nò, ñQîâ°óÆAÃ¹Æ Ã¨Â¬Ã· à â è£ó¬õŠð¶ à â ðì câ¡Ã¬Ã¨Â£Ã´â èâ ´Šð£´ îMËâèŠðì «õâ¡Â´â¹. Ãòâ¢Ã°Â£Ã¹ à ìô¬ê¾è¬÷â ªêÅõîŸè£ù å¼ MôÆA¡ Fø¬ùâ èâ ´Šð´Ëî£î ìñŠ¹èŠ(â´Ë¶âè£â ´: ªè£P˶â¡EèO⢠êšÃ´ ðóõ⢠º¬øJ⢠ÃòÆ°⹠CPò ðâ¹Â¹Ã¨Ã·Â£â¢ «î£ô®Jâ¢
84 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ñ¼â°Â«Ã®Å¸Ã¸â¢, ï£ÅèÅ, ñQîâ °óÆ°èO⢠º¶°Š¬ð»ìÃ⹠ªð£¼ËîŠðâ ì à â ªê½Ë¶ ðâ¹Â¹Ã¨Å ñŸÃ⹠ðâ¡Â¬Ã MôÆ°èÃâè£ù ²îâ°Fóñ£ù ªî£¿õ ìñŠ¹èÅ) ªïPº¬ø «ï£âèÆèÃì¡ ªð£¼â°Â¶â¹Ã°Â® ðò¡ð´ËîŠð´A¡øù. «î¬õò£ù èâ ´Šð£â ´ º¬øèÃâ° ãŸøî£è Ãâ¢Ã´Â£Ã® MôÆ°è¬÷ ÃÅM⢠üâ°Â¶ ÃèŸø «õâ¡Â´â¹. èâ ´Šð£´ ê£îùÆèŠðò¡ ð´ËîŠðâ ì£â¢, ìõ Hø õNè÷£⢠G¬ø«õŸø º®ò£î Ãâ¢Ã´Â¶ ï¬ìº¬øâ° ñ£ø£ù Ãó£ÅâC Ãôâ° è¬÷ G¬ø«õŸÃõîŸè£è¾â¹, MôÆ°èŠÃâ¢Ã´Â¶ ðEò£÷ËèÃâ°â Ã¨Â£Ã²â¹ Ã£Å¸Ã°Â´ÃµÂ¬Ã®Ë Ã®Â´â°â¹Ã°Â® ò£è¾⹠õ®õ¬ñâèŠðì «õâ¡Â´â¹. H¡õ¼ð¬õ èâ ´Šð£´âè£ù ºâAòñ£ù õNè£â ´îâ¢Ã¨Ã·Â£Â°â¹: · èâ ´Šð£´ ê£îùÆèŠõ£Nì õêFâè£ù å¼ õöâèñ£ù º¬øò£èâ è¼îŠðìâÃ죶. «ñ½⹠ìõ MôÆ°Šðò¡ð£â ´ ªïPº¬øJ⢠Gò£òŠð´ËîŠðì «õâ¡Â´â¹. · MôÆ°è¬÷â ¬èò£ÃõFâ¢, GËõAŠðF⢠å¼ õêFâè£è èâ ´Šð£´ ê£îùÆè¬÷Šðò¡ð´Ëîâ Ã죶. · ªð÷bèâ èâ ´Šð£´â° ñ£Ÿø£èâ è¼îŠðì «õâ¡Â´â¹. · Ãó£ÅâC «ï£âèÆè¬÷ G¬ø«õŸÃõ °¬øâ°Ã® ðâ êñ£ù è£ô«ïó«ñ èâ ´Šð£´ üâè «õâ¡Â´â¹. · èâ ´Šð£´ ê£îùÆèO⢠¬õâèŠðì «õâ¡Â®Ã² MôÆ°èÅ, à ðèóÃÆèÅ, ðEò£÷ËèÃâ° îèõ¬ñŠ¬ðŠªðø ðJŸC ÃOâè «õâ¡Â´â¹ («ïËñ¬ø õ½Ãâ ì½ì¡). · Ã®Ã¨ÃµÂ¬Ã±Ã²Ë Ã®ÃµÃâ¹ MôÆ°èŠÃÅM⢠üâ°Â¶ ÃèŸøŠðì «õâ¡Â´â¹. · äãC»C bËñ£QËîð®, êKò£ù ììªõOJ⢠MôÆ°è¬÷â èâ¡Ã¨Â£Eâè ãŸð£´ ªêÅòŠðì «õâ¡Â´â¹. èâ ´Šð£´ì¡ ªî£ì˹¬ìò ¹â¡Ã¨Å, «ï£ÅèŠè£ÃŠðâ ì£⢠è£â¢Ã¯Â¬Ã¬Å ðó£ñKŠ¹ õöÆèŠðì
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠85 «õâ¡Â´â¹. ¹â¡Ã¨Å, «ï£ŠÃâ¢Ã´Â¶ è´¬ñò£ù ïìË” ñ£Ÿø⹠ÃAò¬õ ªð¼â¹Ã°Â£Â½â¹ MôÆÂ°Ã¨Â¬Ã·Ë Ã®Å¸Ã¨Â£Lè ñ£è Ãâ¢Ã´Â¶ Góâ°Ã®Ã³Ã±Â£Ã¨ ÃèŸÃõ¬î ÃõCòñ£â° A¡øù. · èâ ´Šð£®¡ «ï£âèâ¹, Ãî¡ è£ôõ¬óò¬ø ÃAò¬õ ÃÅM⢠ôð´⹠ïðËèÃâÂ°Ë ÂªÃ®Oõ£è M÷âèŠðì «õâ¡Â´â¹. ðô à JËè£â°⹠Ãìõ CA␠º¬øèŠÃÅõè ìñŠH⢠Ãìõ CA␠º¬ø芪ðKò¬õ, CPò¬õ âù õ¬èŠð´ËîŠðìô£⹠(USDA 1985). º¡ bËñ£QËîð®, å¼ ï¬ìº¬ø ªðKòî£ Ãâ¢Ã´Â¶ CPòî£ Ã¢Â¡Ã°Â¬Ã®Ë Ã®QËîQ ªïPº¬ø îŠð¬ìJ⢠è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË Ã±Å¸Ã⹠äãC»C (NRC 2003b; Silverman et al. 2007) ñFÅ d´ ªêÅò «õâ¡Â´â¹. (ôî⢠ªîOMŸ° ÃËFò£ò⹠4, Ãìõ CA␠º¬øè¬÷Šð£Ëâè¾â¹). Ãù õ¬èŠð£â Â¬Ã¬Ë Ã®Â£â¡Â®, å¼ MôÆA¡ e¶ ïìËîŠð ´⹠ðô Ãà ¬õ C A⬠êèŠMô Æ A ¡ ïâ¢ÃµÂ£âºM⢠ãŸð´Ë¶⹠î£âèËÂ¬Ã®Ë bËñ£Qâè ñFÅ d´ ªêÅòŠðì «õâ¡Â´â¹. å¼ MôÆA⢠ðô ªðKò Ãìõ CA␠º¬øèO¡ ǔ› â¡ð¶ (1) å¼ Ãó£ÅâCË Fâ ì⹠Ãâ¢Ã´Â¶ ªïPº¬øJ¡ ÃËFò£õCòâ ÃÃèÅ, (2) ÃÅõ£÷ó£⢠Mâ¦Ã«Â£Ã¹ gFò£è Gò£òŠð´ËîŠðâ ì£⢠Ãâ¢Ã´Â¶ ãŸÃâªè£Å÷Šðâ ì£⢠ñâ ´«ñ ñ¼Ë¶õâ è£óÃÆèÃâè£ù ÃõCòË” ãŸÃâªè£Å÷ º®»â¹. (3) ÃKî£ù MôÆ° õ÷Æè¬÷Šð£¶è£â°⹠õ¬èJ⢠å«ó MôÆA⢠ðô ªðKò Ãìõ CAâ¬êèŠïì˶õ¬î Gò£òŠð´Ëîâôâ¹. Ãù£⢠îQËîQ ªïPº¬øèO⢠ðò¡ð´Ëî å«óªò£¼ MôÆA¡ e¶ ÃËî¬èò ï¬ìº¬øè¬÷ŠH¡ðŸÃõ¶ îMËâèŠðì «õâ¡Â´â¹. «ñ½⹠Ô äãC»C MñËêù gFò£è ñFŠð£Å¾ ªêÅò «õâ¡Â´â¹. ªð£¼â°Â¶â¹Â«Ã°Â£Â¶, äæ, ȉv®ã / ãHäâv-â° å¼ «è£K⏘â êñËÅ Hâè «õâ¡Â´â¹. êâ ìËî£⢠ð£¶è£âèŠð´⹠MôÆA⢠îQËîQ ªòù ªî£ìËHâ¢Ã´Â£Ã® Ãó£ÅâC ªïPº¬øè¬÷â ªè£â¡Â´ (ȉv®ã 1985, 1997a) ðô à JËè£â°⹠Ãìõ CA␠º¬øèÃâ° à â ð´Ëî, 効î⢠ªðø «õâ¡Â´â¹.
86 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ».âv.®.ã-M¡ èâ ´Šð£â ´â°Šõó£î MôÆ°è¬÷ «ñŸÃPò Ã÷¾«è£â¢Ã¨Â¬Ã·Å ÃËËF ªêÅ»⹠ðô à JËè£â°⹠ï¬ìº¬øèÃâ° à â ð´Ëî ÃÃñFŠðîŸ è£ù Gò£òÆèŠå¿Æ°ð´ËîŠðâ ì à JKùÆèÃâÂ°Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ è£óEèÃâ° ÃÃÆè «õâ¡Â´â¹. ðô à JË Ã¨Â£â°⹠Ãìõ CAââ° 効î⢠ÃOâèŠðâ ì£â¢, MÂ¬Ã·Â¾Ã¨Â¬Ã·Ë ÂªÃ®Â£Ã¬Ëâ°Â¶ ñFÅ d´ ªêÅõî¡Ãô⹠MôÆ°èO¡ ïâ¢ÃµÂ£âºM⢠äãC»C °PŠð£è èõù⹠ªê½Ëî «õâ¡Â´â¹. ðô ªðKò à JËè£â°⹠Ãìõ CA␠º¬øè¬÷â ªêÅõ ªêô¾â «êIŠ¹èŠñâ ´⹠«ð£¶ñ£ù è£óÃñ£è üâè º®ò£¶. CPòªîù õ¬èŠð´ËîŠðâ ì Cô ï¬ìº¬øèÅ, Hâ°Â¬Ã®Ã² èEêñ£ù ï¬ìº¬ø õL Ãâ¢Ã´Â¶ °¬øð£â Â¬Ã¬Ë Ãâ¡Ã¬âôâ¹. ëî«ð£⢠å¼ MôÆA⢠å¡Ãâ° «ñŸðâ ì º¬ø ìõ GèâºËîŠðâ ì£⢠Mâ¦Ã«Â£Ã¹ gFò£è Gò£òŠð´ËîŠðì «õâ¡Â´â¹ à þ, Fóõ å¿Æ°º¬ø Cô à ìLòâ¢, ïóâ¹Hòâ¢, ïìË” ê£Ëâ°Ã® Ãó£ÅâC ªïPº¬øèO¡ îŠð¬ìJ⢠à þ Ãâ¢Ã´Â¶ Fóõ à â ªè£Å÷L⢠èâ ´Šð£´ «î¬õŠðìô£â¹. Ãâèâ ´Šð£´ ªêòâ¢ÂºÂ¬Ã¸J⢠à þ Ãâ¢Ã´Â¶ Fóõ ÃôÆèÃâè£ù º¡ Fâ ìIìŠðâ ì õöÆè¬ôâ ªè£â¡Â®Â¼âèâôâ¹, âù«õ å¼ MôÆ° õöâèñ£ù ììªõOJ⢠Ãâ¢Ã´Â¶ èâ ´Šð£â ®⢠M¼â¹Hò¬î à â ªè£ÅAø¶. ÃF⢠ªñ£Ëî à þ Ãâ¢Ã´Â¶ FóõËF¡ Ã÷¾ èâ¡Â®Å ð£è èâ¡Ã¨Â£EâèŠðâ ´ èâ ´Šð´ËîŠð´Aø¶ (NRC 2003b). Ãâ°Ã® ÞèŠFâ ìIìŠðâ ´â ªêòâ¢Ã°Â´ËîŠð´⹠«ð£¶ MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¬ÃµÅ «ðµ⹠õ¬èJ⢠Mâ¦Ã«Â£Ã¹ «ï£âèË” ììò °¬øâ°Ã® Ã÷¾ èâ ´Šð£«ì ÃõCò⹠â¡ð«î °Pâ«è£Å. à þ Ãâ¢Ã´Â¶ Fóõ å¿Æ°º¬øJ¡ ðò¡ð£â “ à Å֓âAò MôÆ° ªïPº¬øèO¡ õ÷ËâCⰠáà è£óEè¬÷ ñFÅ d´ ªêÅò «õâ¡Â´â¹: «î¬õò£ù Ã÷¾ èâ ´Šð£´; å¿Æ°º¬øJ¡ ð£îèñ£ù M¬÷¾èÅ; MôÆ°èO¡ ëó£âAòâ¹, ïâ¢ÃµÂ£âºÂ¬Ãµ ñFÅ H´õîŸè£ù º¬øèŠ(NRC 2003b). ôîô£è, å¼ °PÅ Hâ ì ªïPº¬ø J⢠ð£¶è£Šð£èŠðò¡ð´Ëîâîò à þ Ãâ¢Ã´Â¶
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠87 Fóõâ èâ ´Šð£â ®¡ Ã÷¬õŠH¡õ¼⹠è£óEèŠð£FâA¡øù: MôÆ°èO¡ ÃùÆèÅ, Ãùõ¬è Ãâ¢Ã´Â¶ Ãù˪Š¹, ð£Lùâ¹, õò¶; à ìŸà ´ ðó£ñKÅ Â¹Ë Â«Ã®Â¬Ãµ; õ£Nì õêF õ¬è; à ÃM¡ «ïóâ¹, áâ ìâêËF¡ ñFŠ¹, à ÃM¡ ï£Ëâê˶ à Å֓âè⹠(Heiderstadt et al. 2000; Rowland 2007); ðK«ê£î¬ùâ° ºâ°Â¬Ã®Ã² ¬èò£Ãî⢠ÃAò¬õ G¬ôò£ù ïìË” ê£Ëâ°Ã® ªêòâ¢FøÃâÂ°Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ à þ Ãâ¢Ã´Â¶ Fóõâ èâ ´Šð£â ®¡ bMóâ¹, ðEJ¡ Cóñâ¹, îQŠðâ ì MôÆ°, MôÆ°âÂ°Ë Â«Ã®Â¬Ãµ ò£ù áâèâ¹, å¼ °PÅ Hâ ì ªïPº¬ø ªî£ìËð£ù ðEâ° MôÆAŸ° ðJŸC î¼⹠ªêòâ¢Fø¡ ÃAòõŸø£⢠ð£FâèŠð´Aø¶. à þ ñŸÃâ¹ Fóõ à â ªè£Å÷⢠ÃõŸP¡ áâ ìâêËÂ¶Ë Â«Ã®Â¬ÃµÃ¨Â¬Ã·Å ÃËËF ªêÅõ¬î à ÃFªêÅò MôÆ°è¬÷ à ¡QŠð£èâ èâ¡Ã¨Â£Eâè «õâ¡Â´â¹ (Toth and Gardiner 2000). à ì⢠â¬ìè¬÷â °¬øâ°Ã®Â¶ õ£óⰠ«î£Ãâ¹ ÃFèâ èâ ´Šð£´èŠ«î¬õŠð´⹠MôÆ° èÃⰠîâè® ðF¾ ªêÅòŠðì «õâ¡Â´â¹ (NRC 2003b). 嚪õ£¼ MôÆ°â°⹠FùêK à þ, Fóõ ¸è˾, à ìâ¢cK¡ Ã÷¾, å¼ ªïPº¬øJL¼â°Â¶ å¼ MôÆÂ¬Ã¨Ë Ã®Å¸Ã¨Â£Lèñ£è Ãâ¢Ã´Â¶ Góâ°Ã®Ã³Ã±Â£Ã¨ ÃèŸÃõîŸè£ù Ã÷¾ «è£ô£èŠðò¡ð´ËîŠð´⹠ââ°Ã®ÂªÃµÂ£Â¼ ïìõ®â, ñ¼Ë¶õ ñ£ŸøÆè¬÷»⹠ÃõÊð´Ëî, â¿îŠðâ ì ðF¾èŠðó£ñKâèŠðì «õâ¡Â´â¹ (Morton 2000; NRC 2003b). èâ ì¬ñâèŠðâ ì âFËM¬ù Ãó£ÅâC ªïPº¬øèO¡ MûòËFâ¢, ÃFè M¼Šðñ£ù à þ Ãâ¢Ã´Â¶ FóõË” «ïËñ¬ø õ½Ãâ ìô£èŠðò¡ð´Ë¶õŠðKⰠ¶¬óâèŠð´Aø¶. à þ ßø⢠âÃ⹠è«ô£Kâ èâ ´Šð£´, å¼ MôÆ° õ÷ËŠ¹ ¸â ð⹠ñŸÃ⹠â¬ìâ èâ ´Šð£â ´ õNº¬øò£è, ÃËFò£ò⹠3 Ã⢠Mõ£FâèŠðâ ´Å֦. ñ¼â°Â¶ õ¬è Ãâ¢Ã´Â£Ã® îóõK Ãóê£òùÆèÅ. Hø ªð£¼â èO¡ ðò¡ð£´ ñ¼â°Â¶ - îóõK Ãóê£òùÆèÅ, Hø ªð£¼â èO¡ ðò¡ð£´ «ê£î¬ù MôÆ°èÃì¡ ïìËîŠðâ ì ÞèO⢠ïâ² Ãâ¢Ã´Â¶ «î¬õòŸø ðâèM¬÷¾èŠâ¬î»⹠ÃPºèŠð´ËîMâ¢Â¬Ã´ â¡ð¬î à ÃFªêÅAø¶.
88 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® âù«õ ìõ MôÆ° ªî£ìËð£ù ìù˶ ï¬ìº¬ø èÃâ°⹠(USDA 1997) A“â°â¹Â«Ã°Â£Â¶ ðò¡ð´ËîŠðì «õâ¡Â´â¹. ñ¼â°Â¶ õ¬è Ãâ¢Ã´Â£Ã® îóõK Ãóê£òùÆèŠÃâ¢Ã´Â¶ ªð£¼â èO¡ ðò¡ð£´ MôÆ°Šðò¡ð£â ´ ªïPº¬øJ⢠MõKâèŠðâ ´ Gò£òŠð´ËîŠðì «õâ¡Â´â¹, äãC»C-Ã⢠ÃÆWèKâèŠðì «õâ¡Â´â¹ (Wolff et al. 2003). â´Ë¶âè£â ì£è, å¼ Fâ ìËF¡ ÃPMò⢠°Pâ«è£Åè¬÷ŠÃËËFªêÅò è£â¢Ã¯Â¬Ã¬ Ãâ¢Ã´Â¶ ñQî ñ¼â°Â¶ îó îò£KŠ¹ A“âè£î«ð£¶, ñ¼â°Â¶ õ¬è Ãâ¢Ã´Â£Ã® îóõK Ãóê£òù⹠Ãâ¢Ã´Â¶ ªð£¼O¡ ðò¡ð£´ ÃõCòñ£è üâèô£â¹. ö«ð£¡ø GèâºÂ¾ èO⢠îóâ¹, ÃÅ–, ªî£ŸøŸø ñ, è£ó ÃIÃ´Ë Ã®Â¡Â¬Ã±, è£ÅâêÃâ ´⹠ñ, Fóõâ è¬óêL¡ ªêP¾, G¬ôŠ¹Ëñ, ñ¼â°Â¶ à ÅÃâ ìËF¡ õN»⹠Ãìºâ¹, îò£KâèŠð´⹠èô¬õJ¡ Ã÷¾, ñ¼â°Fò⢠ê£Ëâ°Ã® à ìLòâèâ¹, MôÆ° ïôâ¹, Ãî¡ ðò¡ð£´ ªî£ìËð£ù ÃPMò⢠Ãâ¹ÃªÆèŠ(NIH 2008) ÃAò¬õ ºâAò è£óE è÷£°â¹. è÷ ÞèO⢠õó£î Ãâ¢Ã´Â¶ iâ ´Šðò¡ð£´ ê£ó£î º¶ªè½â¹Â¹ ÃùÆè¬÷ Ãõî£QËî⢠Ãâ¢Ã´Â¶ ðò¡ð´Ë¶î⢠ÃAò¬õ ÃÅM⢠ÃìÆ°â¹. ðô è÷ ÞèÃâ° êËõ«îê, Ãâ°Ã®â°Ã® ï£â ´ Ãó² ÃÃñF芫î¬õŠð´A¡øù, ìõ º¡ªñ£NòŠðâ ì ÃÅM¡ Mâ¦Ã«Â£Ã¹Ë î°F¬ò ñFÅ d´ ªêÅò «õâ¡Â´â¹, Þ ªêÅòŠðì «õâ¡Â®Ã² MôÆÂ°Ë ÂªÃ®Â£Â¬Ã¨ Ãâ¢Ã´Â¶ ÃùÆèŠeî£ù ê£ËFòñ£ù î£âèËÂ¬Ã®Ë bËñ£Qâè «õâ¡Â´â¹. ôîô£è, MôÆ°è÷£⢠ðó¾⹠«ï£ÅèŠà â ðì ªî£Nâ¢ÃªÂ£Ë ²è£î£ó, ð£¶è£Š¹ŠHóâC¬ùèŠGÃõùâ¹, ð£¶è£Š¹â °¿ Ãâ¢Ã´Â¶ ýõôèËî£⢠ñFŠð£Å¾ ªêÅòŠðì «õâ¡Â´â¹, «ñ½⹠ö, è÷ Þ MôÆ°èŠÃâ¢Ã´Â¶ ÃÆ°Å÷ ïðËèO¡ à ìâ¢Ã¯Ã´â¹, ð£¶è£Š¬ð êñóê⹠ªêÅò£¶ â¡ø îŠð¬ìJ⢠äãC»C-â° à ËFóõ£î⹠ÃOâè «õâ¡Â´â¹. è÷ Þè¬÷ «ñŸ ªè£ÅÃ⹠ºî¡¬ñ ÃÅõ£÷ËèÅ, ö ªî£ì˹¬ìò à JKò⢠«ï£ÅèÅ, ÃîÃì¡ ªî£ì˹¬ìò ð£¶è£Š¹ŠHóâC¬ùèÅ, ªð£¼â°Ã®âîò ââ°Ã®ÂªÃµÂ£Â¼ êâ ìÆèÅ
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠89 MFº¬øèŠðŸP»⹠ÃPâ°F¼âè «õâ¡Â´â¹. «ñ«ô à Å÷F⢠MFMôâ°èŠªîOõ£è õ¬óòÃâèŠðâ ´ äãC»C-ò£⢠ñFÅ d´⹠ªêÅòŠðì «õâ¡Â´â¹. å¼ è÷ ÃÅM¡ ÃµÂ®ÃµÂ¬Ã±Å Â¬Ã°Ë Ã®Ã²Â£KŠðFâ¢, ªî£ì˹¬ìò ªî£Nâ¢ÂºÂ¬Ã¸â °¿âèÅ, A“âèâîò õNè£â ´îâ¢Ã¨Ãì¡ èôâ°Ã®Â£Â«Ã´Â£Câè ÃÅõ£÷ËèŠáâ°MâèŠð´Aø£ËèŠ(H¡ ìʹÃ-¬õŠð£Ëâè ¾â¹) H®Š¹, îQŠðâ ì ììò£÷â¹, õLË Ã®EŠ¹, ñòâèÃâ ìâ¢, Ãìõ CAâ, eâ ¹, ðó£ñKŠ¹, «ð£â°õó˶, ªõO«òŸø⹠Ãâ¢Ã´Â¶ 輬Ãâªè£¬ô êâ¹Ã°â°Ã®Å ðâ ì Fâ ìÆèÃâ° è£â¢Ã¯Â¬Ã¬Ë îèõâ¢Ã¨Å «î¬õŠðìô£â¹. Ãâ°Ã® ïìõ®â¬èèÃì¡ ªî£ì˹¬ìò Câèâ¢Ã¨Å, ÃÅõèËF⢠ðó£ñKâèŠðâ ´ ðò¡ð´ËîŠð´⹠à JKùÆèÃâ° å«ó«ð£⢠Ãâ¢Ã´Â£Mâ ì½⹠æó÷¾ Ã¥ËF¼âèâ îò¬õ. MôÆ° ÃùÆèŠè£´èOL¼â°Â¶ à èŸ øŠð ´â¹Â«Ã°Â£Â¶, ª ïP º¬øò£ù ¶ à õŸ P¡ õ£âºMìËFŸ° eâ¡Â´â¹ F¼â¹Â¹ÃµÃ®Å¸Ã¨Â£Ã¹ Fâ ìÆè¬÷ à Å֓âAòî£è üâè «õâ¡Â´â¹. è÷ à JKò⢠ñŸÃ⹠õùMôÆ° Ãó£ÅâCJ⢠ðò¡ð´ËîŠð´⹠õNº¬ø芪î£ìËð£ù ìùËÂ¶Ë Ã®Ã¨Ãµâ¢Ã¨O¡ ªî£°Šð£è Ãâ°Ã® õNè£â ® ÖËF¼âè Mâ¢Â¬Ã´. Ãù£⢠ñQî£Hñ£ù îŠð¬ìJ⢠ðó£ñKŠ¹, ðò¡ð£â ®¡ îŠð¬ìâ ªè£Å¬èèŠÃòŸ¬è G¬ô¬ñèO¡ W⺠õ£¿⹠MôÆ°èÃâ°Šªð£¼â°Ã®â îò¬õ. è÷ ÞèO¡ ñà ÃÅM⢠ôðâ ´Å÷ äãC»C-âèŠî°Fõ£Åâ°Ã® õùMôÆ° à JKòô£÷¼ì¡ ëô£Câè áâ°MâèŠð´A¡øùË. Mõê£ò MôÆ°èŠMõê£ò MôÆ°èO¡ ðò¡ð£´ Ãó£ÅâCJ⢠à Å÷ ñŸø MôÆ°è¬÷Š«ð£ô«õ Ã«î ªïPº¬øâ è¼Ëî£Å¾èÃâ° à â ðâ ì¶. üŠHÃ⹠ö ªð¼â¹Ã°Â£Â½â¹ Ãóê£Æè MFº¬øèŠÃâ¢Ã´Â¶ ðòù£÷K¡ Ãôâ°èO¡ îŠð¬ìJ⢠ªè£Å¬èèÅ, GÃõùâ ªè£Å¬èèÅ, GËõ£è ìñŠ¹, GF Ãî£óÆèŠà JKò⢠ñ¼Ë¶õâ¹, «õ÷£â¡Â¬Ã± âù õ¬èŠð´ËîŠð´Aø¶. (Stricklin et al. 1990). Ãâ°Ã® õ¬èŠð£´, °PÅ Hâ ì à JKòâ¢
90 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® Ãâ¢Ã´Â¶ «õ÷£⡠Ãó£ÅâC «ï£âèÆèO¡ îŠð¬ì J⢠(Stricklin and Mench 1994) å«ó ÃùËF¡ MôÆ°èÃâè£ù õ£Nì õêF, ðó£ñKÅ H¡ ªïPº¬øèÅ, îóÆè¬÷ ñFÅ H´õîŸè£ù ªõš«õà Ã÷¾«è£â¢Ã¨Â¬Ã·â ªè£â¡Ã¬ Ãóâ “ º¬øâ° õNõ°Ëî¶. Cô ÞèO¡ Ãôâ¹, Ãó£ÅâC Ãôâ°èO⢠à Å÷ «õÃð£´èŠà JKòâ¢, Mõê£ò Ãó£ÅâCèÃⰠÓǘ ªîOõ£ù «õÃð£â ®Ÿ° õNõ°â°â¹. â´Ë¶âè£â ì£è, ñQî «ï£ÅèÅ, à ʹ ñ£Ÿà Ãìõ CAâ, ªðKò Ãìõ CA␠ÃAòõŸP¡ MôÆ° ñ£FKèŠà JKò⢠ñ¼Ë¶õŠðò¡ð£´è÷£èâ è¼îŠð´A¡øù; à þ, ï£Ëâê˶ à ŸðËF °PËî ÞèÅ, à þ⠫ê£î¬ù芫ð£¡ø¬õ ªð£¶õ£è Mõê£òŠðò¡ð£´è÷£èâ è¼îŠð´A¡øù. Ãù£⢠«õÃ𣴠ªîOõ£è Ãâ¢Ã´Â£Ã®, Cô áâ ìâê˶ ñŸÃ⹠«ï£ŠÃž芫ð£ô, GËõ£A èÅ, èâ ´Šð£â ì£÷ËèÅ, äãC»C-âèŠÃËî¬èò Þ è¬÷ âšõ£à ¬èò£Åõ¶ Ã¢Â¡Ã°Â¬Ã®Ë bËñ£QŠðF⢠å¼ î´ñ£ŸøË” âF˪è£ÅAÂ¡Ã¸Ã¹Ë (Stricklin and Mench 1994). Mõê£ò MôÆ°èO¡ Ãó£ÅâC, ðò¡ð£´è¬÷ õ¬èŠð´Ë¶õ¶, ÃõŸP¡ ðó£ñKŠ¹ ðò¡ð£â ®Ÿè£ù îóÆè¬÷ õ¬óòÊ𶠪î£ìËð£ù º®¾èŠäãC»C- ò£⢠Ãó£ÅâCò£÷K¡ °Pâ«è£ÅèÅ, MôÆ°èO¡ ïâ¢ÃµÂ£âºMŸè£ù Ãâè¬ø ÃAòõŸP¡ îŠð¬ìJ⢠â´âèŠðì «õâ¡Â´â¹. Ãó£ÅâCJ¡ õ¬è¬òŠªð£¼â ð´Ëî£ñâ¢, GÃõùÆèŠÃ¬ù˶ Ãó£ÅâC MôÆ° èO¡ «ñŸð£Ë¬õ¬ò»â¹, õL¬ò»⹠¶òóˬî»⹠°¬øŠð¬î»⹠à ÃFªêÅ»⹠â¡à âFËð£ËâèŠð´Aø¶. ªïPº¬ø, Ãó£ÅâCJ¡ õ¬è¬òMì, Þ Gè¿⹠ÃÂ¬Ã±Å Â¬Ã°Ë (ðâ¡Â¬Ã Ãâ¢Ã´Â¶ ÃÅõèâ¹) bËñ£Qâè «õâ¡Â´â¹. à JË Ã±Â¼Ë¶õ Ãó£ÅâCJ⢠ðò¡ð´ËîŠð´⹠Mõê£ò MôÆ°èÃâè£ù õ£Nì ìñŠ¹èŠMõê£ò Ãó£ÅâCJ⢠ðò¡ð´ËîŠð´ðõŸPL¼â°Â¶ «õÃðìô£â¹, Ãâ¢Ã´Â¶ Êð® Ãâ¢Ã´Â£Ã±â¢ üâèô£â¹; Ãóâ¡Â´ õ¬èò£ù Ãó£ÅâC èO½⹠ðò¡ð´ËîŠð´⹠MôÆ°è¬÷â Ãâ¡Â´Ã¨Å, ªî£¿õÆèÅ, ¹â¢ÂªÃµOèÅ, «ñÅâê⢠GôÆèO⢠¬õâè ô£⹠(Tillman 1994). Cô «õ÷£⡠ÞèO⢠²ŸÃâà ö⢠ñ£Ãð£â “â °¬øâè Yó£ù G¬ô¬ñ芫î¬õ.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠91 «ñ½⹠Cô à JË Ã±Â¼Ë¶õ ÞèŠðâ¡Â¬Ã ìñŠ¹ èO⢠ïìËîŠð´A¡øù. «õ÷£⡠Ãó£ÅâCJ⢠ªð¼â¹Ã°Â£Â½â¹ êñè£ôŠðâ¡Â¬Ã à ŸðËF º¬øèO¡ð® (Stricklin and Mench 1994) MôÆ°è¬÷ GËõAâè «õâ¡Â´â¹. ÃòŸ¬è, ²ŸÃâà ö⢠G¬ô¬ñèŠMõê£ò Ãó£ÅâCâ° M¼â¹Ã°Ëîâèî£è üâèô£â¹. ëîêñò⹠ñ£Ãð£â “â °¬øâè ²ŸÃâà ö⢠G¬ô¬ñèO¡ èâ ´Šð£´ à JË Ã±Â¼Ë¶õ Ãó£ÅâCJ⢠M¼â¹Ã°Ëîâèî£è üâèô£⹠(Tillman 1994). õöâèñ£ù ðâ¡Â¬Ã ìñŠ¹èO⢠ðó£ñKâèŠð´⹠à JË Ã±Â¼Ë¶õ Ãó£ÅâCJ⢠ðò¡ð´ËîŠð´⹠Mõê£ò MôÆ°èÃⰠÚõNè£â ® ªð£¼â°Â¶â¹. ðâ¡Â¬Ã ìñŠH⢠ðó£ñKâèŠð´⹠MôÆ°èÃâ°, Ãó£ÅâC ñŸÃ⹠èâ¢M ¹èâ ´õF⢠Mõê£ò MôÆ°èO¡ ðó£ñKŠ¹, ðò¡ð£â ®Ÿè£ù õNè£â ® (FASS 2010) å¼ ðòÃÅ÷ Ãî£óñ£°â¹. ²ŸÃâà ö⢠ªêPÃâ ìâ¢, «ð£â°õó˶, ¬èò£Ãî⢠ðŸPò îèõâ¢Ã¨Å Mõê£ò ñŸÃâ¹ Ã JË Ã±Â¼Ë¶õ Ãó£ÅâC ìñŠ¹èÃâ° à îõâôâ¹. Mõê£ò ìñŠH⢠ðâ¡Â¬Ã MôÆ°èO¡ õêFèŠñŸÃ⹠«ñô£â¡Â¬Ã± ðŸPò ôî⢠îèõâ¢Ã¨Å Iâ ªõvâ Fâ ì ǐ›JL¼â°Â¶â¹ (1987) Mõê£ò ªð£P ò£÷ËèŠÃâ¢Ã´Â¶ MôÆ° ÃPMò⢠G¹ÃËèOì I¼â°Â¶â¹ ªðø º®»â¹. 効î½â°ŠHâ°Â¬Ã®Ã² èâ¡Ã¨Â£EŠ¹ êñKâè êâ ìÆèÅ, å¿Æ°º¬øèÅ, ªè£Å èO¡ð® MôÆ°èO¡ ªêòâ¢Ã°Â£Â´Ã¨Â¬Ã·Ë ªî£ìËâ°Â¶ äãC»C «ñŸð£Ë¬õ ªêÅò «õâ¡Â´â¹. ð£¬îò ªïPº¬ø ñFÅ d´ ñŸÃ⹠å¿Æ°º¬ø ÃÃâèË” âOî£âè ðâ¢Â«ÃµÃ õNº¬øè¬÷Šðò¡ð´Ëîô£â¹. äãC»C-á Ãóâ¹Ã° ªïPº¬ø 効î½â°ŠHø°, ìù˶ õ¬èò£ù ªïPº¬øâ èâ¡Ã¨Â£EŠ¬ð»⹠à Å֓âAò, Hâ°Â¬Ã®Ã² 効î½âè£ù èâ¡Ã¨Â£EŠ¹ PAM (Hãââ¹) ÃÆ° ðóâ°Ã® ªð£¼O⢠è¼îŠð´Aø¶. Hãâ⹠MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¬Ãµ à ÃFŠð´Ëî à î¾Aø¶. Ãó£ÅâC ï¬ìº¬øè¬÷ ªêâ¹Â¬Ã±Å ð´Ë¶ õîŸè£ù õ£ÅŠ¹è¬÷»⹠õöÆèâôâ¹. õNº¬øèOâ¢
92 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® ªî£ìËâCò£ù ªïPº¬ø ñFŠð£Å¾⹠ÃìÆ°â¹; ÃÅõè ñFÅ d´ (õöâèñ£ù õêFèŠÃÅM¡ «ð£¶ Ãâ¢Ã´Â¶ HóË«òèñ£è ïìËîŠð´A¡øù); «îËâ°ÂªÃ®Â´âèŠðâ ì ï¬ìº¬øèÅe¶ è£â¢Ã¯Â¬Ã¬ ñ¼ËÂ¶ÃµË Ãâ¢Ã´Â¶ äãC»C èâ¡Ã¨Â£EŠ¹; MôÆ°Šðó£ñKŠ¹, è£â¢Ã¯Â¬Ã¬ ñŸÃ⹠äãC»C áNòËèÅ, à ÃÅ HùËè÷£⢠MôÆ°èŠð£Ë¬õ JìŠðìâ¢; ªõOÃ¯Ã°Ë Ã¥Â¿Æ°º¬ø ÞèÅ, ñFÅ d´ èŠ- äãC»C, è£â¢Ã¯Â¬Ã¬ ñ¼Ë¶õË, MôÆ°Šðó£ñKŠð£÷Ë, ÃÃâè áNòËèŠÃ¬ùõ¼⹠Hãâ¡-ä ïìËî ô£â¹, ö å¼ èâ¢M ê£Ëâ°Ã® Fâ ìñ£è¾⹠üâèô£â¹. ªî£ìËâCò£ù ªïPº¬ø ñÃÞ ªð£¶õ£è õ¼ì£â°Fó ¹¶ŠHŠ¹ Ãâ¢Ã´Â¶ ñÃÞ â¡ð¶ Hâââv-â° «î¬õò£ù áø£â¡Â´ ñFŠð£Å¾ ÃAòõŸ¬øâ ªè£â¡Â´Å֦. ÃËî¬èò ñFŠ¹¬óèO¡ Ãö⹠å¼ õöâèñ£ù ¹¶ŠHËîLL¼â°Â¶ º¿ªïPº¬ø J¡ º¿¬ñò£ù °¿ ñFŠð£Å¾õ¬ó ñ£Ãð´â¹. âFËè£ô ï¬ìº¬øèÃâè£ù º¡ªñ£NòŠðâ ì F¼ËîÆè¬÷â êñËÅ Hâè¾â¹, ã«îÃ⹠ð£îèñ£ù Ãâ¢Ã´Â¶ âFËð£ó£î GèâºÂ¾Ã¨O¡ M÷âèË” õöÆè¾â¹, ðE º¡«ùŸø⹠°PËî ¹¶ŠHËîâ¢Ã¨Â¬Ã· õöÆè¾⹠Cô GÃõùÆèŠõ¼ì£â°Fó ñFŠð£Å¬õŠðò¡ð´Ë¶ A¡øù. áø£â¡Â´ ñFŠð£Å¾âè£è, ðô GÃõùÆèÃâ° º¿¬ñò£ù ¹Fò ªïPº¬ø êñËÅ HŠ¹ «î¬õŠð´ Aø¶. ºâ°Â¬Ã®Ã² 3 Ãâ¡Â´Ã¨O⢠MôÆ°èO¡ ðò¡ð£´ °PËî «ñâ¹Ã°Â£â ´ ÃPâ¬è¬ò»⹠«è£óô£â¹. ²è£î£ó Ãó£ÅâC MKõ£âèâ êâ ìâ¹, MôÆ° ïôâêâ ì⹠ÃAò Ãóâ¡Â®Â¡Ã°Â® äãC»C 嚪õ£¼ 6 ñ£îÆèÃâ°⹠MôÆ°Šðó£ñKŠ¹, ðò¡ð£â ´ õêFè¬÷ Þ ªêÅò «õâ¡Â´â¹. å¼ º¬øò£ù Hãâ⹠Fâ ìËF¡ å¼ ð°Fò£è, Cô GÃõùÆèŠMôÆ°â ÃìÆè¬÷ ñFÅ d´ ªêÅõ¬î MôÆ° ªïPº¬øè«÷£´ «êË˶ å«ó «ïóËF⢠ñFŠð£Å¾ ªêÅA¡øù. MôÆ° è¬÷â ¬èò£ÃðõËèÃâ° ãŸð´⹠Ãð˶èO¡ îŠð¬ìJâ¢, Hø ÞŠð°FèÃâ° ÃFèñ£è«õ£ Ãâ¢Ã´Â¶ °¬øõ£è«õ£ îâè® Ãž芫î¬õŠðìô£â¹. ðòÃÅ÷ èâ¡Ã¨Â£EŠ¹ à ËFèO¡ â´Ë¶â è£â ´èŠWâºÃ¨â¡Ã¬ÃµÅ¸ÃÅ ÃìÆ°â¹.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠93 · ñòâè ñ¼â°Â¶ à ðèóÃÆèÅ, ªð£¼Ëîñ£ù ªî£ŸøŸø ¸â ðˬîŠðò¡ð´Ë¶îâ¢, èâ ´Šð´ËîŠðâ ì ªð£¼â è¬÷â ¬èò£Ãîâ¢, ðò¡ð´Ë¶î⢠à ÅOâ ì Ãìõ CAâ¬êŠð°Fè¬÷ Þ ªêÅî⢠· ªïPº¬ø ªî£ìËð£ù ²è£î£óâ¹, ð£¶è£Š¹â Câèâ¢Ã¨Â¬Ã· ñFŠð£Å¾ ªêÅî⢠· ñòâèâ¹, Ãìõ CAâ¬êŠðF¾èO¡ Þ · MôÆ°è¬÷Šð£Fâ°⹠ð£îèñ£ù Ãâ¢Ã´Â¶ âFËð£ó£î «ê£î¬ù M¬÷¾è¬÷ õöâèñ£è ñFŠð£Å¾ ªêÅî⢠· ÃÅõè ï¬ìº¬øèÅ, ªêź¬øè¬÷ Ãõî£QË Ã®â¢, ÃÆWèKâèŠðâ ì ªïPº¬øèÃì¡ åŠH´î⢠ð£îèñ£ù GèâºÂ¾Ã¨Ãâè£ù (â´Ë¶âè£â ´: ¹¶¬ñò£ù à JËè£â°⹠Ãìõ CAâ¬êèÅ, õL ÞèÅ, èâ ® õ÷ËâC ÞèÅ) ÃFè ÃðËî£ù ï¬ìº¬øè¬÷ Ãõî£Qâè è£â¢Ã¯Â¬Ã¬ áNòËèÅ, MôÆ° ²è£î£ó ªî£Nâ¢Â¸â ð õâ¢Â½Ã¯Ëè¬÷Šðò¡ ð´Ë¶õ¬î»⹠GÃõùÆèŠðKYLâèô£â¹. ÃõËèO¡ èâ¡Â´H®Š¹è¬÷ äãC»C-Jì⹠êñËÅ Hâèô£â¹. Hãââ¹- á ªêòâ¢ÂºÂ¬Ã¸, bMóËF¡ G¬ô, GÃõù Ã÷¾, Câèô£ù ñâ° ãŸð õ®õ¬ñâèŠðì «õâ¡Â´â¹. «ñ½⹠ââ¢Ã´Â£ êâ°Ã®ËŠðÆèO½⹠MôÆ°èO¡ ïâ¢ÃµÂ£âºÂ¬Ãµ ¬ñòñ£èâ ªè£â¡Ã¬ èõQŠ¹â èô£âê£óË” ÃîKâè «õâ¡Â´â¹ (Klein and Bayne 2007). ðò¡ð´ËîŠðâ ì º¬øèŠÃâ¢Ã´Â¶ èâ¡Ã¨Â£EŠ¬ð Ã²Â£Ë Ã¯Ã¬Ë¶Aø£ËèÅ, Ã¥Â¼Æ A¬ÃâAø£ËèŠâ¡ð¬îŠªð£¼â ð´Ëî£ñâ¢, GÃõù⹠ÃÅõ£÷ËèÃì¡ å¼ÆA¬Ãâ°Ã® èâ¢M «ñâ¹Ã°Â£â “ áâ°Mâ°â¹Â«Ã°Â£Â¶ Hãâ⹠Fâ ìÆ芪õŸP ªðø ÃFè õ£ÅŠ¹Å֦ (Banks and Norton 2008; Collins 2008; Dale 2008; Lowman 2008; Plante and James 2008; Van Sluyters 2008). «ðóNÂ¾Ë Ã®Â´Å Â¹ ñŸÃâ¹ Ãõêó G¬ôâè£ù îò£KŠ¹ MôÆ° õêFèŠCâèô£ù ìñŠ¹èŠÃâ¢Ã´Â¶ °PÅ HìËîâè ðEò£÷ËèŠÃâ¢Ã´Â£Ã®Â¶, Ãâ¢Ã´Â¶ ïìâ°Â¶ÂªÃ¨Â£â¡Â®Â¼â°⹠MôÆ°Šðó£ñKŠ¹, ïâ¢ÃµÂ£âºÂ¬Ãµ
94 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® è´¬ñò£è ð£Fâ°⹠Hø âFËð£ó£î GèâºÂ¾Ã¨Å ÃAò âFËð£ó£î à âºG¬ôèÃâ° à â ðâ ´Mìô£⹠(ILAR 2010). âù«õ õêFèŠå¼ «ðóNÂ¾Ë Ã®Â´Å Â¹Ë Fâ ì˔⠪è£â¡Â®Â¼âè «õâ¡Â´â¹. 裟«ø£â ìâ¹, °OÃâ ìâ¢, ªõŠðñ£âè⢠Ãâ¢Ã´Â¶ °®c¬ó õöÆ°î⢠«ð£¡ø ìñŠ¹è¬÷ ÃöŠðî£⢠MôÆ°èO¡ õL, ¶¡ðâ¹, ÃÃ¸Å Â¹Ã¨Â¬Ã·Ë Ã®Â´âÃ¨Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ ïìõ®â¬èè¬÷ ÃËFâ ì⹠õ¬óòÃâè «õâ¡Â´â¹. º®â°Ã®Â£â¢, ºâAòñ£ù Ãó£ÅâC ïìõ®â¬èèÃâÂ°Ë Â«Ã®Â¬ÃµÃ²Â£Ã¹ Ãâ¢Ã´Â¶ ôªêÅò º®ò£î MôÆ°è¬÷ Ãâ°Ã® õêF âšõ£à ð£¶è£â°⹠â¡ð¬î ÃËFâ ì⹠MõKâè «õâ¡Â´â¹. ¹MJò⢠üŠHìËF¡ ÃP¾ å¼ °PÅ Hâ ì õ¬èò£ù «ðóNM¡ GèâºÃ®Ã¨Â¾ °PËî õNè£â ì¬ô õöÆèâôâ¹. Ãõêó è£ôËFŸ«èŸð MôÆ°èO¡ º¡ÃK¬ñèÅ, GÃÃµÃ¹Ë Â«Ã®Â¬ÃµÃ¨Å, õ÷ÆèŠÃóâ¡Â¬Ã¬Â»â¹ è¼ËF⢠ªè£â¡Â´, ªð£ÃŠð£ù ÃÅõ£÷¼ì¡ ìÃâ°Â¶ «ðóNÂ¾Ë Ã®Â´Å Â¹Ë Fâ ìÆèŠGÃõŠðì «õâ¡Â´â¹. «ðóNM¡ M¬÷¾èOL¼â°Â¶ Ãìñ£Ÿø⹠ªêÅò«õ£ Ãâ¢Ã´Â¶ ð£¶è£âè«õ£ º®ò£î MôÆ°è¬÷ ñQî «ïòË¶ì¡ 輬Ãâªè£¬ô ªêÅò «õâ¡Â´â¹. «ðóNÂ¾Ë Ã®Â´Å Â¹Ë Fâ ì˔⠪êòâ¢Ã°Â´Ë¶õF⢠º¡Ãâ ®«ò ðJŸC ªðø «õâ¡Â®Ã² ÃËFò£õCòŠðEò£÷Ëè¬÷ ììò£÷⹠è£à «õâ¡Â´â¹. å¼ «ðóNM¡«ð£¶ à ìù®ò£èŠðEò£÷ËèO¡ ð£¶è£Š¬ð à ÃFªêŠõâ¹, ÃËFò£õCòŠðEò£÷ËèÃâ° ¸¬ö¬õ õöÆ°õ⹠ºòŸCèŠâ´âèŠðì «õâ¡Â´â¹. ÃËî¬èò Fâ ìÆèŠGÃõùËî£⢠ÃÆWèKâèŠðì «õâ¡Â´â¹. å⠴ªñ£Ëî GÃõùŠ«ðóNÂ¾Ë Ã®Â´Å Â¹Ë Fâ ì⹠äæ Ãâ¢Ã´Â¶ ñŸªø£¼ ÃËî-G¬ô GËõ£Aò£⢠å¼ÆA¬ÃâèŠð´⹠ñêñ£NË Fâ ìËF¡ å¼ ð°Fò£è üâè «õâ¡Â´â¹, êâ ì Ãñô£âè ñŸÃâ¹ Ãõêó è£ôŠðEò£÷ËèÃâ° è¼Ë¶, å¼ÆA¬ÃŠ¹âè£ù Fâ ìËF¡ ïè¬ô °PÅ Hâ ì ð°F Ã÷Mô£ù Fâ ìIì½ì¡ õöÆè «õâ¡Â´â¹ (Vogelweid 1998).
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠95 îó¾â °PŠ¹¬óèŠAAALAC [Association for Assessment and Accreditation of Labo- ratory Animal Care] International. 2003. Who is responsible for offsite ani- mals? Connection Spring: 6-11, 13. Available at www.aaalac.org/publica- tions <http://www.aaalac.org/publications>. ACLAM [American College of Laboratory Animal Medicine]. 1996. Adequate Veterinary Care. Available at www.aclam.org/education/guidelines/ position_adequatecare.html; accessed May 10, 2010. Anderson LC. 2007. Institutional and IACUC responsibilities for animal care and use education and training programs. ILAR J 48:90-95. AVMA [American Veterinary Medical Association]. 2008. Introduc- tion to Ergonomics Guidelines for Veterinary Practice. April. Available at www.avma.org/issues/policy/ergonomics <http://www.avma.org/issues/ policy/ergonomics>. asp; accessed May 10, 2010. AVMA. 2010. Programs accredited by the AVMA Committee on Veterinary Technician Education and Activities (CVTEA). Available at www.avma.org/education/cvea/vettech_programs/ vettech_programs.asp; accessed January 4, 2010. Banks RE, Norton JN. 2008. A sample post-approval monitoring program in academia. ILAR J 49:402-418. Bayne KA, Garnett NL. 2008. Mitigating risk, facilitating research. ILAR J 49:369-371. Boissy A, Manteuffel G, Jensen MB, Moe RO, Spruijt B, Keeling L, Winckler C, Forkman B, Dimitrov I, Langbein J, Bakken M, Veissier I, Aubert A. 2007. Assesment of positive emotions in animals to improve their wel- fare. 92:375-397. Brown RE, Stanford L, Schellinck HM. 2000. Developing standard- ized behavioral tests for knockout and mutant mice. ILAR J 41:163-174. Bush RK. 2001. Assessment and treatment of laboratory animal al- lergy. ILAR J 42:55-64. Bush RK, Stave GM. 2003. Laboratory animal allergy: An update. ILAR J 44:28-51. CCAC [Canadian Council on Animal Care]. 1993. Guide to the Care and Use of Experimental Animals, vol 1, 2nd ed. Olfert ED, Cross BM,
96 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® McWilliam AA, eds. Ontario: CCAC. CCAC. 1998. Guidelines on Choosing an Appropriate Endpoint in Experiments Using Animals for Research, Teaching and Testing. Ottawa. Available at www.ccac.ca/en/CCAC_Programs/ Guidelines_Policies/gdlines/endpts/appopen.htm; accessed May 10, 2010. CDC [Centers for Disease Control and Prevention] and NIH [Na- tional Institutes of Health]. 2000. Primary Containment for Biohazards: Se- lection, Installation and Use of Biological Safety Cabinets, 2nd ed. Wash- ington: Government Printing Office. Available at www.cdc <http:// www.cdc>. gov/od/ohs/biosfty/bsc/bsc.htm; accessed May 25, 2010. CFR [Code of Federal Regulations]. 1984a. Title 10, Part 20. Stan- dards for Protection against Radiation. Washington: Office of the Federal Register. CFR. 1984b. Title 29, Part 1910, Occupational Safety and Health Standards, Subpart G, Occupational Health and Environmental Control, and Subpart Z, Toxic and Hazardous Substances. Washington: Office of the Fed- eral Register. CFR. 1984c. Title 29, Part 1910. Occupational Safety and Health Standards; Subpart I, Personal Protective Equipment. Washington: Office of the Federal Register. CFR. 1998. Title 29, Section 1910.120. Inspection Procedures for the Hazardous Waste Operations and Emergency Response Standard. Wash- ington: Office of the Federal Register. April 24. CFR. 2002a. Title 42, Part 73. Possession, Use and Transfer of Se- lect Agents and Toxins. Washington: Office of the Federal Register. Decem- ber 13. CFR. 2002b. Title 7, Part 331; and Title 9, Part 121. Agricultural Bioterrorism Protection Act of 2002: Possession, Use and Transfer of Se- lect Agents and Toxins. Washington: Office of the Federal Register. Decem- ber 13. Cohen JI, Davenport DS, Stewart JA, Deitchmann S, Hilliard JK, Chapman LE, B Virus Working Group. 2002. Recommendations for pre- vention of and therapy for exposure to B virus (Cercopithecine herpesvirus 1). Clin Infect Dis 35:1191-1203.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠97 Colby LA, Turner PV, Vasbinder MA. 2007. Training strategies for laboratory animal veterinarians: Challenges and opportunities. ILAR J 48:143-155. Collins JG. 2008. Postapproval monitoring and the IACUC. ILAR J 49:388-392. Conarello SL, Shepard MJ. 2007. Training strategies for research investigators and technicians. ILAR J 48:120-130. Crawley JN. 1999. Behavioral phenotyping of transgenic and knock- out mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835:18- 26. Dale WE. 2008. Postapproval monitoring and the role of the com- pliance office. ILAR J 49:393-401. Dennis MB. 1999. Institutional animal care and use committee re- view of genetic engineering. In: Gonder JC, Prentice ED, Russow L-M, eds. Genetic Engineering and Animal Welfare: Preparing for the 21st Century. Greenbelt MD: Scientists Center for Animal Welfare. Dennis MB. 2000. Humane endpoints for genetically engineered animal models. ILAR J 41:94-98. DHHS [Department of Health and Human Services]. 2009. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. Chosewood LC, Wilson DE, eds. Washington: Government Printing Office. Available at <http://www.cdc.gov/biosafety/publications/bmbl5/index>. htm; accessed July 30, 2010. FASS [Federation of Animal Science Societies]. 2010. Guide for the Care and Use of Agricultural Animals in Research and Teaching, 3rd ed. Champlain, IL: FASS. Fechter LD. 1995. Combined effects of noise and chemicals. Occup Med 10:609-621. Foshay WR, Tinkey PT. 2007. Evaluating the effective- ness of training strategies: Performance goals and testing. ILAR J 48:156- 162. Frasier D, Talka J. 2005. Facility design considerations for select agent animal research. ILAR J 46:23-33. Gonder JC. 2002. Regulatory compliance. In: Suckow MA, Dou- glas FA, Weichbrod RH, eds. Management of Laboratory Animal Care and
98 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® Use Programs. Boca Raton, FL: CRC Press. p 163-185. Gondo Y. 2008. Trends in large-scale mouse mutagenesis: From ge- netics to functional genomics. Nat Rev Genet 9:803-810. Gordon S. 2001. Laboratory animal allergy: A British perspective on a global problem. ILAR J 42:37-46. Gordon S, Wallace J, Cook A, Tee RD, Newman Taylor AJ. 1997. Reduction of exposure to laboratory animal allergens in the workplace. Clin Exp Allergy 27:744-751. Greene ME, Pitts ME, James ML. 2007. Training strategies for insti- tutional animal care and use committee (IACUC) members and the institu- tional official (IO). ILAR J 48:131-142. Harrison DJ. 2001. Controlling exposure to laboratory animal aller- gens. ILAR J 42:17-36. Heiderstadt KM, McLaughlin RM, Wright DC, Walker SE, Gomez- Sanchez CE. 2000. The effect of chronic food and water restriction on open- field behaviour and serum corticosterone levels in rats. Lab Anim 34:20-28. Hendriksen CFM, Steen B. 2000. Refinement of vaccine potency testing with the use of humane endpoints. ILAR J 41:105-113. Huerkamp MJ, Gladle MA, Mottet MP, Forde K. 2009. Ergonomic considerations and allergen management. In: Hessler JR, Lerner NMD, eds. Planning and Designing Research Animal Facilities. San Diego: Elsevier. p 115-128. ILAR [Institute for Laboratory Animal Research, National Research Council]. 2000. Humane Endpoints for Animals Used in Biomedical Re- search and Testing. ILAR J 41:59-123. ILAR. 2010. Disaster planning and management. ILAR J 51:101- 192. IRAC [Interagency Research Animal Committee]. 1985. US Gov- ernment Principles for Utilization and Care of Vertebrate Animals Used in Testing, Research, and Training. Federal Register, May 20, 1985. Washing- ton: Office of Science and Technology Policy. Available at http:// oacu.od.nih.gov/regs/USGovtPrncpl.htm; accessed May 10, 2010. Klein HJ, Bayne KA. 2007. Establishing a culture of care, conscience, and responsibility: Addressing the improvement of scientific discovery and
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠99 animal welfare through science based performance standards. ILAR J 48:3- 11. Kreger MD. 1995. Training Materials for Animal Facility Person- nel: AWIC Quick Bibliography Series, 95-08. Beltsville MD: National Ag- ricultural Library. Lassnig C, Kolb A, Strobl B, Enjuanes L, Müller M. 2005. Studying human pathogens in human models: Fine tuning the humanized mouse. Transgenic Res 14:803-806. Laule GE, Bloomsmith MA, Schapiro SJ. 2003. The use of positive reinforcement training techniques to enhance the care, management, and welfare of primates in the laboratory. J Appl Anim Welf Sci 6:163-173. Lowman RP. 2008. The institutional official and postapproval moni- toring: The view from 10,000 feet. ILAR J 49:379-387. Mann MD, Prentice ED. 2004. Should IACUCs review scientific merit of animal research projects? Lab Anim (NY) 33:26-31. McCullough NV. 2000. Personal respiratory protection. In: Fleming DO, Hunt DL, eds. Biological Safety Principles and Practices. Washington: ASM Press. p 383-404. Meunier LD. 2006. Selection, acclimation, training and preparation of dogs for the research setting. ILAR J 47:326-347. Midwest Plan Service. 1987. Structures and Environment Handbook, 11th ed. rev. Ames: Midwest Plan Service, Iowa State University. Miller G. 2007. Science and the public: Animal extremists get per- sonal. Science 318:1856-1858. Moorehead RA, Sanchez OH, Baldwin RM, Khokha R. 2003. Transgenic overexpression of IGF-II induces spontaneous lung tumors: A model for human lung adenocarcinoma. Oncogene 22:853-857. Morton DB. 2000. A systematic approach for establishing humane endpoints. ILAR J 41:80-86. Morton WR, Knitter GH, Smith PV, Susor TG, Schmitt K. 1987. Alternatives to chronic restraint of nonhuman primates. JAVMA 191:1282-1286. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM. 2007. Murine norovirus 1 infection is associated with histopathological changes
100 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® in immunocompetent hosts, but clinical disease is prevented by STAT1- dependent interferon responses. J Virol 81:3251-3263. Newcomer CE. 2002. Hazard identification and control. In: Suckow MA, Douglas FA, Weichbrod RH, eds. Management of Laboratory Animal Care and Use Programs. Boca Raton, FL: CRC Press. p 291-324. NIH [National Institutes of Health]. 2002. Guidelines for Research Involving Recombinant DNA Molecules. April. Available at <http:// oba.od.nih.gov/rdna/nih_guidelines_oba.html>; accessed May 20, 2010. NIH. 2008. Guidelines for the Use of Non-Pharmaceutical-Grade Chemicals/Compounds in Laboratory Animals. Animal Research Advisory Committee, Office of Animal Care and Use, NIH. Available at <http:// oacu.od.nih.gov/ARAC/documents/Pharmaceutical_Compounds>. pdf; ac- cessed May 20, 2010. NIOSH [National Institute for Occupational Safety and Health]. 1997a. Elements of Ergonomics Programs: A Primer Based on Workplace Evaluations of Musculoskeletal Disorders (NIOSH Publication No. 97-117). Cincinnati: NIOSH. p 16-24. NIOSH. 1997b. Musculoskeletal Disorders and Workplace Factors: A Critical Review of Epidemiologic Evidence for Work-Related Muscu- loskeletal Disorders of the Neck, Upper Extremity, and Low Back. Bernard B, ed. Cincinnati: DHHS, PHS, CDDC, NIOSH. p 1-12. NRC [National Research Council]. 1991. Education and Training in the Care and Use of Laboratory Animals: A Guide for Developing Institu- tional Programs. Washington: National Academy Press. NRC. 1997. Occupational Health and Safety in the Care and Use of Research Animals. Washington: National Academy Press. NRC. 2003a. Occupational Health and Safety in the Care and Use of Nonhuman Primates. Washington: National Academies Press. NRC. 2003b. Guidelines for the Care and Use of Mammals in Neu- roscience and Behavioral Research. Washington: National Academies Press. NRC. 2004. Biotechnology Research in an Age of Terrorism. Wash- ington: National Academies Press. OECD [Organisation for Economic Co-operation and Development]. 1999. Guidance Document on Humane Endpoints for Experimental Ani- mals Used in Safety Evaluation Studies. Paris: OECD.
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠101 Olfert ED, Godson DL. 2000. Humane endpoints for infectious dis- ease animal models. ILAR J 41:99-104. OSHA [Occupational Safety and Health Administration]. 1998a. Occupational Safety and Health Standards. Subpart G, Occupational Health and Environmental Controls (29 CFR 1910). Washington: Department of Labor. OSHA. 1998b. Occupational Safety and Health Standards. Subpart Z, Toxic and Hazardous Substances, Bloodborne Pathogens (29 CFR 1910.1030). Washington: Department of Labor. OSHA. 1998c. Occupational Safety and Health Standards. Subpart G, Occupational Health and Environmental Controls, Occupational Noise Exposure (29 CFR 1910.95). Washington: Department of Labor. OSHA. 1998d. Occupational Safety and Health Standards. Subpart I, Personal Protective Equipment, Respiratory Protection (29 CFR 1910.134). Washington: Department of Labor. Paster EV, Villines KA, Hickman DL. 2009. Endpoints for mouse abdominal tumor models: Refinement of current criteria. Comp Med 59:234- 241. PHS [Public Health Service]. 2002. Public Health Service Policy on Humane Care and Use of Laboratory Animals. Department of Health and Human Services, National Institutes of Health, Office of Laboratory Ani- mal Welfare. Available at <http://grants.nih.gov/grants/> olaw/references/ phspol.htm; accessed January 14, 2010. PL [Public Law] 104-191. 1996. Health Insurance Portability and Accountability Act (HIPAA) of 1996. Washington: Government Printing Office. PL 107-56. 2001. Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (USA PA- TRIOT) Act of 2001. Washington: Government Printing Office. October 26. PL 107-188. 2002. Public Health Security and Bioterrorism Prepared- ness and Response Act of 2002. Washington: Government Printing Office. June 12. Plante A, James ML. 2008. Program oversight enhancements (POE): The big PAM. ILAR J 49:419-425.
102 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® Prescott MJ, Buchanan-Smith HM. 2003. Training nonhuman pri- mates using positive reinforcement techniques. J Appl Anim Welf Sci 6:157- 161. Pritt S, Duffee N. 2007. Training strategies for animal care techni- cians and veterinary technical staff. ILAR J 48:109-119. Reeb-Whitaker CK, Harrison, DJ, Jones RB, Kacergis JB, Myers DD, Paigen B. 1999. Control strategies for aeroallergens in an animal facil- ity. J Allergy Clin Immunol 103:139-146. Reinhardt V. 1991. Training adult male rhesus monkeys to actively cooperate during inhomecage venipuncture. Anim Technol 42:11-17. Reinhardt V. 1995. Restraint methods of laboratory non-human pri- mates: A critical review. Anim Welf 4:221-238. Richmond JY, Hill RH, Weyant RS, Nesby-OâDell SL, Vinson PE. 2003. Whatâs hot in animal biosafety? ILAR J 44:20-27. Rowland NE. 2007. Food or fluid restriction in common laboratory animals: Balancing welfare considerations with scientific inquiry. Comp Med 57:149-160. Sargent EV, Gallo F. 2003. Use of personal protective equipment for respiratory protection. ILAR J 44:52-56. Sass N. 2000. Humane endpoints and acute toxicity testing. ILAR J 41:114-123. Sauceda R, Schmidt MG. 2000. Refining macaque handling and re- straint techniques. Lab Anim 29:47-49. Schweitzer IB, Smith E, Harrison DJ, Myers DD, Eggleston PA, Stockwell JD, Paigen B, Smith AL. 2003. Reducing exposure to laboratory animal allergens. Comp Med 53:487-492. Seward JP. 2001. Medical surveillance of allergy in laboratory ani- mal handlers. ILAR J 42:47-54. Silverman J, Sukow MA, Murthy S, eds. 2007. The IACUC Handbook, 2nd ed. Boca Raton, FL: CRC Press. Stokes WS. 2000. Reducing unrelieved pain and distress in labora- tory animals using humane endpoints. ILAR J 41:59-61. Stokes WS. 2002. Humane endpoints for laboratory animals used in regulatory testing. ILAR J 43:S31-S38. Stricklin WR, Mench JA. 1994. Oversight of the use of agricultural
MôÆ°Šðó£ñKŠ¹, ðò¡ð£â Â´Ë Fâ ì⹠103 animals in university teaching and research. ILAR News 36:9-14. Stricklin WR, Purcell D, Mench JA. 1990. Farm animals in agricul- tural and biomedical research. In: The Well-Being of Agricultural Animals in Biomedical and Agricultural Research: Proceedings from a SCAW-Spon- sored Conference, September 6-7. Washington: Scientists Center for Ani- mal Welfare. p 1-4. Thomann WR. 2003. Chemical safety in animal care, use, and re- search. ILAR J 44:13-19. Thulin H, Bjorkdahl M, Karlsson AS, Renstrom A. 2002. Reduction of exposure to laboratory animal allergens in a research laboratory. Ann Occup Hyg 46:61-68. Tillman P. 1994. Integrating agricultural and biomedical research policies: Conflicts and opportunities. ILAR News 36:29-35. Toth LA. 1997. The moribund state as an experimental endpoint. Contemp Top Lab Anim Sci 36:44-48. Toth LA. 2000. Defining the moribund condition as an experimental endpoint for animal research. ILAR J 41:72-79. Toth LA, Gardiner TW. 2000. Food and water restriction protocols: Physiological and behavioral considerations. Contemp Top Lab Anim Sci 39:9-17. UKCCCR [United Kingdom Coordinating Committee on Cancer Research]. 1997. Guidelines for the Welfare of Animals in Experimental Neoplasia, 2nd ed. London: UKCCCR. USC [United States Code]. Title 42, Chapter 6a, Subchapter III, Part H, Section 289d: Animals in Research. Available at <http://uscode.house.gov/ download/pls/42CGA.txt>. USDA [US Department of Agriculture]. 1985. 9 CFR 1A. (Title 9, Chapter 1, Subchapter A): Animal Welfare. Available at http:// e c f r. g p o a c c e s s . g o v / c g i / t / t e x t / t e x t - i d x ? s i d = 8 3 1 4 3 1 3 b d 7adf2c9f1964e2d82a88d92andc=ecfrandtpl=/ecfrbrowse/Title09/ 9cfrv1_02.tpl; accessed January 14, 2010. USDA. 1997a. APHIS Policy #14, âMultiple Survival Surgery: Single vs. Multiple Proceduresâ (April 14). Available at www.aphis.usda.gov/ animal_welfare/downloads/policy/policy14 <http://www.aphis.usda.gov/
104 ÃÅõè MôÆ°è¬÷Š«ðµî⢠ñŸÃ⹠ðò¡ð£â ®Ÿè£ù õNè£â ® animal_welfare/downloads/policy/policy14>. pdf; accessed January 4, 2010. USDA. 1997b. APHIS Policy #3, âVeterinary Careâ (July 17). Avail- able at www.aphis.usda <http://www.aphis.usda>. gov/animal_welfare/ downloads/policy/policy3.pdf; accessed January 9, 2010. USDA. 2002. Facilities Design Standards. Manual 242.1. Available at www.afm.ars.usda <http://www.afm.ars.usda>. gov/ppweb/PDF/242- 01M.pdf; accessed May 10, 2010. Van Sluyters RC. 2008. A guide to risk assessment in animal care and use programs: The metaphor of the 3-legged stool. ILAR J 49:372-378. Yeates JW, Main DCJ. 2009. Assesment of positive welfare: A re- view. Vet Rev 175:293-300. Vogelweid CM. 1998. Developing emergency management plans for university laboratory animal programs and facilities. Contemp Top Lab Anim Sci 37:52-56. Wallace J. 2000. Humane endpoints and cancer research. ILAR J 41:87-93. Wolff A, Garnett N, Potkay S, Wigglesworth C, Doyle D, Thornton, D. 2003. Frequently asked questions about the Public Health Service Policy on Humane Care and Use of Laboratory Animals. Lab Anim 32(9):33-36. Wolfle TL, Bush RK. 2001. The science and pervasiveness of labo- ratory animal allergy. ILAR J 42:1-3. Wood RA. 2001. Laboratory animal allergens. ILAR J 42:12-16.